Processing 00000000.tx.1: Age- and Stage-dependent Accumulation of Advanced Glycation End Products in Intracellular Deposits in Normal and Alzheimer's Disease Brains Hans-Joachim Lth1, Vera Ogunlade2, Bjrn Kuhla3, Rosemarie Kientsch-Engel4, Peter Stahl4, Julie Webster5, Thomas Arendt1 and Gerald Mnch3 1 Department of Neuroanatomy, Paul Flechsig Institute of Brain Research, University of Leipzig, Jahnallee 59, 04109 Leipzig, Germany, 2 Department of Neuropathology, Institute of Pathology, University of Leipzig, Liebigstrasse 26, 04103 Leipzig, Germany, 3 Neuroimmunological Cell Biology Unit, IZKF Leipzig, Inselstrasse 22, 04103 Leipzig, Germany, 4 Roche Diagnostics GmbH, 82372 Penzberg, Germany and 5 Comparative Genomics Centre, James Cook University, Townsville 4811, Australia  Abstract Top Abstract Introduction Material and Methods Results Discussion References  In this immunohistochemical study, the age- and stage-dependent accumulation of advanced glycation end-products (AGEs) in Alzheimer's disease (AD) and their relation to the formation of neurofibrillary tangles and neuronal cell death was investigated. 

Phrase: "Age-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "Stage-dependent Accumulation of Advanced Glycation End Products"

Phrase: "in Intracellular Deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "in Normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "Alzheimer's Disease Brains Hans-Joachim Lth1,"

Phrase: "Vera Ogunlade2,"

Phrase: "Bjrn Kuhla3,"

Phrase: "Rosemarie Kientsch-Engel4,"

Phrase: "Peter Stahl4,"

Phrase: "Julie Webster5,"

Phrase: "Thomas Arendt1"

Phrase: "and"

Phrase: "Gerald Mnch3 1 Department of Neuroanatomy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "Paul Flechsig Institute of Brain Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0035172:Research Institute [Organization]
   753   C0021622:institute [Organization]
   753   C1272753:Institute [Idea or Concept]

Phrase: "University of Leipzig,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Jahnallee 59,"

Phrase: "04109 Leipzig,"

Phrase: "Germany,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "2 Department of Neuropathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587493:Neuropathology department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "Institute of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021622:institute [Organization]
   790   C1272753:Institute [Idea or Concept]

Phrase: "University of Leipzig,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Liebigstrasse 26,"

Phrase: "04103 Leipzig,"

Phrase: "Germany,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "3 Neuroimmunological Cell Biology Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0439148:Unit [Quantitative Concept]
   804   C1519795:Unit [Quantitative Concept]
   804   C1704753:Unit [Manufactured Object]
   804   C1880519:Unit [Quantitative Concept]

Phrase: "IZKF Leipzig,"

Phrase: "Inselstrasse 22,"

Phrase: "04103 Leipzig,"

Phrase: "Germany,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "4 Roche Diagnostics GmbH,"

Phrase: "82372 Penzberg,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "and"

Phrase: "5 Comparative Genomics Centre,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205099:Center [Spatial Concept]

Phrase: "James Cook University,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0335326:Cook [Daily or Recreational Activity]
   827   C1306756:Cook [Professional or Occupational Group]

Phrase: "Townsville 4811,"

Phrase: "Australia  Abstract Top Abstract Introduction Material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Material [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References  In this immunohistochemical study,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C2985663:Study Reference [Intellectual Product]
   760   C0557651:Study [Manufactured Object]
   760   C1441616:Immunohistochemical [Laboratory Procedure]
   760   C1514811:Reference [Idea or Concept]
   760   C1706462:Reference [Conceptual Entity]
   760   C2603343:Study [Research Activity]

Phrase: "the age-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "stage-dependent accumulation of advanced glycation end-products (AGEs)"

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)"

Phrase: "and"

Phrase: "their relation to the formation of neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0080103:Relation [Family Group]
   744   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "neuronal cell death"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C2754100:neuronal cell death [Cell Function]
           neuron death
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.2: For this purpose, the distribution of AGEs in neurons and glia was analyzed in the auditory association area of superior temporal gyrus (Brodmann area 22) of young and old non-demented controls and compared with early- and late-stage AD. 

Phrase: "For this purpose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "the distribution of AGEs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0680977:product distribution [Functional Concept]
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "glia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027836:Glia [Cell]
  1000   C1087003:Glia [Plant]

Phrase: "was"

Phrase: "analyzed in the auditory association area of superior temporal gyrus"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   782   C0152309:Superior temporal gyrus [Body Part, Organ, or Organ Component]
   777   C2322884:Superior temporal area [Body Location or Region]
   760   C0228234:Temporal gyrus [Body Part, Organ, or Organ Component]
   760   C0458311:Temporal gyrus [Body Part, Organ, or Organ Component]
   757   C0004302:Auditory area [Body Part, Organ, or Organ Component]
   757   C1276856:Auditory area [Organ or Tissue Function]
   739   C0004083:Association [Mental Process]
   739   C0017446:Area [Geographic Area]
   739   C0205146:Area [Spatial Concept]
   739   C0439825:Auditory [Functional Concept]
   739   C0439849:Association [Qualitative Concept]
   739   C0442043:Temporal [Spatial Concept]
   739   C0596306:Association [Phenomenon or Process]
   739   C0699792:association [Social Behavior]
   739   C0936012:Analyzed [Research Activity]
   739   C1282910:Superior [Spatial Concept]
   739   C2362314:Temporal [Temporal Concept]

Phrase: "(Brodmann area 22"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1272540:Brodmann area 22 [Body Part, Organ, or Organ Component]
  1000   C2322884:Brodmann area 22 [Body Location or Region]
   901   C0599720:Brodmann area [Body Location or Region]
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]

Phrase: ")"

Phrase: "of young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "and"

Phrase: "old non-demented controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0243148:control [Qualitative Concept]
   779   C1550141:Control [Substance]
   779   C1882979:Control [Conceptual Entity]
   779   C2587213:Control [Functional Concept]
   779   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "compared with early-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1279919:Early [Temporal Concept]
   790   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "late-stage AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1279941:Late stage [Temporal Concept]
Processing 00000000.tx.3: A possible co-localization of AGEs with typical hallmarks of AD, such as hyperphosphorylated tau (as a marker for disturbed kinase/phosphatase activity), nNOS (as a marker for nitroxidative stress) and caspase-3 (as a marker of apoptotic cell death), was also investigated. 

Phrase: "A possible co-localization of AGEs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]

Phrase: "with typical hallmarks"

Phrase: "of AD,"

Phrase: "such as hyperphosphorylated tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "("

Phrase: "as a marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005516:Marker [Clinical Attribute]

Phrase: "for disturbed kinase/phosphatase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C1150423:kinase activity [Molecular Function]
   861   C1149880:phosphatase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "nNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417759:nNOS [Gene or Genome]

Phrase: "("

Phrase: "as a marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005516:Marker [Clinical Attribute]

Phrase: "for nitroxidative stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "as a marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005516:Marker [Clinical Attribute]

Phrase: "of apoptotic cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:apoptotic cell death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "also"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.4: Our results show that the percentage of AGE-positive neurons (and astroglia) increase both with age and, in AD patients, with the progression of the disease (Braak stages). 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the percentage of AGE-positive neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "("

Phrase: "and"

Phrase: "astroglia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astroglia [Cell]

Phrase: ")"

Phrase: "increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "both with age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001779:Age [Organism Attribute]
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "in AD patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with the progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242656:progression [Pathologic Function]
  1000   C0449258:Progression [Functional Concept]

Phrase: "of the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "(Braak stages"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.5: Interestingly, nearly all if those neurons which show diffuse cytosolic AGE immunoreactivity also contain hyperphosphoryated tau, suggesting a link between AGE accumulation and the formation of early neurofibrillary tangles. 

Phrase: "Interestingly,"

Phrase: "nearly"

Phrase: "all"

Phrase: "if"

Phrase: "those neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "which"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "diffuse cytosolic AGE immunoreactivity also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0597879:immunoreactivity [Molecular Function]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "hyperphosphoryated tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a link between AGE accumulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1517892:Link [Intellectual Product]
   760   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "the formation of early neurofibrillary tangles."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
Processing 00000000.tx.6: Many, but not all, neurons show a co-localization of AGEs with other markers of neurodegeneration, such as nNOS and caspase-3. 

Phrase: "Many,"

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all,"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a co-localization of AGEs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]

Phrase: "with other markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0005516:Marker [Clinical Attribute]

Phrase: "of neurodegeneration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "such as nNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417759:nNOS [Gene or Genome]

Phrase: "and"

Phrase: "caspase-3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.7: Key Words: advanced glycation endproducts  Alzheimer's disease  Braak stages  neurofibrillary tangles  nitric oxide  Introduction Top Abstract Introduction Material and Methods Results Discussion References  Alzheimer's disease (AD) is a neurodegenerative disease that affects a growing proportion of the elderly population. 

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "advanced glycation endproducts  Alzheimer's disease  Braak stages  neurofibrillary tangles  nitric oxide  Introduction Top Abstract Introduction Material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   785   C0520510:Material [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)"

Phrase: "is"

Phrase: "a neurodegenerative disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "that"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "a growing proportion of the elderly population."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709707:Proportion [Quantitative Concept]
Processing 00000000.tx.8: The clinical manifestation of this age-related neurodegenerative disease is gradual onset with progressive memory loss and cognitive dysfunction. 

Phrase: "The clinical manifestation of this age-related neurodegenerative disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1280464:Manifestation of [Qualitative Concept]
           manifestation
   742   C0205319:manifestation [Functional Concept]

Phrase: "is"

Phrase: "gradual onset with progressive memory loss"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332164:Gradual onset [Qualitative Concept]
   753   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "cognitive dysfunction."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0338656:Cognitive dysfunction [Mental or Behavioral Dysfunction]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.9: The histological hallmarks of AD include widespread neuronal cell death and the formation of neurofibrillary tangles (NFTs) and amyloid plaques. 

Phrase: "The histological hallmarks of AD"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "widespread neuronal cell death"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C2754100:neuronal cell death [Cell Function]
           neuron death
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the formation of neurofibrillary tangles (NFTs)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "amyloid plaques."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
  1000   C2936349:Plaques, Amyloid [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
Processing 00000000.tx.10: NFTs show a hierarchical spreading pattern from the allocortex to isocortical association areas with the early involvement of the entorhinal region, a major relay station between the hippocampus and isocortex (Braak and Braak, 1991). 

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a hierarchical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0699032:Hierarchy [Functional Concept]

Phrase: "spreading"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332261:Spreading [Qualitative Concept]
   966 E C1947932:Spread [Activity]

Phrase: "pattern from the allocortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Pattern [Spatial Concept]

Phrase: "to isocortical association areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0205146:areas [Spatial Concept]
   793 E C0017446:Area [Geographic Area]

Phrase: "with the early involvement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1314939:Involvement [Functional Concept]

Phrase: "of the entorhinal region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "a major relay station between the hippocampus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883167:Station [Manufactured Object]

Phrase: "and"

Phrase: "isocortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175173:Isocortex [Body Part, Organ, or Organ Component]

Phrase: "(Braak"

Phrase: "and"

Phrase: "Braak,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.11: NFTs consist mainly of abnormally phosphorylated tau protein (Braak et al., 1993). 

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "consist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332529:CONSIST [Qualitative Concept]

Phrase: "mainly of abnormally phosphorylated tau protein"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C2827507:Phosphorylated Tau Protein [Laboratory Procedure]
   790   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   783 E C1421563:protein tau [Gene or Genome]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "(Braak et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.12: Tau can be phosphorylated at many sites and by several kinases, e.g. mitogen-activated protein kinase (MAPK), glycogen synthase kinase 3 (GSK-3), cyclin-dependent kinase 5 (cdk5) and JNK/p38 (Atzori et al., 2001; Otth et al., 2002; Pei et al., 2002). 

Phrase: "Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "can"

Phrase: "be"

Phrase: "phosphorylated at many sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205145:Sites [Spatial Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "and by several kinases,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1515981:And [Idea or Concept]

Phrase: "e.g. mitogen-activated protein kinase (MAPK),"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026249:Mitogen [Pharmacologic Substance]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1879547:Activated [Activity]
   779 E C1515877:Activate [Functional Concept]

Phrase: "glycogen synthase kinase 3 (GSK-3),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cyclin-dependent kinase 5 (cdk5)"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0249586:Cyclin-Dependent Kinase 5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CYCLIN-DEPENDENT KINASE 5 [Gene or Genome]
   923   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1150565:cyclin [Molecular Function]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "JNK/p38"

Phrase: "(Atzori et al.,"

Phrase: "2001"

Phrase: "; Otth et al.,"

Phrase: "2002"

Phrase: "; Pei et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.13: Nineteen phosphorylated sites have been identified with most localized to the amino- and carboxyl-terminal flanking regions of the microtubule-binding domain (Reynolds et al., 2000). 

Phrase: "Nineteen phosphorylated sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified with most"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "localized to the amino-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392752:Localized [Spatial Concept]

Phrase: "and"

Phrase: "carboxyl-terminal flanking regions of the microtubule-binding domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C1183338:Region of microtubule [Cell Component]
           Microtubule region
   742   C0230171:flanking [Body Location or Region]
   708   C0017446:Region [Geographic Area]
   708   C0205147:Region [Spatial Concept]

Phrase: "(Reynolds et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.14: NFTs go through three different stages of development: stage 1, pre-NFT; 

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "go through three different stages of development"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   748   C0205449:Three [Quantitative Concept]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1306673:Stages [Qualitative Concept]
   748   C1527148:Development [Functional Concept]
   748   C1705242:Different [Qualitative Concept]
   748   C1822658:GO [Gene or Genome]
   738   C0870411:Developmental stages [Temporal Concept]
   714 E C0205390:Stage [Temporal Concept]
   714 E C1300072:Stage [Clinical Attribute]

Phrase: ":"

Phrase: "stage 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441766:Stage 1 [Intellectual Product]
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]

Phrase: "pre-NFT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085400:NFT [Acquired Abnormality]

Phrase: ";"
Processing 00000000.tx.15: stage 2, intra-neuronal NFTs; 

Phrase: "stage 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441767:Stage 2 [Intellectual Product]
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]

Phrase: "intra-neuronal NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   827 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: ";"
Processing 00000000.tx.16: and stage 3, extra-neuronal NFTs, with possibly all present simultaneously in the brain of a patient in one stage of the AD (Augustinack et al., 2002). 

Phrase: "and"

Phrase: "stage 3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441771:Stage 3 [Intellectual Product]
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]

Phrase: "extra-neuronal NFTs,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   827 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "with possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "all"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "simultaneously in the brain of a patient"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0030705:*^patient [Patient or Disabled Group]
   748   C0521115:simultaneously [Temporal Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in one stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]

Phrase: "of the AD (Augustinack et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.17: Senile plaques (SP) are complicated lesions composed of amyloid peptides, plaque-associated molecules and degenerating neuronal processes (Braak et al., 1989). 

Phrase: "Senile plaques (SP)"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "are"

Phrase: "complicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231242:Complicated [Functional Concept]

Phrase: "lesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0221198:lesions [Finding]
   966 E C1546698:Lesion [Intellectual Product]

Phrase: "composed of amyloid peptides,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "plaque-associated molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "and"

Phrase: "degenerating neuronal processes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   848   C0085103:neuron process [Cell Component]
   793   C1184743:Process [Body Part, Organ, or Organ Component]
   793   C1522240:Process [Phenomenon or Process]

Phrase: "(Braak et al.,"

Phrase: "1989"

Phrase: ")."
Processing 00000000.tx.18: Diffuse amyloid deposits evolve over time with formation of discrete seeds that eventually become neuritic SP. 

Phrase: "Diffuse amyloid deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936349:Amyloid Deposits [Acquired Abnormality]
   827   C0333562:Deposits [Functional Concept]

Phrase: "evolve over time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0040223:Time [Temporal Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "with formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of discrete seeds"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0036563:Seed [Plant]
   861   C1705192:Seed [Laboratory Procedure]
   861   C1882540:{Seed} [Quantitative Concept]
   861   C2346495:Seed [Conceptual Entity]
   805 E C1519232:Seminal [Clinical Attribute]

Phrase: "that eventually"

Phrase: "become"

Phrase: "neuritic SP."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   913   C0333463:Neuritic Plaques [Acquired Abnormality]
           Senile Plaques
           plaques
   827   C0392079:Senile [Finding]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
   771 E C0231337:Old age [Finding]
   771 E C1999167:Old age [Population Group]
Processing 00000000.tx.19: In response to interaction with amyloid peptides and other pro-inflammatory factors, microglia and astrocytes produce a number of molecules that may be locally toxic to neuronal processes in the vicinity of SP (Lue et al., 2001). 

Phrase: "In response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "with amyloid peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "other pro-inflammatory factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "microglia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206116:Microglia [Cell]
   928 E C0521398:Microglial [Body Location or Region]

Phrase: "and"

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "produce"

Phrase: "a number of molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "locally toxic to neuronal processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0600688:toxic [Injury or Poisoning]
   760   C1407029:Toxic [Qualitative Concept]

Phrase: "in the vicinity"

Phrase: "of SP"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "(Lue et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.20: This includes cytokines, reactive oxygen and nitrogen intermediates, and proteases (Gasic-Milenkovic et al., 2003). 

Phrase: "This"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "cytokines,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "reactive oxygen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "nitrogen intermediates,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205103:Intermediate [Spatial Concept]
   827   C1550465:intermediate [Idea or Concept]
   827   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: "(Gasic-Milenkovic et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.21: Advanced glycation end-products (AGEs), derived from the reaction of reactive carbonyl- or dicarbonyl compounds with lysine or arginine groups on proteins (Mnch et al., 1999), are present in -amyloid plaques and NFTs (Wong et al., 2001; Reddy et al., 2002). 

Phrase: "Advanced glycation end-products"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "(AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "derived from the reaction of reactive carbonyl-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205332:Reactive [Qualitative Concept]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1441547:Derived [Qualitative Concept]
   748   C3245521:derived [Idea or Concept]

Phrase: "or"

Phrase: "dicarbonyl compounds with lysine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0205198:Compound [Qualitative Concept]
   737   C1706082:Compound [Chemical]

Phrase: "or"

Phrase: "arginine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "groups on proteins"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0441833:Group [Idea or Concept]
   790   C0687744:group [Population Group]
   790   C1257890:Group [Population Group]
   790   C1552516:Group [Health Care Related Organization]
   790   C1552839:groups [Idea or Concept]
   790   C1705428:Group [Conceptual Entity]
   790   C1705429:Group [Population Group]

Phrase: "(Mnch et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "are"

Phrase: "present in -amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   861   C2936349:Plaques, Amyloid [Acquired Abnormality]
   779 E C0011389:Plaque [Disease or Syndrome]
   779 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(Wong et al.,"

Phrase: "2001"

Phrase: "; Reddy et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.22: The first description of AGE in AD dates back to 1994, when it was demonstrated that plaque fractions of brains of AD patients contain higher levels of AGEs than age-matched control brains (Vitek et al., 1994). 

Phrase: "The first description of AGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678257:Description [Idea or Concept]

Phrase: "in AD"

Phrase: "dates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "back to 1994,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004600:Back [Body Location or Region]
   790   C0205095:Back [Spatial Concept]
   790   C0460009:Back [Body Location or Region]
   790   C1995000:Back [Body Location or Region]

Phrase: "when"

Phrase: "it"

Phrase: "was"

Phrase: "demonstrated"

Phrase: "that plaque fractions of brains of AD patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   754   C1264633:Fraction of [Quantitative Concept]
           Fractions
   711 E C1554103:Fraction [Idea or Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "higher levels of AGEs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "than age-matched control brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0006104:Brains [Body Part, Organ, or Organ Component]
   779 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Vitek et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.23: In a further study, the presence of AGE in NFTs and senile plaques has been elegantly demonstated by immunohistochemical methods using antibodies specific for the defined AGEs pyrraline and pentosidine (Smith et al., 1994). 

Phrase: "In a further study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "the presence of AGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "has"

Phrase: "been"

Phrase: "elegantly demonstated by immunohistochemical methods"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific for the defined AGEs pyrraline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205369:Specific [Qualitative Concept]
   742   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "pentosidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070317:pentosidine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(Smith et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.24: Although some authors have suggested that AGEs are very late markers (tombstones) of the disease (Mattson et al., 1995), it now widely accepted that they are active participants in the progression of the disease by rendering modified protein deposits insoluble and undegradeable, and by activating or enhancing the inflammatory response (Smith et al., 1995). 

Phrase: "Although"

Phrase: "some authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "are"

Phrase: "very late markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0005516:Marker [Clinical Attribute]

Phrase: "(tombstones"

Phrase: ")"

Phrase: "of the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "(Mattson et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: ","

Phrase: "it now widely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1948052:Now [Temporal Concept]

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "that"

Phrase: "they"

Phrase: "are"

Phrase: "active participants in the progression of the disease"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0679646:participants [Population Group]
   711 E C2698741:Participant [Classification]

Phrase: "by rendering modified protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposit [Functional Concept]

Phrase: "insoluble"

Phrase: "and"

Phrase: "undegradeable,"

Phrase: "and by activating"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1515981:And [Idea or Concept]
   790   C1879547:activating [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "or"

Phrase: "enhancing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2349975:Enhance [Activity]

Phrase: "the inflammatory response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1155266:Inflammatory Response [Pathologic Function]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "(Smith et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.25: In a further histochemical study, most senile plaques (including diffuse plaques) and cerebral amyloid angiopathy (CAA) from Alzheimer's brains have been shown to exhibit AGE and ApoE immunoreactivity together. 

Phrase: "In a further histochemical study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "most senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "diffuse plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333463:plaques [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "cerebral amyloid angiopathy (CAA) from Alzheimer's brains"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0085220:Cerebral Amyloid Angiopathy [Disease or Syndrome]
   790   C2931784:Amyloid angiopathy [Disease or Syndrome]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0042373:Angiopathy [Disease or Syndrome]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "AGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "ApoE immunoreactivity together."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]
Processing 00000000.tx.26: Interestingly, 5% of plaques were AGE-positive but -amyloid (A)-negative. 

Phrase: "Interestingly,"

Phrase: "5% of plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0333463:plaques [Acquired Abnormality]
   790   C0439084:>5 [Quantitative Concept]
   790   C0728893:+5 [Quantitative Concept]
   756 E C0011389:Plaque [Disease or Syndrome]
   756 E C0332461:Plaque [Finding]

Phrase: "were"

Phrase: "AGE-positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]

Phrase: "but -"

Phrase: "amyloid (A)-negative."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.27: When the authors looked at NFTs, they found that AGEs were mainly present in intracellular NFTs, whereas ApoE was mainly present in extracellular NFTs (Sasaki et al., 1998). 

Phrase: "When"

Phrase: "the authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "looked at NFTs,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   799 E C3543859:neurofibrillary tangle [Cell Component]
   737   C0233426:look [Organism Attribute]

Phrase: "they"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "were"

Phrase: "mainly"

Phrase: "present in intracellular NFTs,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   773 E C3543859:neurofibrillary tangle [Cell Component]
   760   C0150312:Present [Quantitative Concept]
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "whereas"

Phrase: "ApoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "was"

Phrase: "mainly"

Phrase: "present in extracellular NFTs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   773 E C3543859:neurofibrillary tangle [Cell Component]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0521119:Extracellular [Cell Component]

Phrase: "(Sasaki et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.28: Moreover, when AGEs immunoreactivitiy was compared in tau of normal brains, preparations of soluble PHF-tau as well as insoluble PHF from AD brains, all three principal tau components showed AGE immunoreactivity in Western blots indicating that tau is glycated in PHF-tau. 

Phrase: "Moreover,"

Phrase: "when"

Phrase: "AGEs immunoreactivitiy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "was"

Phrase: "compared in tau of normal brains,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C1707455:Compared [Activity]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]
   753   C2347086:% Normal [Quantitative Concept]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "preparations of soluble PHF-tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0455052:Preparation [Health Care Activity]
   726   C1521827:Preparation [Functional Concept]

Phrase: "as well as"

Phrase: "insoluble PHF from AD brains,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597162:PHF [Cell or Molecular Dysfunction]

Phrase: "all three principal tau components"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   858   C1882460:Principal Component [Quantitative Concept]
   812   C0449432:Components [Manufactured Object]
   779 E C1705248:Component [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "AGE immunoreactivity in Western blots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597879:immunoreactivity [Molecular Function]

Phrase: "indicating"

Phrase: "that tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "is"

Phrase: "glycated in PHF-tau."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2700455:PHF-Tau [Amino Acid, Peptide, or Protein]
   770   C0597162:PHF [Cell or Molecular Dysfunction]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
Processing 00000000.tx.29: Moreover, immunoelectron microscopic analyses indicate that a CML antibody labels predominantly PHF in aggregates. 

Phrase: "Moreover,"

Phrase: "immunoelectron microscopic analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "indicate"

Phrase: "that"

Phrase: "a CML antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "labels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181496:Label [Manufactured Object]
  1000   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "predominantly PHF in aggregates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597162:PHF [Cell or Molecular Dysfunction]
Processing 00000000.tx.30: Taken together, these results sugges that tau becomes AGE-modified in PHF-tau and that this is contributing to tangle formation in AD (Ko et al., 1999). 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results sugges"

Phrase: "that tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "becomes"

Phrase: "AGE-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "modified in PHF-tau"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2700455:PHF-Tau [Amino Acid, Peptide, or Protein]
   770   C0392747:Modified [Functional Concept]
   770   C0597162:PHF [Cell or Molecular Dysfunction]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "that"

Phrase: "this"

Phrase: "is"

Phrase: "contributing to tangle formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
   770   C1880177:Contributing [Activity]

Phrase: "in AD (Ko et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.31: In a further study, granules positive for A, AGE and RAGE (one of the AGE receptors) were identified in the perikaryon of hippocampal neurons (especially from CA3 and CA4) in healthy and AD subjects. 

Phrase: "In a further study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "granules positive for A,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]

Phrase: "AGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "RAGE (one of the AGE receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "identified in the perikaryon of hippocampal neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   748   C0027882:Neurons [Cell]
   748   C0205396:Identified [Qualitative Concept]
   748   C0599444:Perikaryon [Cell Component]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]

Phrase: "(especially from CA3"

Phrase: "and"

Phrase: "CA4"

Phrase: ")"

Phrase: "in healthy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0018684:Health [Idea or Concept]
   928   C0031206:healthiness [Finding]

Phrase: "and"

Phrase: "AD subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.32: Interestingly, A-, AGE- and RAGE-positive granules were co-localized in one part of a single astrocyte, which led the authors to the conclusion that glycated A is taken up via RAGE and is degraded through the lysosomal pathway in astrocytes (Sasaki et al., 2001). 

Phrase: "Interestingly,"

Phrase: "A-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "AGE-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "RAGE-positive granules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0010837:Granules [Cell Component]
   827   C0993609:Granules [Biomedical or Dental Material]
   743 E C0205248:Granular [Qualitative Concept]

Phrase: "were"

Phrase: "co-localized in one part of a single astrocyte,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C1292711:Part of [Spatial Concept]
   742   C0004112:Astrocyte [Cell]
   742   C0037179:Single [Population Group]
   742   C0087136:single [Finding]
   742   C0205171:Single [Quantitative Concept]
   742   C0205447:One [Quantitative Concept]
   742   C0392752:Localized [Spatial Concept]
   742   C0449719:Part [Spatial Concept]
   742   C1709471:Part [Quantitative Concept]

Phrase: "which"

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "the authors to the conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0221193:Authors [Professional or Occupational Group]

Phrase: "that glycated A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "via RAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034634:Rage [Mental Process]
  1000   C3539760:RAGE [Gene or Genome]

Phrase: "and"

Phrase: "is"

Phrase: "degraded through the lysosomal pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0521450:Lysosomal [Body Location or Region]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
   760   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "in astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "(Sasaki et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.33: It has been suggested that formation of AGE cross-links in these AD-specific lesions is an early step in seed formation similar to that found for Lewy bodies (Mnch et al., 2000). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that formation of AGE cross-links"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "in these AD-specific lesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0221198:lesions [Finding]
   793 E C1546698:Lesion [Intellectual Product]

Phrase: "is"

Phrase: "an early step in seed formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0220781:formation [Biologic Function]
   804   C0439634:formation [Spatial Concept]
   804   C1522492:Formation [Functional Concept]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "found for Lewy bodies"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0150312:Found [Quantitative Concept]
   770   C0242821:bodies [Human]
   770   C1995017:Bodies [Cell Component]
   737 E C0243095:Find [Finding]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "(Mnch et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.34: AGE cross-linking also contributes to the insolubility and protease-resistance of such deposits (Bulteau et al., 2001; Sebekova et al., 1998). 

Phrase: "AGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "also"

Phrase: "contributes to the insolubility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880177:Contribute [Activity]

Phrase: "and"

Phrase: "protease-resistance of such deposits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]

Phrase: "(Bulteau et al.,"

Phrase: "2001"

Phrase: "; Sebekova et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.35: Cell culture experiments have demonstrated that AGEs exert direct toxicity to cells through predominantly apoptotic mechanisms (Artwohl et al., 2003; Kaji et al., 2003; Takeuchi et al., 2003). 

Phrase: "Cell culture experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0007585:Cell Culture [Laboratory Procedure]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "direct toxicity to cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "through predominantly apoptotic mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "(Artwohl et al.,"

Phrase: "2003"

Phrase: "; Kaji et al.,"

Phrase: "2003"

Phrase: "; Takeuchi et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.36: Furthermore, it was shown in retinal neurons that apoptosis induced by the AGE precursor glyoxal was mediated by activation of caspase-3 (Reber et al., 2003). 

Phrase: "Furthermore,"

Phrase: "it"

Phrase: "was"

Phrase: "shown in retinal neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2350331:Retinal Neurons [Cell]
   770   C0027882:Neurons [Cell]
   770   C0035298:Retinal [Body Part, Organ, or Organ Component]
   737   C1547282:Show [Intellectual Product]

Phrase: "that apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "induced by the AGE precursor glyoxal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0001779:Age [Organism Attribute]
   753   C0017992:Glyoxal [Organic Chemical,Pharmacologic Substance]
   753   C0205263:Induced [Functional Concept]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "mediated by activation of caspase-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   783   C1159825:Caspase Activation [Molecular Function]
   753   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C1879547:Activation [Activity]

Phrase: "(Reber et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.37: Some but not all studies suggest that neuronal death in AD is the result of an apoptotic mechanism (Jellinger and Stadelmann, 2001; Roth, 2001). 

Phrase: "Some"

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that neuronal death in AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C2754100:neuron death [Cell Function]
   760   C0011065:Death [Organism Function]
   760   C1306577:Death, NOS [Finding]

Phrase: "is"

Phrase: "the result of an apoptotic mechanism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "(Jellinger"

Phrase: "and"

Phrase: "Stadelmann,"

Phrase: "2001"

Phrase: "; Roth,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.38: However, the stereotypical manifestations that define the terminal phases of apoptosis, such as chromatin condensation, apoptotic bodies, and blebbing, are rarely seen in AD, but activated caspases, including caspase-3, are sometimes found in association degenerating neurons in AD (Gastard et al., 2003). 

Phrase: "However,"

Phrase: "the stereotypical manifestations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205319:manifestations [Functional Concept]
   861   C1280464:manifestations [Qualitative Concept]

Phrase: "that"

Phrase: "define"

Phrase: "the terminal phases of apoptosis,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0585064:Phases [Temporal Concept]
   760   C1067936:Phasis [Eukaryote]
   726 E C0205390:Phase [Temporal Concept]

Phrase: "such as chromatin condensation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0233656:Condensation [Mental or Behavioral Dysfunction]
   861   C0598405:condensation [Natural Phenomenon or Process]

Phrase: "apoptotic bodies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C3269134:apoptotic body [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "blebbing,"

Phrase: "are"

Phrase: "rarely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522498:Rarely [Qualitative Concept]

Phrase: "seen in AD,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "but"

Phrase: "activated caspases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "caspase-3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "sometimes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Sometimes [Temporal Concept]

Phrase: "found in association degenerating neurons"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0004083:Association [Mental Process]
   760   C0011164:degenerating [Pathologic Function]
   760   C0027882:Neurons [Cell]
   760   C0150312:Found [Quantitative Concept]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
   726 E C0243095:Find [Finding]
   726 E C1880269:Degenerate [Functional Concept]

Phrase: "in AD (Gastard et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.39: In a further study, activated caspase-3 immunoreactivity was seen in neurons, astrocytes and blood vessels, was elevated in AD, and exhibited a high degree of colocalization with neurofibrillar tangles and senile plaques, suggesting that activated caspase-3 may be a factor in functional decline (Su et al., 2001). 

Phrase: "In a further study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "activated caspase-3 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "seen in neurons,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "and"

Phrase: "blood vessels,"
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
  1000   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   966 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   966 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   928 E C1558950:VASCULAR [Finding]
   928 E C1801960:Vascular [Qualitative Concept]
   907 E C0005767:Blood [Tissue]
   907 E C0005768:blood [Body Substance]
   907 E C0229664:Blood [Body Substance]
   907 E C0392895:Bloods [Population Group]
   888 E C0333275:Bloody [Qualitative Concept]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "elevated in AD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205250:Elevated [Qualitative Concept]
   790   C3163633:Elevated [Qualitative Concept]

Phrase: "and"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a high degree of colocalization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "with neurofibrillar tangles"

Phrase: "and"

Phrase: "senile plaques,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that activated caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "be"

Phrase: "a factor in functional decline"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   797 E C0960756:factor A [Organic Chemical]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "(Su et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.40: Therefore, the next step would be to confirm the co-localization AGEs with apoptotic markers such as caspase-3 to determine if AGE deposition and caspase activation are causally linked. 

Phrase: "Therefore,"

Phrase: "the next step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "would"

Phrase: "be"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the co-localization AGEs with apoptotic markers"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   739   C0205179:Advanced [Qualitative Concept]
   739   C0444930:End [Spatial Concept]
   739   C0598528:glycation [Phenomenon or Process]
   739   C1514468:Products [Entity]
   739   C2746065:End [Temporal Concept]
   706 E C0725066:Advance [Medical Device]
   706 E C1704444:Product [Quantitative Concept]

Phrase: "such as caspase-3 to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "determine"

Phrase: "if"

Phrase: "AGE deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposition [Functional Concept]

Phrase: "and"

Phrase: "caspase activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1159825:Caspase Activation [Molecular Function]
   861   C1879547:Activation [Activity]

Phrase: "are"

Phrase: "causally"

Phrase: "linked."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]
Processing 00000000.tx.41: nNOS is another marker that is uniquely expressed in the vulnerable pyramidal neurons in AD but not in healthy non-demented controls. 

Phrase: "nNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417759:nNOS [Gene or Genome]

Phrase: "is"

Phrase: "another marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005516:Marker [Clinical Attribute]

Phrase: "that"

Phrase: "is"

Phrase: "uniquely"

Phrase: "expressed in the vulnerable pyramidal neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027882:Neurons [Cell]

Phrase: "in AD"

Phrase: "but"

Phrase: "not in healthy non-demented controls."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C2986479:Healthy Control [Qualitative Concept]
   753   C0860630:demented [Mental or Behavioral Dysfunction]
   753   C1518422:Non [Functional Concept]
           Not
   719   C0243148:control [Qualitative Concept]
   719   C1550141:Control [Substance]
   719   C1882979:Control [Conceptual Entity]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.42: nNOS was detected in neurons containing NFTs and those not yet affected by neurofibrillary degeneration. 

Phrase: "nNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417759:nNOS [Gene or Genome]

Phrase: "was"

Phrase: "detected in neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0027882:Neurons [Cell]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "those"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "affected by neurofibrillary degeneration."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0085400:Neurofibrillary degeneration [Acquired Abnormality]
   770   C0011164:Degeneration [Pathologic Function]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   770   C1880269:Degeneration [Functional Concept]
   737 E C0001721:Affect [Mental Process]
Processing 00000000.tx.43: The involvement of nitric oxide (NO) in the pathological process of AD and the role of NO in oxidative stress has been suggested in earlier investigation of our group (Lth et al., 2001, 2002). 

Phrase: "The involvement of nitric oxide (NO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "in the pathological process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030660:Pathological process [Pathologic Function]
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "of AD"

Phrase: "and"

Phrase: "the role of NO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "suggested in earlier investigation of our group"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1261322:Investigation [Health Care Activity]
   748   C1552516:Group [Health Care Related Organization]
   748   C1552578:investigation [Idea or Concept]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
   714   C1279919:Early [Temporal Concept]
   714   C1705535:Suggest [Idea or Concept]

Phrase: "(Lth et al.,"

Phrase: "2001,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.44: In this study, AGE deposition was analyzed in the brains of young and old non-demented patients. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "AGE deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposition [Functional Concept]

Phrase: "was"

Phrase: "analyzed in the brains of young"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0332239:Young [Temporal Concept]
   753   C0936012:Analyzed [Research Activity]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "old non-demented patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C1829939:{Non-patient} [Clinical Attribute]
   812   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.45: The latter were compared with age-matched AD patients in early and late stages of the disease. 

Phrase: "The latter"

Phrase: "were"

Phrase: "compared with age-matched AD patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0001779:Age [Organism Attribute]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0150103:matched [Research Activity]
   753   C1707455:Compared [Activity]
   753   C1708943:Matched [Qualitative Concept]

Phrase: "in early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205087:Late [Temporal Concept]

Phrase: "stages of the disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   819   C0699749:disease stage [Diagnostic Procedure]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205390:Stage [Temporal Concept]
   770   C1300072:Stage [Clinical Attribute]
   770   C1306673:Stage [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.46: In particular, AGEs were co-localized with hyperphosphorylated tau in different stages of tangle formation and with markers of neurodegeneration and/or cell death (nNOS and caspase-3).  

Phrase: "In particular, AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   937   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   804   C0205179:Advanced [Qualitative Concept]
   804   C0444930:End [Spatial Concept]
   804   C0598528:glycation [Phenomenon or Process]
   804   C1514468:Products [Entity]
   804   C2746065:End [Temporal Concept]
   771 E C0725066:Advance [Medical Device]
   771 E C1704444:Product [Quantitative Concept]
   748 E C0205088:Terminal [Temporal Concept]
   748 E C1705314:Terminal [Manufactured Object]
   748 E C1705315:Terminal [Spatial Concept]

Phrase: "were"

Phrase: "co-localized with hyperphosphorylated tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392752:Localized [Spatial Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "in different stages"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "of tangle formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "and with markers of neurodegeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   760   C1515981:And [Idea or Concept]
   726   C0005516:Marker [Clinical Attribute]

Phrase: "and/or"

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(nNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417759:nNOS [Gene or Genome]

Phrase: "and"

Phrase: "caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.47: Material and Methods Top Abstract Introduction Material and Methods Results Discussion References  Cases Brains used in the present study were obtained from 12 non-demented controls, subdivided into an older (6590 years, five males, three females) and a younger (3050 years, four males) group, as well as from 20 patients with AD, subdivided into an advanced (Braak stage VVI; six males, four females) and early (Braak stage III; three males, seven females) stage of the disease (according to Braak and Braak, 1991). 

Phrase: "Material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Material [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Material [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cases Brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "used in the present study"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   781   C0869040:study use [Research Activity]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1273517:used [Finding]
   760   C2603343:Study [Research Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "obtained from 12 non-demented controls,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0860630:demented [Mental or Behavioral Dysfunction]
   753   C1301820:Obtained [Functional Concept]
   753   C1518422:Non [Functional Concept]
   719   C0243148:control [Qualitative Concept]
   719   C1550141:Control [Substance]
   719 E C1706701:Obtain [Activity]
   719   C1882979:Control [Conceptual Entity]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]

Phrase: "subdivided into an older"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0580836:Old [Temporal Concept]

Phrase: "(6590 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "five males,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0024554:Males [Finding]
   861   C0086582:Males [Population Group]
   827 E C1706180:Male [Qualitative Concept]
   827 E C1706428:Male [Qualitative Concept]
   827 E C1706429:Male [Organism Attribute]

Phrase: "three females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0015780:Females [Finding]
   861   C0086287:Females [Population Group]
   827 E C0043210:female [Population Group]
   827 E C1705497:Female [Qualitative Concept]
   827 E C1705498:Female [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "a younger"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   966   C0332239:Young [Temporal Concept]
   916 E C0001578:youth [Age Group]
   916 E C0087178:Youth [Age Group]

Phrase: "(3050 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "four males"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0024554:Males [Finding]
   861   C0086582:Males [Population Group]
   827 E C1706180:Male [Qualitative Concept]
   827 E C1706428:Male [Qualitative Concept]
   827 E C1706429:Male [Organism Attribute]

Phrase: ")"

Phrase: "group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "as well as from 20 patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0205170:Well [Qualitative Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "with AD,"

Phrase: "subdivided into an advanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205179:Advanced [Qualitative Concept]

Phrase: "(Braak stage VVI"

Phrase: "; six males,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0024554:Males [Finding]
   861   C0086582:Males [Population Group]
   827 E C1706180:Male [Qualitative Concept]
   827 E C1706428:Male [Qualitative Concept]
   827 E C1706429:Male [Organism Attribute]

Phrase: "four females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0015780:Females [Finding]
   861   C0086287:Females [Population Group]
   827 E C0043210:female [Population Group]
   827 E C1705497:Female [Qualitative Concept]
   827 E C1705498:Female [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "(Braak stage III"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0441771:Stage III [Intellectual Product]
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: "; three males,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0024554:Males [Finding]
   861   C0086582:Males [Population Group]
   827 E C1706180:Male [Qualitative Concept]
   827 E C1706428:Male [Qualitative Concept]
   827 E C1706429:Male [Organism Attribute]

Phrase: "seven females"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0015780:Females [Finding]
   861   C0086287:Females [Population Group]
   827 E C0043210:female [Population Group]
   827 E C1705497:Female [Qualitative Concept]
   827 E C1705498:Female [Qualitative Concept]

Phrase: ")"

Phrase: "stage of the disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   819   C0699749:disease stage [Diagnostic Procedure]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205390:Stage [Temporal Concept]
   770   C1300072:Stage [Clinical Attribute]
   770   C1306673:Stage [Qualitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "("

Phrase: "according to Braak"

Phrase: "and"

Phrase: "Braak,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.48: The presence of a dementia syndrome was defined in accordance with ICD-10 research criteria. 

Phrase: "The presence of a dementia syndrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "defined in accordance with ICD-10 research criteria."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1137110:ICD-10 [Intellectual Product]
   744   C0035168:research [Research Activity]
   744   C0242481:Research [Research Activity]
   744   C0243161:criteria [Intellectual Product]
   744   C1704788:Defined [Conceptual Entity]
   744   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.49: Because of insufficient operationalization within ICD-10, the NINDS-AIREN criteria were additionally applied in all cases with a dementia syndrome (McKhann et al., 1984). 

Phrase: "Because of insufficient operationalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683955:operationalization [Research Activity]

Phrase: "within ICD-10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1137110:ICD-10 [Intellectual Product]

Phrase: "the NINDS-AIREN criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243161:criteria [Intellectual Product]

Phrase: "were"

Phrase: "additionally"

Phrase: "applied in all cases"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0185125:Applied [Health Care Activity]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1632850:Apply [Functional Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]
   737 E C1879355:Apply [Functional Concept]

Phrase: "with a dementia syndrome"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0039082:Syndrome [Disease or Syndrome]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "(McKhann et al.,"

Phrase: "1984"

Phrase: ")."
Processing 00000000.tx.50: The AD cases were matched with respect to age (mean age: aged controls, 79.3  8.1 years; 

Phrase: "The AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "matched with respect to age (mean age"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0001779:Age [Organism Attribute]
   748   C0150103:matched [Research Activity]
   748   C0444504:Mean [Quantitative Concept]
   748   C0679133:respect [Social Behavior]
   748   C1708943:Matched [Qualitative Concept]
   748   C2347634:Mean [Quantitative Concept]
   748   C2348143:Mean [Quantitative Concept]

Phrase: ":"

Phrase: "aged controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "79.3  8.1 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.51: AD, 83.8  6.6 years; 

Phrase: "AD,"

Phrase: "83.8  6.6 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.52: P > 0.20, Student's t-test), post-mortem interval (old controls, 64  30 h; AD, 47  33 h; P > 0.20) and the Premortem Severity Index (PMSI) by Monfort et al. 

Phrase: "P > 0.20,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Student's t-test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "post-mortem interval"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   901   C0004398:postmortem [Diagnostic Procedure]
   901   C0580205:Postmortem [Temporal Concept]
   901   C0848632:post mortem [Finding]
   827   C0687676:Post [Temporal Concept]
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]
   827   C1704687:Post [Manufactured Object]
   755 E C1514253:Postal [Functional Concept]

Phrase: "(old controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "64  30 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "; AD,"

Phrase: "47  33 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "; P > 0.20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "the Premortem Severity Index (PMSI) by Monfort et al."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0439793:Severity [Qualitative Concept]
   744   C0918012:Index [Intellectual Product]
   744   C1552854:index [Idea or Concept]
   744   C1637833:% index [Quantitative Concept]
   744   C2983285:Severity [Intellectual Product]
Processing 00000000.tx.53: (1985) (P > 0.20) to minimize the likelihood of an artificial influence by premortem hypoxia and hypovolemia. 

Phrase: "(1985"

Phrase: ")"

Phrase: "(P > 0.20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "the likelihood of an artificial influence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033204:Likelihood [Quantitative Concept]

Phrase: "by premortem hypoxia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242184:Hypoxia [Pathologic Function]
   861   C1963140:HYPOXIA [Finding]

Phrase: "and"

Phrase: "hypovolemia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0546884:Hypovolaemia [Finding]
   928 E C0752266:Hypovolemic [Laboratory or Test Result]
Processing 00000000.tx.54: The young control group (mean age = 25.6 years) was used to evaluate age-related changes as well as to compare with changes found in early-stage AD. 

Phrase: "The young control group (mean age = 25.6 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   836   C1510829:Age-Years [Temporal Concept]
   793   C0439234:years [Temporal Concept]
   760 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "age-related changes"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   827   C0001779:Age [Organism Attribute]
   827   C0392747:changes [Functional Concept]
   827   C0439849:Related [Qualitative Concept]
   827   C0443172:changes [Quantitative Concept]
   827   C0445223:Related [Finding]
   793 E C0163712:Relate [Organic Chemical]
   793 E C1705241:Change [Quantitative Concept]
   755 E C0080103:Relation [Family Group]
   755 E C0869014:Relations [Social Behavior]

Phrase: "as well as"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare with changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C1707455:Compare [Activity]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "found in early-stage AD."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C1517886:Early Stage [Classification]
   806   C2363430:Early stage [Temporal Concept]
   760   C0150312:Found [Quantitative Concept]
   760   C0205390:Stage [Temporal Concept]
   760   C1279919:Early [Temporal Concept]
   760   C1300072:Stage [Clinical Attribute]
   760   C1306673:Stage [Qualitative Concept]
   726 E C0243095:Find [Finding]
Processing 00000000.tx.55: The whole procedure of case recruitment, acquisition of patients' personal data, performing the autopsy, and handling the autoptic material was performed in accordance with the Helsinki Declaration in its latest version, and the convention of the council of Europe on Human Rights and Biomedicine. 

Phrase: "The whole procedure of case recruitment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   753   C1948041:Procedure [Therapeutic or Preventive Procedure]
   753   C2700391:Procedure [Activity]
   753   C3274430:PROCEDURE [Health Care Activity]
   753   C3538935:Procedure [Idea or Concept]
   753   C3539779:Procedure [Intellectual Product]

Phrase: "acquisition of patients' personal data,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1706701:Acquisition [Activity]

Phrase: "performing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0884358:Perform [Functional Concept]
   966   C2947996:Perform [Pharmacologic Substance]

Phrase: "the autopsy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004398:Autopsy [Diagnostic Procedure]

Phrase: "and"

Phrase: "handling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018578:Handling [Behavior]
  1000   C1832073:Handling [Finding]

Phrase: "the autoptic material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Material [Substance]

Phrase: "was"

Phrase: "performed in accordance with the Helsinki Declaration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C0018898:Helsinki Declaration [Regulation or Law]
   748   C0884358:Performed [Functional Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in its latest version,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "and"

Phrase: "the convention of the council of Europe"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086047:convention [Human-caused Phenomenon or Process]
   748   C0439858:Convention [Qualitative Concept]

Phrase: "on Human Rights"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020138:Human Rights [Idea or Concept]
   861   C0035621:Rights [Qualitative Concept]
   861   C0086418:Human [Human]
   861   C0205090:Right [Spatial Concept]

Phrase: "and"

Phrase: "Biomedicine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879848:Biomedicine [Biomedical Occupation or Discipline]
Processing 00000000.tx.56: It was also approved by the Ethical Committee responsible for Leipzig University. 

Phrase: "It"

Phrase: "was"

Phrase: "also"

Phrase: "approved by the Ethical Committee"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0026531:ethical [Idea or Concept]
   760   C0205540:Approved [Qualitative Concept]
   760   C2699414:Committee [Group]

Phrase: "responsible for Leipzig University."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]
Processing 00000000.tx.57: Brains of non-demented controls were obtained at routine autopsy from patients who died without a history of neuropsychiatric disorder, mental impairment or diabetes mellitus. 

Phrase: "Brains of non-demented controls"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C0596948:brain controls [Mental Process]
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "obtained at routine autopsy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0004398:Autopsy [Diagnostic Procedure]
   770   C0205547:Routine [Qualitative Concept]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "who"

Phrase: "died without a history of neuropsychiatric disorder,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   804   C0730226:History of - disorder [Finding]
   748   C0011065:Died [Organism Function]
   748   C0012634:Disorder [Disease or Syndrome]
   748   C0019664:History [Occupation or Discipline]
   748   C0019665:history [Intellectual Product]
   748   C0262512:History, NOS [Organism Attribute]
   748   C0262926:History [Finding]
   748   C1546956:Died [Finding]
   748   C1705255:History [Conceptual Entity]
   748   C2004062:History [Finding]

Phrase: "mental impairment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0278061:mental impairment [Mental or Behavioral Dysfunction]
  1000   C1306341:Mental impairment [Mental or Behavioral Dysfunction]
   861   C0684336:Impairment [Pathologic Function]

Phrase: "or"

Phrase: "diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.58: There had to be clear evidence that the patient was alert, well oriented and capable of functioning relatively independently shortly before death. 

Phrase: "There"

Phrase: "had"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "clear evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "was"

Phrase: "alert, well oriented"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205170:Well [Qualitative Concept]
   827   C1704322:Oriented [Spatial Concept]
   827   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "capable of functioning relatively independently shortly"

Phrase: "before"

Phrase: "death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]
Processing 00000000.tx.59: No pathological signs were detected by neuropathological examination. 

Phrase: "No pathological signs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0220912:signs [Functional Concept]
   861   C0220913:signs [Manufactured Object]
   861   C0311392:SIGNS [Finding]
   827 E C1547188:Sign [Idea or Concept]

Phrase: "were"

Phrase: "detected by neuropathological examination."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.60: The clinical diagnosis of AD was based on the occurrence of significant intellectual dysfunction, i.e. the presence of deficits in at least four aspects of cognitive and social behaviour. 

Phrase: "The clinical diagnosis of AD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332140:Diagnosis, clinical [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: "was"

Phrase: "based on the occurrence of significant intellectual dysfunction,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   744   C0031847:dysfunction [Functional Concept]
   744   C0237881:significant [Quantitative Concept]
   744   C0243132:occurrence [Functional Concept]
   744   C0277785:Dysfunction, NOS [Qualitative Concept]
   744   C0750502:Significant [Idea or Concept]
   744   C1527178:Based [Functional Concept]
   744   C1546944:Significant [Qualitative Concept]
   744   C1554210:occurrence [Idea or Concept]
   744   C1705938:Based [Idea or Concept]
   744   C2745955:Occurrence [Temporal Concept]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the presence of deficits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in"

Phrase: "at least four aspects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1547011:Aspect [Quantitative Concept]
   793   C1879746:Aspect [Qualitative Concept]

Phrase: "of cognitive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516691:Cognitive [Functional Concept]

Phrase: "and"

Phrase: "social behaviour."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0037397:Social Behavior [Social Behavior]
   861   C0004927:Behavior [Individual Behavior]
   861   C2707008:Behavior [Clinical Attribute]
   789 E C2986890:Behavioral [Idea or Concept]
Processing 00000000.tx.61: Other causes of dementia were excluded by medical, psychiatric and paraclinical examination (following the Diagnostic and Statistical Manual of Mental Disorders, 3rd revised edn, DSM-IIIR, American Psychiatric Association). 

Phrase: "Other causes of dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0015127:causes [Functional Concept]
   770   C1314792:Causes [Functional Concept]
   737 E C1524003:Cause [Conceptual Entity]

Phrase: "were"

Phrase: "excluded by medical, psychiatric"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205476:Medical [Functional Concept]
   770   C0205487:Psychiatric [Functional Concept]
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737 E C0332196:Exclude [Functional Concept]

Phrase: "and"

Phrase: "paraclinical examination"

Phrase: "("

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the Diagnostic and Statistical Manual of Mental Disorders,"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
  1000   C1136324:Diagnostic and Statistical Manual of Mental Disorders [Intellectual Product]
   877   C0599833:Diagnostic and Statistical Manual [Intellectual Product]
   818   C0004936:Mental disorders [Mental or Behavioral Dysfunction]
   795   C0011900:Diagnostic [Finding]
   795   C0012634:Disorders [Disease or Syndrome]
   795   C0024763:Manual [Intellectual Product,Manufactured Object]
   795   C0038215:Statistical [Occupation or Discipline]
   795   C0175674:Manual [Functional Concept]
   795   C0229992:mental [Mental Process]
   795   C0348026:Diagnostic [Functional Concept]
   785 E C0033975:mental disorder [Mental or Behavioral Dysfunction]
   768 E C0152097:diaphragm disorders [Disease or Syndrome]
   760 E C0277577:PSYCHIC DISORDER [Mental or Behavioral Dysfunction]
   712 E C0229993:Psychic [Functional Concept]

Phrase: "3rd revised edn,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1419408:EDN [Gene or Genome]

Phrase: "DSM-IIIR,"

Phrase: "American Psychiatric Association"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0004083:Association [Mental Process]
   827   C0205487:Psychiatric [Functional Concept]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
   755 E C0033872:Psychiatry [Professional or Occupational Group]
   755 E C0033873:Psychiatry [Biomedical Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.62: Cases with a history of diabetes mellitus were excluded. 

Phrase: "Cases with a history of diabetes mellitus"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   774   C0085970:cases history [Intellectual Product]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.63: Each case met the National Institute of Neurologic and Communicative Disorders and Stroke (NINCDS) and also the Alzheimer's Disease and Related Disorders Association (ADRDA) criteria for definite diagnosis of Alzheimer's disease, based on the presence of NFTs and neuritic plaques observed in the hippocampal formation and neocortical areas, as recommended (Braak and Braak, 1991). 

Phrase: "Each case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "the National Institute of Neurologic and Communicative Disorders and Stroke (NINCDS)"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   845   C2350584:National Institute of Neurological Disorders and Stroke [Health Care Related Organization]
   779   C0549469:disorders of the nervous system [Disease or Syndrome]
   760   C0009460:Communicative Disorders [Mental or Behavioral Dysfunction]
   757   C0027765:Neurologic Disorders [Disease or Syndrome]
           Disorder of nervous system
   739   C0009452:Communicative [Social Behavior]
   739   C0012634:Disorders [Disease or Syndrome]
   739   C0021622:institute [Organization]
   739   C0038454:Stroke [Disease or Syndrome]
           Stroke, neurological
   739   C0205494:Neurologic [Qualitative Concept]
   739   C1272753:Institute [Idea or Concept]
   739   C3245503:national [Intellectual Product]

Phrase: "and"

Phrase: "also"

Phrase: "the Alzheimer's Disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Related Disorders Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "(ADRDA"

Phrase: ")"

Phrase: "criteria for definite diagnosis of Alzheimer's disease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0243161:criteria [Intellectual Product]

Phrase: "based on the presence of NFTs"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   778   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   745 E C3543859:neurofibrillary tangle [Cell Component]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "neuritic plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:Neuritic Plaques [Acquired Abnormality]
           plaques
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   789   C0027813:Neuritides [Disease or Syndrome]

Phrase: "observed in the hippocampal formation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0175202:Hippocampal Formation [Body Part, Organ, or Organ Component]
   760   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "neocortical areas,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "as"

Phrase: "recommended"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034866:Recommended [Idea or Concept]

Phrase: "(Braak"

Phrase: "and"

Phrase: "Braak,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.64: Preparation of Tissue Tissue blocks were taken from the auditory association area of superior temporal gyrus (Brodmann area 22), and immersed in 4% paraformaldehyde/0.5% glutaraldehyde in phosphate buffer (0.1 M, pH 7.4) for 4 days at 4C. 

Phrase: "Preparation of Tissue Tissue blocks"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0200728:Tissue Preparation [Laboratory Procedure]
   760   C0455052:Preparation [Health Care Activity]
   760   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "taken from the auditory association area of superior temporal gyrus"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   782   C0152309:Superior temporal gyrus [Body Part, Organ, or Organ Component]
   777   C2322884:Superior temporal area [Body Location or Region]
   760   C0228234:Temporal gyrus [Body Part, Organ, or Organ Component]
   760   C0458311:Temporal gyrus [Body Part, Organ, or Organ Component]
   757   C0004302:Auditory area [Body Part, Organ, or Organ Component]
   757   C1276856:Auditory area [Organ or Tissue Function]
   739   C0004083:Association [Mental Process]
   739   C0017446:Area [Geographic Area]
   739   C0205146:Area [Spatial Concept]
   739   C0439825:Auditory [Functional Concept]
   739   C0439849:Association [Qualitative Concept]
   739   C0442043:Temporal [Spatial Concept]
   739   C0596306:Association [Phenomenon or Process]
   739   C0699792:association [Social Behavior]
   739   C1282910:Superior [Spatial Concept]
   739   C1883727:Taken [Conceptual Entity]
   739   C2362314:Temporal [Temporal Concept]
   706 E C1515187:Take [Health Care Activity]

Phrase: "(Brodmann area 22"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1272540:Brodmann area 22 [Body Part, Organ, or Organ Component]
  1000   C2322884:Brodmann area 22 [Body Location or Region]
   901   C0599720:Brodmann area [Body Location or Region]
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "immersed in 4% paraformaldehyde/0.5% glutaraldehyde"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0444499:0/5 [Quantitative Concept]
   748   C0017814:Glutaraldehyde [Biomedical or Dental Material,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "in phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0031701:phosphate [Organophosphorus Compound]
   861   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(0.1 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "for 4 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442765:4 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.65: Blocks were subsequently immersed in 15% sucrose in phosphate buffered saline (PBS) for 24 h, followed by 30% sucrose in PBS for 48 h. 

Phrase: "Blocks"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:blocks [Pathologic Function]
  1000   C0332206:Blocks [Functional Concept]
  1000   C1533157:Blocks [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]
   916 E C2983591:BLOCKED [Research Activity]

Phrase: "were"

Phrase: "subsequently"

Phrase: "immersed in 15% sucrose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "in phosphate buffered saline (PBS)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "for 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "followed by 30% sucrose"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "in PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "for 48 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.66: Coronal sections, 30 m thick, were cut on a freezing microtome and processed for the immunohistochemical detection of AGE, AT8, nNOS and caspase-3. 

Phrase: "Coronal sections,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205123:Coronal [Spatial Concept]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "30 m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "thick,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1280412:Thick [Qualitative Concept]

Phrase: "were"

Phrase: "cut on a freezing microtome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0000925:Cut [Injury or Poisoning]
   760   C0016701:Freezing [Natural Phenomenon or Process]
   760   C0181856:microtome [Medical Device]
   760   C0700320:microtome [Laboratory Procedure]
   760   C1883724:CUT [Phenomenon or Process]

Phrase: "and"

Phrase: "processed for the immunohistochemical detection of AGE,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0001779:Age [Organism Attribute]
   748   C1441616:Immunohistochemical [Laboratory Procedure]
   748   C1511790:Detection [Therapeutic or Preventive Procedure]
   748   C1522240:Processed [Phenomenon or Process]
   714 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "AT8,"

Phrase: "nNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417759:nNOS [Gene or Genome]

Phrase: "and"

Phrase: "caspase-3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.67: The Gallyas staining method for demonstration of neuritic plaques, NFTs and neuropil threads was performed following the original description (Gallyas, 1971). 

Phrase: "The Gallyas"

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "method for demonstration of neuritic plaques,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "neuropil threads"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the original description"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678257:Description [Idea or Concept]

Phrase: "(Gallyas,"

Phrase: "1971"

Phrase: ")."
Processing 00000000.tx.68: Furthermore, the thioflavin S method was used for staging of the AD brains as described previously (Braak and Braak, 1991). 

Phrase: "Furthermore,"

Phrase: "the thioflavin S method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "was"

Phrase: "used for staging of the AD brains"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   757   C1524063:Use of [Functional Concept]
   748   C0006104:Brains [Body Part, Organ, or Organ Component]
   748   C0332305:Staging [Functional Concept]
   748   C1273517:used [Finding]
   714 E C0042153:use [Functional Concept]
   714 E C0205390:Stage [Temporal Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1269537:Brain [Body Part, Organ, or Organ Component]
   714 E C1300072:Stage [Clinical Attribute]
   714 E C1306673:Stage [Qualitative Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Braak"

Phrase: "and"

Phrase: "Braak,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.69: Immunohistochemistry For immunohistochemistry, we have used the polyclonal AGE-antibody K 1936, as described previously (Wong et al., 2001), and the monoclonal AGE-antibody 4G,9 which was directed against the defined AGE carboxymethyllysine (CML) (Castellani et al., 2001). 

Phrase: "Immunohistochemistry For immunohistochemistry,"

Phrase: "we"

Phrase: "have"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the polyclonal AGE-antibody K 1936,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   853   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0313240:antibody k [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0001779:Age [Organism Attribute]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C1708601:K' [Quantitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Wong et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the monoclonal AGE-antibody 4G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "9"

Phrase: "which"

Phrase: "was"

Phrase: "directed against the defined AGE carboxymethyllysine (CML)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0001779:Age [Organism Attribute]
   753   C0083528:carboxymethyl-lysine [Amino Acid, Peptide, or Protein]
   753   C1704788:Defined [Conceptual Entity]
   753   C3539106:Defined [Intellectual Product]
   719   C0439851:Direct [Qualitative Concept]
   719   C1947931:Direct [Qualitative Concept]

Phrase: "(Castellani et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.70: In general, all AGE antibodies stain the same structures, including the somata of neurons and astroglia, blood vessels and neurite amyloid plaques. 

Phrase: "In general,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "all AGE antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "stain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "the same structures,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the somata of neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   887   C0599444:Soma of neuron [Cell Component]
           soma
   777   C2952302:Neuronal somata [Cell Component]
   737   C0702216:Soma [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "astroglia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astroglia [Cell]

Phrase: "blood vessels"
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
  1000   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   966 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   966 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   928 E C1558950:VASCULAR [Finding]
   928 E C1801960:Vascular [Qualitative Concept]
   907 E C0005767:Blood [Tissue]
   907 E C0005768:blood [Body Substance]
   907 E C0229664:Blood [Body Substance]
   907 E C0392895:Bloods [Population Group]
   888 E C0333275:Bloody [Qualitative Concept]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "neurite amyloid plaques."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   901   C2936349:Plaques, Amyloid [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
Processing 00000000.tx.71: Since the antibody K 1936 stains AGEs in astrocytes more intensely than the other AGE antibody, this antibody was used for most of the experiments. 

Phrase: "Since"

Phrase: "the antibody K 1936 stains AGEs in astrocytes more intensely"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   784   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   735   C0205179:Advanced [Qualitative Concept]
   735   C0444930:End [Spatial Concept]
   735   C0598528:glycation [Phenomenon or Process]
   735   C1514468:Products [Entity]
   735   C2746065:End [Temporal Concept]
   702 E C0725066:Advance [Medical Device]
   702 E C1704444:Product [Quantitative Concept]

Phrase: "than the"

Phrase: "other AGE antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "this antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "used for most of the experiments."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   767   C1524063:Use of [Functional Concept]
   753   C0681814:Experiments [Research Activity]
   753   C1273517:used [Finding]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1706386:Experiment [Conceptual Entity]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.72: For double immunofluorescence experiments, the monoclonal AGE (CML) antibody 4G9 was also used. 

Phrase: "For double immunofluorescence experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "the monoclonal AGE (CML"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0083528:carboxymethyl-lysine [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "antibody 4G9"

Phrase: "was"

Phrase: "also"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.73: In detail, free floating sections were briefly boiled in sodium citrate buffer (NaCl 150 mM, Na-citrate 100 mM, pH 6.0) and pre-incubated with 1% H2O2 for 30 min, followed by blocking of nonspecific binding sites with 5% normal goat serum (Sigma), 0.5% Triton X-100 (FERAK, Berlin, Germany) in 0.1 M Tris-buffered saline (TBS, pH 7.4) for 1 h. 

Phrase: "In detail,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1522508:Detail [Qualitative Concept]
  1000   C1561567:detail [Functional Concept]

Phrase: "free floating sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]
   734   C0443223:Free-floating [Qualitative Concept]

Phrase: "were"

Phrase: "briefly"

Phrase: "boiled in sodium citrate buffer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0142825:sodium citrate [Organic Chemical,Pharmacologic Substance]
   806   C3256468:citrate buffer [Pharmacologic Substance]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0008857:Citrate [Organic Chemical]
   760   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   760   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   760   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   726   C0242301:Boil [Disease or Syndrome]
   726   C1546559:Boil [Intellectual Product]

Phrase: "(NaCl 150 mM,"

Phrase: "Na-citrate 100 mM,"

Phrase: "pH 6.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "pre-incubated with 1% H2O2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0332152:Pre [Temporal Concept]
   760   C0740175:Pre [Qualitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C2257086:PRE [Genetic Function]

Phrase: "for 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "followed by"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332283:Followed by [Temporal Concept]
           followed
   799 E C1719822:Follow [Intellectual Product]

Phrase: "blocking of nonspecific binding sites"
Meta Candidates (Total=18; Excluded=7; Pruned=0; Remaining=11)
   806   C0005456:Binding Sites [Receptor]
   781   C0457192:Nonspecific site [Body Location or Region]
   781   C2945843:Site of [Qualitative Concept]
   773 E C0682969:Binding Site [Amino Acid Sequence]
   760   C0205145:Sites [Spatial Concept]
   760   C0205370:Non-specific [Qualitative Concept]
   760   C0233660:Blocking [Mental or Behavioral Dysfunction]
   760   C0243122:binding [Functional Concept]
   760   C0332206:Blocking [Functional Concept]
   760   C0750540:Nonspecific [Idea or Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   726 E C0028778:Block [Pathologic Function]
   726 E C1515974:Site [Body Location or Region]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2825164:Site [Spatial Concept]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "with 5% normal goat serum"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   812   C0018019:goat [Mammal]
   812   C0205307:Normal [Qualitative Concept]
   812   C0229671:Serum [Body Substance]
   812   C0439166:% normal [Quantitative Concept]
   812   C1265549:goat [Mammal]
   812   C1510458:Goat [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   812   C2347086:% Normal [Quantitative Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "0.5% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "(FERAK,"

Phrase: "Berlin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005125:Berlin [Geographic Area]

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "in 0.1 M Tris-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   810   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   799   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0036082:Saline [Substance]
   799   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   799   C0814229:TRI [Intellectual Product]

Phrase: "(TBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "for 1 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.74: Next, sections were incubated with one of the following primary antibodies overnight at 4C: polyclonal AGE-antibodies (K 1936 and K 2188) and one monoclonal CML antibody (4G9), polyclonal anti-nNOS (rabbit, anti-nNOS, Transduction Laboratories, 1:1000), anti-polyclonal AT8 (1: 1000 diluted polyclonal anti-AT8, Innogenetics, Ghent, Belgium), anti-caspase-3 (1:1000 diluted polyclonal anti-caspase-3, Promega, Madison, WI) or anti-GFAP (1:1000 diluted anti-human GFAP, clone 6D2, Dako). 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated with one of the following primary antibodies overnight"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   742   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0205225:Primary [Qualitative Concept]
   742   C0205447:One [Quantitative Concept]
   742   C0439583:Overnight [Temporal Concept]
   742   C0439631:Primary [Therapeutic or Preventive Procedure]
   742   C1439852:Incubated [Laboratory Procedure]
   708 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   708   C0332283:follow [Temporal Concept]
   708   C1719822:Follow [Intellectual Product]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: ":"

Phrase: "polyclonal AGE-antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   896   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(K 1936"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "K 2188"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "one monoclonal CML antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(4G9"

Phrase: ")"

Phrase: ","

Phrase: "polyclonal anti-nNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1417759:nNOS [Gene or Genome]

Phrase: "(rabbit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: "anti-nNOS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1417759:nNOS [Gene or Genome]

Phrase: "Transduction Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ")"

Phrase: ","

Phrase: "anti-polyclonal AT8"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000 diluted polyclonal anti-AT8,"

Phrase: "Innogenetics,"

Phrase: "Ghent,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "anti-caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000 diluted polyclonal anti-caspase-3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: "Madison,"

Phrase: "WI)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: "or"

Phrase: "anti-GFAP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017626:GFAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1415042:GFAP [Gene or Genome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000 diluted anti-human GFAP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017626:GFAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1415042:GFAP [Gene or Genome]

Phrase: "clone 6D2,"

Phrase: "Dako"

Phrase: ")."
Processing 00000000.tx.75: Primary antibodies were detected by (i) biotinylated goat anti-rabbit IgG or (ii) biotinylated goat anti-mouse immunoglobulin (1:1000, Dianova, Hamburg, Germany). 

Phrase: "Primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "detected by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0442726:Detected [Finding]
   833   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(i) biotinylated goat anti-rabbit IgG or (ii"

Phrase: ")"

Phrase: "biotinylated goat anti-mouse immunoglobulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C1621846:immunoglobulin [Molecular Function]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000,"

Phrase: "Dianova,"

Phrase: "Hamburg,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.76: Immunoreactivity was visualized with 3,3'-diaminobenzidine/H2O2. 

Phrase: "Immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "visualized with 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0234621:Visualized [Functional Concept]

Phrase: "3'-diaminobenzidine/H2O2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.77: Primary antibodies were omitted in control incubations. 

Phrase: "Primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "omitted in control incubations."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C0750563:omitted [Idea or Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.78: For simultaneous detection of AGE and AT8, nNOS or caspase-3, sections were incubated with a cocktail containing the primary antibodies: monoclonal anti-AGE (monoclonal CML, antibody 4G9) and the corresponding polyclonal antibody (AT8, nNOS or caspase3). 

Phrase: "For simultaneous detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of AGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "AT8,"

Phrase: "nNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417759:nNOS [Gene or Genome]

Phrase: "or"

Phrase: "caspase-3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated with a cocktail"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0678420:Cocktail [Food]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "monoclonal anti-AGE (monoclonal CML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0083528:carboxymethyl-lysine [Amino Acid, Peptide, or Protein]

Phrase: "antibody 4G9"

Phrase: ")"

Phrase: "and"

Phrase: "the corresponding polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(AT8,"

Phrase: "nNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417759:nNOS [Gene or Genome]

Phrase: "or"

Phrase: "caspase3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.79: Immunodetection was carried out accordingly with a cocktail of the CyDye-labeled species-specific secondary antibodies goat anti-rabbit IgG-Cy2 (diluted 1:100, Dianova, Hamburg, Germany) and goat anti-mouse IgG-Cy3 (diluted 1:1000, Dianova, Hamburg, Germany). 

Phrase: "Immunodetection"

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out accordingly with a cocktail"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439787:Out [Spatial Concept]
   760   C0678420:Cocktail [Food]
   760   C0849355:Out [Qualitative Concept]

Phrase: "of the CyDye-labeled species-specific secondary antibodies goat anti-rabbit IgG-Cy2"

Phrase: "("

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100,"

Phrase: "Dianova,"

Phrase: "Hamburg,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "goat anti-mouse IgG-Cy3"

Phrase: "("

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000,"

Phrase: "Dianova,"

Phrase: "Hamburg,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.80: All incubation steps were separated by intensive washing with TBS. 

Phrase: "All incubation steps"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]

Phrase: "were"

Phrase: "separated by intensive washing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086972:Separated [Finding]
   770   C0441648:Washing [Activity]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]

Phrase: "with TBS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]
Processing 00000000.tx.81: Sections were mounted and covered with Entellan (Merck, Darmstadt, Germany). 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "mounted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449878:mounted [Finding]
   966 E C0181909:Mount [Medical Device]

Phrase: "and"

Phrase: "covered with Entellan"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0439844:Covered [Functional Concept]
   790   C0631124:entellan [Biomedical or Dental Material]
   790   C1999244:Covered [Functional Concept]
   756 E C0180153:cover [Medical Device]
   756 E C1707529:Cover [Medical Device]

Phrase: "(Merck,"

Phrase: "Darmstadt,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.82: Quantitative Determination of AGE-positive Neurons and Astroglia For quantitative determination of AGE-positive nerve cells in the young control group (n = 3, mean age = 25.6), the old control group (n = 3, mean age = 78.6), the early AD (n = 3, mean age = 81.6) and the late AD group (n = 3, mean age = 82.3), sections of a defined area of the cerebral cortex (Brodmann area 22) were immunostained for AGEs. 

Phrase: "Quantitative Determination of AGE-positive Neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0868918:Age determination [Quantitative Concept]
   753   C1148554:determination [Laboratory Procedure]

Phrase: "and"

Phrase: "Astroglia For quantitative determination of AGE-positive nerve cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0004112:Astroglia [Cell]

Phrase: "in the young control group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   901   C0009932:Control Group [Group]
   827   C0243148:control [Qualitative Concept]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1550141:Control [Substance]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(n = 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "mean age = 25.6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Age [Organism Attribute]
   812   C0444504:Mean [Quantitative Concept]
   812   C2347634:Mean [Quantitative Concept]
   812   C2348143:Mean [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the old control group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   901   C0009932:Control Group [Group]
   827   C0243148:control [Qualitative Concept]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1550141:Control [Substance]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(n = 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "mean age = 78.6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Age [Organism Attribute]
   812   C0444504:Mean [Quantitative Concept]
   812   C2347634:Mean [Quantitative Concept]
   812   C2348143:Mean [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the early AD (n = 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1279919:Early [Temporal Concept]

Phrase: "mean age = 81.6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Age [Organism Attribute]
   812   C0444504:Mean [Quantitative Concept]
   812   C2347634:Mean [Quantitative Concept]
   812   C2348143:Mean [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the late AD group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "(n = 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "mean age = 82.3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Age [Organism Attribute]
   812   C0444504:Mean [Quantitative Concept]
   812   C2347634:Mean [Quantitative Concept]
   812   C2348143:Mean [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "sections of a defined area of the cerebral cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   708   C0205155:Section [Spatial Concept]
   708   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   708   C1522472:Section [Substance]
   708   C1552923:Section [Quantitative Concept]
   708   C1705191:Section [Physical Object]

Phrase: "(Brodmann area 22"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1272540:Brodmann area 22 [Body Part, Organ, or Organ Component]
  1000   C2322884:Brodmann area 22 [Body Location or Region]
   901   C0599720:Brodmann area [Body Location or Region]
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "immunostained for AGEs."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   882   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   753   C0205179:Advanced [Qualitative Concept]
   753   C0444930:End [Spatial Concept]
   753   C0598528:glycation [Phenomenon or Process]
   753   C1514468:Products [Entity]
   753   C2746065:End [Temporal Concept]
   719 E C0725066:Advance [Medical Device]
   719 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.83: The percentage of AGE-positive neurons was determined by divison of the number of AGE-positive cells by the total number of neurons (Nissl staining). 

Phrase: "The percentage of AGE-positive neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "determined by divison of the number of AGE-positive cells"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   760   C0439178:% positive cells [Quantitative Concept]
           % Positive
   757   C0178537:age cells [Temporal Concept]
   741   C0007584:Cell Number [Laboratory Procedure]
   739   C0001779:Age [Organism Attribute]
   739   C0007634:Cells [Cell]
   739   C0237753:*Number [Quantitative Concept]
   739   C0449788:Number [Quantitative Concept]
   739   C1446409:Positive [Qualitative Concept]
   739   C1514241:Positive [Finding]
   739   C2825490:Positive [Qualitative Concept]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "by the total number"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0237753:*Number [Quantitative Concept]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "("

Phrase: "Nissl staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
   827 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: ")."
Processing 00000000.tx.84: AGE-positive astrocytes were quantified in a similar manner comparing them to the total number of GFAP positive astrocytes. 

Phrase: "AGE-positive astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004112:Astrocytes [Cell]

Phrase: "were"

Phrase: "quantified in a similar manner comparing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C2348205:Similar [Qualitative Concept]
   719   C1707455:Compare [Activity]
   719   C1709793:Quantify [Quantitative Concept]

Phrase: "them to the total number of GFAP positive astrocytes."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   742   C0004112:Astrocytes [Cell]
   742   C0017626:GFAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0237753:*Number [Quantitative Concept]
   742   C0439175:% total [Quantitative Concept]
   742   C0439178:% Positive [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C1415042:GFAP [Gene or Genome]
   742   C1446409:Positive [Qualitative Concept]
   742   C1514241:Positive [Finding]
   742   C2825490:Positive [Qualitative Concept]
Processing 00000000.tx.85: Twelve sections were analyzed for each brain, and a computer-assisted microscopy system was used (Kontron Videoplan, Zeiss, Jena, Germany).  

Phrase: "Twelve sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "analyzed for each brain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0936012:Analyzed [Research Activity]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "a computer-assisted microscopy system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   902   C0009612:Computer System [Intellectual Product,Manufactured Object]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(Kontron Videoplan,"

Phrase: "Zeiss,"

Phrase: "Jena,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.86: Results Top Abstract Introduction Material and Methods Results Discussion References  Intracellular AGE Deposits in Nerve Cells Increase with Aging In the cerebral cortex of healthy humans, a significant difference in the number of AGE deposits between the different age groups could be detected (Figs 1A,B and 2A,B). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Material [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Intracellular AGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "Deposits in Nerve Cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   833   C0027882:Nerve Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0027740:Nerve [Tissue]
   770   C0027757:NERVE [Tissue]
   770   C0333562:Deposit [Functional Concept]
   770   C1280541:Nerve [Body Part, Organ, or Organ Component]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   715 E C0599851:Neural [Functional Concept]

Phrase: "Increase with Aging"
Meta Candidates (Total=9; Excluded=7; Pruned=0; Remaining=2)
   790   C0001811:Ageing [Organism Function]
   790   C0442805:Increase [Functional Concept]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]

Phrase: "In the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "of healthy humans,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086418:Humans [Human]
   789   C0018684:Health [Idea or Concept]
   789   C0031206:healthiness [Finding]

Phrase: "a significant difference in the number of AGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0699810:age difference [Age Group]
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "deposits between the different age groups"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   790   C0027362:Age Groups [Age Group]
   756 E C2348001:Age Group [Population Group]
   753   C0001779:Age [Organism Attribute]
   753   C0333562:Deposit [Functional Concept]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705242:Different [Qualitative Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   748   C0699810:age difference [Age Group]

Phrase: "could"

Phrase: "be"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Figs 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "2A,"

Phrase: "B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.87: AGE deposition was detected in some subpial astroglia, and in a few blood vessels and nerve cells (0.4%, see Table 1) in the cerebral cortex of the young (25.6 years) control group (Table 1, Figs 1A and 2A). 

Phrase: "AGE deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposition [Functional Concept]

Phrase: "was"

Phrase: "detected in some subpial astroglia,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0004112:Astroglia [Cell]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and in a few blood vessels"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   753   C1515981:And [Idea or Concept]
   718 E C1558950:VASCULAR [Finding]
   718 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "nerve cells"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0027882:Nerve Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0027740:Nerve [Tissue]
   861   C0027757:NERVE [Tissue]
   861   C1280541:Nerve [Body Part, Organ, or Organ Component]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   805 E C0599851:Neural [Functional Concept]
   789 E C0027769:nervy [Sign or Symptom]

Phrase: "(0.4%,"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "in the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "of the young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "(25.6 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "control group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(Table 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "Figs 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "2A"

Phrase: ")."
Processing 00000000.tx.88: The number of AGE-positive nerve cells was increased to 24.6% in the group of older (78.4 years) non-demented humans (Table 1, Figs 1B and 2B). 

Phrase: "The number of AGE-positive nerve cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "increased to 24.6%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "in the group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "of older"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0580836:Old [Temporal Concept]

Phrase: "(78.4 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "non-demented humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086418:Humans [Human]

Phrase: "(Table 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "Figs 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450354:2b [Intellectual Product]
  1000   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.89: Furthermore, AGE deposits in blood vessels and in astrocytes could be observed in increasing numbers in the old group (Fig. 1B, arrow head). 

Phrase: "Furthermore,"

Phrase: "AGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "deposits in blood vessels"
Meta Candidates (Total=13; Excluded=10; Pruned=0; Remaining=3)
   833   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   799 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   799 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   770   C0333562:Deposit [Functional Concept]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]
   740 E C0005767:Blood [Tissue]
   740 E C0005768:blood [Body Substance]
   740 E C0229664:Blood [Body Substance]
   740 E C0392895:Bloods [Population Group]
   722 E C0333275:Bloody [Qualitative Concept]

Phrase: "and in astrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004112:Astrocytes [Cell]
   790   C1515981:And [Idea or Concept]

Phrase: "could"

Phrase: "be"

Phrase: "observed in increasing numbers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0237753:*Number [Quantitative Concept]
   770   C0442808:Increasing [Functional Concept]
   770   C0449788:Number [Quantitative Concept]
   770   C1441672:Observed [Functional Concept]

Phrase: "in the old group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "arrow head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0018670:Head [Body Location or Region]
   861   C1281590:Head [Body Part, Organ, or Organ Component]
   861   C1706305:Head [Manufactured Object]
   805 E C0205096:Cephalic [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.90: This increase in AGE immunostaining was visible in both the number of AGE immunoreactive neurons and in the intensity of the local deposits (Table 1). 

Phrase: "This increase in AGE immunostaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "visible in both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205379:Visible [Qualitative Concept]

Phrase: "the number of AGE immunoreactive neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "and in the intensity of the local deposits"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205276:Local [Spatial Concept]
   744   C0333562:Deposits [Functional Concept]
   744   C0522510:Intensity [Qualitative Concept]
   744   C1515981:And [Idea or Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: AGEs were very rarely observed in astrocytes of the subpial region in brains of young humans (Fig. 1A). 

Phrase: "AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "were"

Phrase: "very rarely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442824:Very [Qualitative Concept]
   861   C0522498:Rarely [Qualitative Concept]

Phrase: "observed in astrocytes of the subpial region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004112:Astrocytes [Cell]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   748   C1441672:Observed [Functional Concept]

Phrase: "in brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of young humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Humans [Human]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.92: The intensity of the immunoreaction in astrocytes in the subpial region increased continuously with age, and was highest in old human brains (Fig. 1B). 

Phrase: "The intensity of the immunoreaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "in astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "in the subpial region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "continuously with age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "was"

Phrase: "highest in old human brains"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1522410:Highest [Qualitative Concept]
   726 E C0205250:High [Qualitative Concept]
   726 E C1299351:High [Qualitative Concept]
   726 E C2700149:HIGH [Intellectual Product]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.93: View larger version (125K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(125K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.94: Localization of AGEs in the cerebral cortex of representative young and old human (non-demented) control brains and in the cortex of typical early and late-stage AD brains. 

Phrase: "Localization of AGEs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "in the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "of representative young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332239:Young [Temporal Concept]

Phrase: "and"

Phrase: "old human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Human [Human]

Phrase: "(non-demented"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0860630:demented [Mental or Behavioral Dysfunction]
   861   C1518422:Non [Functional Concept]

Phrase: ")"

Phrase: "control brains"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and in the cortex of typical early"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0007776:Cortex [Body Part, Organ, or Organ Component]
   748   C1176472:Cortex [Body Part, Organ, or Organ Component]
   748   C1279919:Early [Temporal Concept]
   748   C1515981:And [Idea or Concept]
   748   C2700441:Cortex [Plant]
   748   C3538928:Typical [Qualitative Concept]

Phrase: "and"

Phrase: "late-stage AD brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0006104:Brains [Body Part, Organ, or Organ Component]
   779 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.95: AGE deposition was observed in the cerebral cortex (Brodman area 22) of a control brain from of a 25 year old patient's brain in some subpial astroglial cells (arrow head), in few blood vessels and in few neurons (arrow) (A). 

Phrase: "AGE deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposition [Functional Concept]

Phrase: "was"

Phrase: "observed in the cerebral cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C1441672:Observed [Functional Concept]
   760   C2700441:Cortex [Plant]

Phrase: "(Brodman area 22"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1272540:Brodmann area 22 [Body Part, Organ, or Organ Component]
  1000   C2322884:Brodmann area 22 [Body Location or Region]
   901   C0599720:Brodmann area [Body Location or Region]
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]

Phrase: ")"

Phrase: "of a control brain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0243148:control [Qualitative Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "from"

Phrase: "of a 25 year old patient's brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in some subpial astroglial cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(arrow head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0018670:Head [Body Location or Region]
   861   C1281590:Head [Body Part, Organ, or Organ Component]
   861   C1706305:Head [Manufactured Object]
   805 E C0205096:Cephalic [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "in few blood vessels"
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
   901   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   867 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   867 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   829 E C1558950:VASCULAR [Finding]
   829 E C1801960:Vascular [Qualitative Concept]
   808 E C0005767:Blood [Tissue]
   808 E C0005768:blood [Body Substance]
   808 E C0229664:Blood [Body Substance]
   808 E C0392895:Bloods [Population Group]
   790 E C0333275:Bloody [Qualitative Concept]
   755 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "and in few neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0027882:Neurons [Cell]
   770   C1515981:And [Idea or Concept]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.96: In a 76 year old control brain, the number of AGE-positive nerve cells was increased (arrow), compared with the young brain (B). 

Phrase: "In a 76 year old control brain,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C0243148:control [Qualitative Concept]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]

Phrase: "the number of AGE-positive nerve cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "compared with the young brain (B)."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0332239:Young [Temporal Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.97: AGE deposits in blood vessels and in astrocytes were observed in increasing numbers in comparison to the young brain (B). 

Phrase: "AGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "deposits in blood vessels"
Meta Candidates (Total=13; Excluded=10; Pruned=0; Remaining=3)
   833   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   799 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   799 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   770   C0333562:Deposit [Functional Concept]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]
   740 E C0005767:Blood [Tissue]
   740 E C0005768:blood [Body Substance]
   740 E C0229664:Blood [Body Substance]
   740 E C0392895:Bloods [Population Group]
   722 E C0333275:Bloody [Qualitative Concept]

Phrase: "and in astrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004112:Astrocytes [Cell]
   790   C1515981:And [Idea or Concept]

Phrase: "were"

Phrase: "observed in increasing numbers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0237753:*Number [Quantitative Concept]
   770   C0442808:Increasing [Functional Concept]
   770   C0449788:Number [Quantitative Concept]
   770   C1441672:Observed [Functional Concept]

Phrase: "in comparison to the young brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.98: The intensity of immunoreaction in astrocytes in the subpial region (arrow head) increased continuously with age. 

Phrase: "The intensity of immunoreaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522510:Intensity [Qualitative Concept]

Phrase: "in astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "in the subpial region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "(arrow head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0018670:Head [Body Location or Region]
   861   C1281590:Head [Body Part, Organ, or Organ Component]
   861   C1706305:Head [Manufactured Object]
   805 E C0205096:Cephalic [Spatial Concept]

Phrase: ")"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "continuously with age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001779:Age [Organism Attribute]
Processing 00000000.tx.99: The number and intensity of AGE-positive nerve cells (arrow), astrocytes and blood vessels was increased in the cerebral cortex (Brodman area 22) of an early AD case (C) compared with the non-demented age-matched control brain (B). 

Phrase: "The number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "intensity of AGE-positive nerve cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0522510:Intensity [Qualitative Concept]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "and"

Phrase: "blood vessels"
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
  1000   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   966 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   966 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   928 E C1558950:VASCULAR [Finding]
   928 E C1801960:Vascular [Qualitative Concept]
   907 E C0005767:Blood [Tissue]
   907 E C0005768:blood [Body Substance]
   907 E C0229664:Blood [Body Substance]
   907 E C0392895:Bloods [Population Group]
   888 E C0333275:Bloody [Qualitative Concept]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "increased in the cerebral cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]

Phrase: "(Brodman area 22"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1272540:Brodmann area 22 [Body Part, Organ, or Organ Component]
  1000   C2322884:Brodmann area 22 [Body Location or Region]
   901   C0599720:Brodmann area [Body Location or Region]
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]

Phrase: ")"

Phrase: "of an early AD case (C)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0868928:Case [Functional Concept]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]

Phrase: "compared with the non-demented age-matched control brain"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   762   C0596948:brain control [Mental Process]
   742   C0001779:Age [Organism Attribute]
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0150103:matched [Research Activity]
   742   C0243148:control [Qualitative Concept]
   742   C0860630:demented [Mental or Behavioral Dysfunction]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   742   C1518422:Non [Functional Concept]
   742   C1550141:Control [Substance]
   742   C1707455:Compared [Activity]
   742   C1708943:Matched [Qualitative Concept]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]

Phrase: "(B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.100: In late-stage AD, the number of astrocytes around the senile plaques (arrows) was significantly increased (D). 

Phrase: "In late-stage AD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1279941:Late stage [Temporal Concept]

Phrase: "the number of astrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "around the senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "was"

Phrase: "significantly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.101: Scale bar = 500 m.  

Phrase: "Scale bar = 500 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.102: View larger version (175K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(175K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.103: Higher magnification images of typical AGE-positive structures in a young and old healthy brain, as well as in an early and late-stage AD brain. 

Phrase: "Higher magnification images of typical AGE-positive structures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1704254:Image [Intellectual Product]
   711   C1704922:Image [Entity]
   711   C3542466:Image [Intellectual Product]

Phrase: "in a young"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "and"

Phrase: "old healthy brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "as well as in an early"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205170:Well [Qualitative Concept]
   753   C1279919:Early [Temporal Concept]
   753   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "late-stage AD brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.104: In the young control brains (<30 years), some weak AGE immunoreactivity could already be observed, but only in a few (<0.5%) nerve cells (A). 

Phrase: "In the young control brains"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "("

Phrase: "<30 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "some weak AGE immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "could"

Phrase: "already"

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "but"

Phrase: "only in a few"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205171:Only [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]

Phrase: "("

Phrase: "<0.5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: ")"

Phrase: "nerve cells"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0027882:Nerve Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0027740:Nerve [Tissue]
   861   C0027757:NERVE [Tissue]
   861   C1280541:Nerve [Body Part, Organ, or Organ Component]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   805 E C0599851:Neural [Functional Concept]
   789 E C0027769:nervy [Sign or Symptom]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.105: In the brain of an old human (>70 years), more nerve cells (25%) were positive for AGEs (B). 

Phrase: "In the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of an old human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Human [Human]

Phrase: "("

Phrase: ">70 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "more nerve cells"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   901   C0027882:Nerve Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]

Phrase: "(25%"

Phrase: ")"

Phrase: "were"

Phrase: "positive for AGEs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0439178:% Positive [Quantitative Concept]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C2825490:Positive [Qualitative Concept]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "(B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.106: In early stages of AD, the number of AGE-positive nerve cells was increased (38%), and astrocytes were labeled (C). 

Phrase: "In early stages"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C2363430:early stages [Temporal Concept]
   983 E C1517886:Early Stage [Classification]
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "of AD,"

Phrase: "the number of AGE-positive nerve cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(38%"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "were"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(C"

Phrase: ")."
Processing 00000000.tx.107: In late stages of AD, the majority of nerve cells (>70%) and plaque-associated astrocytes showed strong AGE immunoreactivity (D). 

Phrase: "In late stages"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1279941:late stages [Temporal Concept]
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "of AD,"

Phrase: "the majority of nerve cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "("

Phrase: ">70%"

Phrase: ")"

Phrase: "and"

Phrase: "plaque-associated astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004112:Astrocytes [Cell]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "strong AGE immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.108: Scale bar = 50 m.  

Phrase: "Scale bar = 50 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.109: View this table: [in this window] [in a new window]  Table 1 Semiquantitative determination of the percentage of AGE-positive neurons compared with the total number of neurons (visualized by Nissl stain) in the cerebral cortex (area 22) of controls of different ages, and of cases with early and late stages of AD  View this table: [in this window] [in a new window]  Table 2 Semiquantitative determination of the percentage of AGE-positive astrocytes compared with the total number of GFAP-positive astrocytes in the cerebral cortex (area 22) of controls of different ages, and of cases with early and late stage of AD  Intracellular AGE Deposits Increase in Brains of Alzheimer's Patients Compared with Age-matched, Non-demented Controls The deposition of AGEs in brains of patients with both early (IIII) and late (V and VI) stages of AD were compared with age-matched, non-demented brains with respect to the number of AGE-immunoreactive deposits and their intensity. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1 Semiquantitative determination of the percentage of AGE-positive neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0868918:Age determination [Quantitative Concept]
   738   C1148554:determination [Laboratory Procedure]

Phrase: "compared with the total number of neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0027882:Neurons [Cell]
   748   C0237753:*Number [Quantitative Concept]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1707455:Compared [Activity]

Phrase: "("

Phrase: "visualized by Nissl stain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   770   C0234621:Visualized [Functional Concept]

Phrase: ")"

Phrase: "in the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "(area 22"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: ")"

Phrase: "of controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "of different ages,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "and of cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0868928:Cases [Functional Concept]
   790   C1515981:And [Idea or Concept]
   790   C1533148:Cases [Quantitative Concept]
   756 E C1706255:CASE [Medical Device]
   756 E C1706256:Case [Conceptual Entity]

Phrase: "with early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205087:Late [Temporal Concept]

Phrase: "stages of AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205390:Stage [Temporal Concept]
   790   C1300072:Stage [Clinical Attribute]
   790   C1306673:Stage [Qualitative Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2 Semiquantitative determination of the percentage of AGE-positive astrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0868918:Age determination [Quantitative Concept]
   738   C1148554:determination [Laboratory Procedure]

Phrase: "compared with the total number of GFAP-positive astrocytes"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   742   C0004112:Astrocytes [Cell]
   742   C0017626:GFAP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0237753:*Number [Quantitative Concept]
   742   C0439175:% total [Quantitative Concept]
   742   C0439178:% Positive [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C1415042:GFAP [Gene or Genome]
   742   C1446409:Positive [Qualitative Concept]
   742   C1514241:Positive [Finding]
   742   C1707455:Compared [Activity]
   742   C2825490:Positive [Qualitative Concept]

Phrase: "in the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "(area 22"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: ")"

Phrase: "of controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "of different ages,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "and of cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0868928:Cases [Functional Concept]
   790   C1515981:And [Idea or Concept]
   790   C1533148:Cases [Quantitative Concept]
   756 E C1706255:CASE [Medical Device]
   756 E C1706256:Case [Conceptual Entity]

Phrase: "with early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205087:Late [Temporal Concept]

Phrase: "stage of AD  Intracellular AGE Deposits"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0001779:Age [Organism Attribute]
   753   C0175996:intracellular [Cell Component]
   753   C0178719:Intracellular [Spatial Concept]
   753   C0205390:Stage [Temporal Concept]
   753   C0333562:Deposits [Functional Concept]
   753   C1300072:Stage [Clinical Attribute]
   753   C1306673:Stage [Qualitative Concept]

Phrase: "Increase in Brains of Alzheimer's Patients"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0442805:Increase [Functional Concept]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "Compared with Age-matched, Non-demented"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0001779:Age [Organism Attribute]
   753   C0150103:matched [Research Activity]
   753   C0860630:demented [Mental or Behavioral Dysfunction]
   753   C1518422:Non [Functional Concept]
   753   C1707455:Compared [Activity]
   753   C1708943:Matched [Qualitative Concept]

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "The deposition of AGEs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0333562:Deposition [Functional Concept]

Phrase: "in brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with both early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "(IIII"

Phrase: ")"

Phrase: "and"

Phrase: "late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205087:Late [Temporal Concept]

Phrase: "(V"

Phrase: "and"

Phrase: "VI)"

Phrase: "stages of AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205390:Stage [Temporal Concept]
   790   C1300072:Stage [Clinical Attribute]
   790   C1306673:Stage [Qualitative Concept]

Phrase: "were"

Phrase: "compared with age-matched, non-demented brains"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0001779:Age [Organism Attribute]
   748   C0006104:Brains [Body Part, Organ, or Organ Component]
   748   C0150103:matched [Research Activity]
   748   C0860630:demented [Mental or Behavioral Dysfunction]
   748   C1518422:Non [Functional Concept]
   748   C1707455:Compared [Activity]
   748   C1708943:Matched [Qualitative Concept]
   714 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "with respect to the number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of AGE-immunoreactive deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]

Phrase: "and"

Phrase: "their intensity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522510:Intensity [Qualitative Concept]
Processing 00000000.tx.110: The numbers of AGE-positive neurons were clearly increased in AD brains (to 37.5% in early AD and 72.6% in late AD), compared with non-demented brains of the same age (24.6%; Table 1). 

Phrase: "The numbers of AGE-positive neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "were"

Phrase: "clearly"

Phrase: "increased in AD brains"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "("

Phrase: "to 37.5%"

Phrase: "in early AD"

Phrase: "and"

Phrase: "72.6% in late AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0283766:AD 6 [Organic Chemical,Pharmacologic Substance]
   760   C0205087:Late [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "compared with non-demented brains"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C0860630:demented [Mental or Behavioral Dysfunction]
   760   C1518422:Non [Functional Concept]
   760   C1707455:Compared [Activity]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of the same age (24.6%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0001779:Age [Organism Attribute]
   812   C0445247:Same [Qualitative Concept]

Phrase: "; Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.111: The even more obvious difference between AD patients and controls was the occurrence of senile plaques in great quantities in AD brains, which were accompanied by AGE-positive astrocytes (Figs 2AD and 3). 

Phrase: "The even more obvious difference between AD patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "the occurrence of senile plaques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243132:occurrence [Functional Concept]
   760   C1554210:occurrence [Idea or Concept]
   760   C2745955:Occurrence [Temporal Concept]

Phrase: "in great quantities"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1265611:QUANTITIES [Quantitative Concept]
   827 E C1554108:Quantity [Intellectual Product]
   827 E C1561573:Quantity [Intellectual Product]

Phrase: "in AD brains,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "which"

Phrase: "were"

Phrase: "accompanied by AGE-positive astrocytes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0001779:Age [Organism Attribute]
   760   C0004112:Astrocytes [Cell]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C2825490:Positive [Qualitative Concept]

Phrase: "(Figs 2AD"

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.112: Besides astrocytes in the subpial regions, many astrocytes around senile plaques showed intensive AGE immunoreactivity (Fig. 3C,D). 

Phrase: "Besides astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "in the subpial regions,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "many astrocytes around senile plaques"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0004112:Astrocytes [Cell]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "intensive AGE immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "(Fig. 3C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: "D)."
Processing 00000000.tx.113: Notably, AGEs could be detected in astrocytes that were in physical contact to amyloid plaques, and also in those farther from the plaques, indicating that soluble factors may contribute to intracellular AGE formation in astrocytes. 

Phrase: "Notably,"

Phrase: "AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "could"

Phrase: "be"

Phrase: "detected in astrocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0004112:Astrocytes [Cell]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "were in physical contact"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0221190:Physical contact [Phenomenon or Process]
   833   C0392367:Physical contact [Phenomenon or Process]
   770   C0031809:Physical [Health Care Activity]
   770   C0205485:Physical [Functional Concept]
   770   C0332158:contact [Functional Concept]
   770   C0337611:Contact [Population Group]
   770   C1509143:Physical [Finding]
   770   C1705415:Contact [Idea or Concept]

Phrase: "to amyloid plaques,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
  1000   C2936349:Plaques, Amyloid [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "also in those farther"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0205108:far [Spatial Concept]

Phrase: "from the plaques,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "indicating"

Phrase: "that soluble factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "contribute to intracellular AGE formation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0001779:Age [Organism Attribute]
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
   760   C1880177:Contribute [Activity]

Phrase: "in astrocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]
Processing 00000000.tx.114: Furthermore, AGE immunostaining could also be observed in blood vessels and glial cells in the white matter of the cerebral cortex of AD patients, but not in non-demented controls (Fig. 4). 

Phrase: "Furthermore,"

Phrase: "AGE immunostaining"

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "observed in blood vessels"
Meta Candidates (Total=13; Excluded=10; Pruned=0; Remaining=3)
   833   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   799 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   799 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   770   C1441672:Observed [Functional Concept]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]
   740 E C0005767:Blood [Tissue]
   740 E C0005768:blood [Body Substance]
   740 E C0229664:Blood [Body Substance]
   740 E C0392895:Bloods [Population Group]
   722 E C0333275:Bloody [Qualitative Concept]

Phrase: "and"

Phrase: "glial cells in the white matter of the cerebral cortex of AD patients,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   750   C0027836:Glial Cells [Cell]
           Glial
   735   C0007634:Cells [Cell]
   735   C3282337:Cells [Cell]
   732   C0023516:White Cell [Cell]
   732   C1166657:cell cortex [Cell Component]
   702 E C1269647:Cell [Cell]
   702 E C1704653:Cell [Medical Device]
   702 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "not in non-demented controls"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0860630:demented [Mental or Behavioral Dysfunction]
   760   C1518422:Non [Functional Concept]
           Not
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.115: View larger version (190K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(190K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.116: AGE-positive astrocytes in the layer I and II and in deeper layers of the cerebral cortex of control and AD brains. 

Phrase: "AGE-positive astrocytes in the layer I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0004112:Astrocytes [Cell]

Phrase: "and"

Phrase: "II"

Phrase: "and in deeper layers of the cerebral cortex of control"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   786   C2337405:Layer of cerebral cortex [Body Part, Organ, or Organ Component]
   760   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   739   C0243148:control [Qualitative Concept]
   739   C0934502:layers [Body Part, Organ, or Organ Component]
   739   C1176472:Cortex [Body Part, Organ, or Organ Component]
   739   C1515981:And [Idea or Concept]
   739   C1550141:Control [Substance]
   739   C1882979:Control [Conceptual Entity]
   739   C2587213:Control [Functional Concept]
   739   C2700441:Cortex [Plant]
   739   C3274648:Control [Qualitative Concept]
   706   C0205125:Deep [Spatial Concept]
   706 E C1522408:Layer [Qualitative Concept]
   706 E C1561599:Layer [Intellectual Product]

Phrase: "and"

Phrase: "AD brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.117: AGE-positive astrocytes were detected in the cerebral cortex (layers I and II) of a non-demented old control (A) and an AD brain (B). 

Phrase: "AGE-positive astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004112:Astrocytes [Cell]

Phrase: "were"

Phrase: "detected in the cerebral cortex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   760   C0442726:Detected [Finding]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C2700441:Cortex [Plant]

Phrase: "(layers I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "II"

Phrase: ")"

Phrase: "of a non-demented old control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "(A"

Phrase: ")"

Phrase: "and"

Phrase: "an AD brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.118: Astrocytes in layers V/VI of a non-demented control (C) and AD brain (D) were also immunopositive for AGEs. 

Phrase: "Astrocytes in layers V/VI of a non-demented control (C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0004112:Astrocytes [Cell]

Phrase: ")"

Phrase: "and"

Phrase: "AD brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "("

Phrase: "D)"

Phrase: "were"

Phrase: "also immunopositive for AGEs."
Processing 00000000.tx.119: In AD brains, AGE-positive astrocytes were located around senile plaques (D), while they were more isolated in control brains (C). 

Phrase: "In AD brains,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "AGE-positive astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004112:Astrocytes [Cell]

Phrase: "were"

Phrase: "located around senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   770   C0392079:Senile [Finding]
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0332461:Plaque [Finding]
   715 E C0231337:Old age [Finding]
   715 E C1999167:Old age [Population Group]

Phrase: "("

Phrase: "D)"

Phrase: ","

Phrase: "while"

Phrase: "they"

Phrase: "were"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "isolated in control brains"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   819   C0596948:brains control [Mental Process]
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0205409:Isolated [Functional Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(C"

Phrase: ")."
Processing 00000000.tx.120: Scale bar = 20 m.  

Phrase: "Scale bar = 20 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.121: View larger version (74K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(74K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.122: Demonstration of AGE-positive glial cells in the white matter of the cortex of a control and an AD case. 

Phrase: "Demonstration of AGE-positive glial cells"

Phrase: "in the white matter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0682708:White matter [Tissue]
   861   C0007457:White [Population Group]
   861   C0043157:White [Population Group]
   861   C0220938:White [Qualitative Concept]

Phrase: "of the cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "of a control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "an AD case."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.123: In the white matter of the old control brains, AGE immunoreactivity was only observed in blood vessels (A). 

Phrase: "In the white matter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0682708:White matter [Tissue]
   861   C0007457:White [Population Group]
   861   C0043157:White [Population Group]
   861   C0220938:White [Qualitative Concept]

Phrase: "of the old control brains,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "AGE immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "observed in blood vessels"
Meta Candidates (Total=13; Excluded=10; Pruned=0; Remaining=3)
   833   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   799 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   799 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   770   C1441672:Observed [Functional Concept]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]
   740 E C0005767:Blood [Tissue]
   740 E C0005768:blood [Body Substance]
   740 E C0229664:Blood [Body Substance]
   740 E C0392895:Bloods [Population Group]
   722 E C0333275:Bloody [Qualitative Concept]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.124: In contrast, AGEs were also detected in astrocytes of the white matter in the AD brains (B). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "were"

Phrase: "also"

Phrase: "detected in astrocytes of the white matter"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0682708:White matter [Tissue]
   748   C0004112:Astrocytes [Cell]
   748   C0007457:White [Population Group]
   748   C0043157:White [Population Group]
   748   C0220938:White [Qualitative Concept]
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in the AD brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.125: Scale bar = 20 m.  

Phrase: "Scale bar = 20 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.126: Deposition of AGEs in Brains of AD Patients Increased with Braak Stage The progression of AD pathology can be analyzed and described by the six different AD stages introduced by Braak and Braak (1991). 

Phrase: "Deposition of AGEs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333562:Deposition [Functional Concept]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "in Brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of AD Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "Increased with Braak Stage"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205217:Increased [Quantitative Concept]
   770   C0205390:Stage [Temporal Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1300072:Stage [Clinical Attribute]
   770   C1306673:Stage [Qualitative Concept]

Phrase: "The progression of AD pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0242656:progression [Pathologic Function]
   760   C0449258:Progression [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "described by the six different AD stages"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0205452:Six [Quantitative Concept]
   748   C1306673:Stages [Qualitative Concept]
   748   C1552738:described [Idea or Concept]
   748   C1705242:Different [Qualitative Concept]
   714 E C0205390:Stage [Temporal Concept]
   714 E C1300072:Stage [Clinical Attribute]

Phrase: "introduced by Braak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1292748:introduce [Functional Concept]

Phrase: "and"

Phrase: "Braak"

Phrase: "(1991"

Phrase: ")."
Processing 00000000.tx.127: Brains were staged by analysis of fibrillar amyloid plaques (thioflavin S method) and by analysis of NFTs (immunoreaction of the antibody AT8). 

Phrase: "Brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "staged by analysis of fibrillar amyloid plaques"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   778   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   778   C2936349:Plaques, Amyloid [Acquired Abnormality]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   714 E C0011389:Plaque [Disease or Syndrome]
   714   C0205390:Stage [Temporal Concept]
   714 E C0332461:Plaque [Finding]
   714   C1300072:Stage [Clinical Attribute]
   714   C1306673:Stage [Qualitative Concept]

Phrase: "(thioflavin S method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: "and by analysis of NFTs"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   756 E C3543859:neurofibrillary tangle [Cell Component]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1515981:And [Idea or Concept]
   753   C1524024:analysis [Functional Concept]

Phrase: "(immunoreaction of the antibody AT8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0872193:immunoreaction [Organism Function]

Phrase: ")."
Processing 00000000.tx.128: Using this classification system, the stage-dependent deposition of AGEs was determined in more detail in AD patients with defined Braak stages. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this classification system,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0008902:Classification system [Classification]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "the stage-dependent deposition of AGEs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0333562:Deposition [Functional Concept]

Phrase: "was"

Phrase: "determined in more detail"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1522508:Detail [Qualitative Concept]
   770   C1561567:detail [Functional Concept]

Phrase: "in AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "with defined Braak stages."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1306673:Stages [Qualitative Concept]
   793 E C0205390:Stage [Temporal Concept]
   793 E C1300072:Stage [Clinical Attribute]
Processing 00000000.tx.129: Unexpectedly, deposition of AGEs in astrocytes, neurons and blood vessels could be observed in this area in Braak stages I and II (Fig. 1C), in which the neurofibrillary pathology is still limited to the entorhinal cortex, and has not spread to the investigated Brodmann area 22 (which is a part of the unaffected isocortex). 

Phrase: "Unexpectedly,"

Phrase: "deposition of AGEs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333562:Deposition [Functional Concept]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "in astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "blood vessels"
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
  1000   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   966 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   966 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   928 E C1558950:VASCULAR [Finding]
   928 E C1801960:Vascular [Qualitative Concept]
   907 E C0005767:Blood [Tissue]
   907 E C0005768:blood [Body Substance]
   907 E C0229664:Blood [Body Substance]
   907 E C0392895:Bloods [Population Group]
   888 E C0333275:Bloody [Qualitative Concept]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "could"

Phrase: "be"

Phrase: "observed in this area"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017446:Area [Geographic Area]
   770   C0205146:Area [Spatial Concept]
   770   C1441672:Observed [Functional Concept]

Phrase: "in Braak stages I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0441766:Stage I [Intellectual Product]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "II"

Phrase: "(Fig. 1C"

Phrase: ")"

Phrase: ","

Phrase: "in which"

Phrase: "the neurofibrillary pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "is"

Phrase: "still"

Phrase: "limited to the entorhinal cortex,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
   806   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
   760   C0007776:Cortex [Body Part, Organ, or Organ Component]
   760   C0439801:Limited [Functional Concept]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]
   760   C3542948:Limited [Intellectual Product]
   726 E C1549649:Limit [Idea or Concept]
   726 E C2349209:Limit [Conceptual Entity]

Phrase: "and"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "spread to the investigated Brodmann area 22"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C1272540:Brodmann area 22 [Body Part, Organ, or Organ Component]
   814   C2322884:Brodmann area 22 [Body Location or Region]
   778   C0599720:Brodmann area [Body Location or Region]
   748   C0017446:Area [Geographic Area]
   748   C0205146:Area [Spatial Concept]
   748   C0332261:Spread [Qualitative Concept]
   748   C1292732:investigated [Functional Concept]
   748   C1947932:Spread [Activity]

Phrase: "("

Phrase: "which"

Phrase: "is"

Phrase: "a part of the unaffected isocortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.130: The presence of markers of carbonyl stress (increased levels of AGEs) in areas yet unaffected by AD-specific lesions is reminiscent of data obtained by Smith and Perry, where markers of oxidative stress were shown to precede tangle and plaque formation in AD (Perry et al., 2002). 

Phrase: "The presence of markers of carbonyl stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(increased levels of AGEs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: "in areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205146:areas [Spatial Concept]
   966 E C0017446:Area [Geographic Area]

Phrase: "yet unaffected by AD-specific lesions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2986417:Unaffected [Conceptual Entity]

Phrase: "is"

Phrase: "reminiscent of data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0871247:reminiscence [Mental Process]

Phrase: "obtained by Smith"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0554249:Smith [Professional or Occupational Group]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "Perry,"

Phrase: "where markers of oxidative stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0005516:Marker [Clinical Attribute]

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "precede"

Phrase: "tangle"

Phrase: "and"

Phrase: "plaque formation in AD (Perry et al.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.131: The deposits quite clearly increased in intensity over stages IVVI (Figs 1D and 2C,D). 

Phrase: "The deposits quite clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]

Phrase: "increased in intensity"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C0522510:Intensity [Qualitative Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "over stages"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0205136:Over [Spatial Concept]
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "IVVI"

Phrase: "(Figs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0349966:Figs [Food]
   966 E C1337208:FIG [Food]

Phrase: "1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: "and"

Phrase: "2C,"

Phrase: "D)."
Processing 00000000.tx.132: In the late stages, the number of AGE-positive neurons was extremely high (72% of neurons) (Figs 1D and 2D, Table 1). 

Phrase: "In the late stages,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1279941:late stages [Temporal Concept]
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "the number of AGE-positive neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "extremely high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "(72% of neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: ")"

Phrase: "(Figs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0349966:Figs [Food]
   966 E C1337208:FIG [Food]

Phrase: "1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: "and"

Phrase: "2D, Table 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0039224:Table [Manufactured Object]
   827   C1705052:2D [Spatial Concept]
   827   C1706073:Table [Medical Device]
   827   C1706074:Table [Intellectual Product]
   827   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.133: AGE-positive astroglia, associated with the increased number of senile plaques, also increased in number and intensity of their immunoreactivity (Figs 1C,D and 2C,D). 

Phrase: "AGE-positive astroglia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004112:Astroglia [Cell]

Phrase: "associated with the increased number of senile plaques,"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   793   C0449793:Number of plaques [Quantitative Concept]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   744   C0205217:Increased [Quantitative Concept]
   744   C0237753:*Number [Quantitative Concept]
   744   C0392079:Senile [Finding]
   744   C0442805:Increased [Functional Concept]
   744   C0449788:Number [Quantitative Concept]
   711 E C0011389:Plaque [Disease or Syndrome]
   711 E C0332461:Plaque [Finding]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "also"

Phrase: "increased in number"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0205217:Increased [Quantitative Concept]
   790   C0237753:*Number [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C0449788:Number [Quantitative Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "intensity of their immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522510:Intensity [Qualitative Concept]

Phrase: "(Figs 1C,"

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "2C,"

Phrase: "D)."
Processing 00000000.tx.134: Co-localization of AGEs with Different Hallmarks of AD AGEs and Hyperphosphorylated Tau (AT8 Immunoreactivity) As outlined in the Introduction, NFTs go through three different stages of development (stage 1, pre-NFTs; stage 2, intra-neuronal NFTs; and stage 3, extra-neuronal NFTs; Braak et al., 1994; Augustinack et al., 2002). 

Phrase: "Co-localization of AGEs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "with Different Hallmarks"

Phrase: "of AD AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   937   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   804   C0205179:Advanced [Qualitative Concept]
   804   C0444930:End [Spatial Concept]
   804   C0598528:glycation [Phenomenon or Process]
   804   C1514468:Products [Entity]
   804   C2746065:End [Temporal Concept]
   771 E C0725066:Advance [Medical Device]
   771 E C1704444:Product [Quantitative Concept]
   748 E C0205088:Terminal [Temporal Concept]
   748 E C1705314:Terminal [Manufactured Object]
   748 E C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "Hyperphosphorylated Tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(AT8 Immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: ")"

Phrase: "As"

Phrase: "outlined in the Introduction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1293116:Introduction [Health Care Activity]
   770   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "go through three different stages of development"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   748   C0205449:Three [Quantitative Concept]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1306673:Stages [Qualitative Concept]
   748   C1527148:Development [Functional Concept]
   748   C1705242:Different [Qualitative Concept]
   748   C1822658:GO [Gene or Genome]
   738   C0870411:Developmental stages [Temporal Concept]
   714 E C0205390:Stage [Temporal Concept]
   714 E C1300072:Stage [Clinical Attribute]

Phrase: "(stage 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441766:Stage 1 [Intellectual Product]
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]

Phrase: "pre-NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "; stage 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441767:Stage 2 [Intellectual Product]
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]

Phrase: "intra-neuronal NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   827 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: ";"

Phrase: "and"

Phrase: "stage 3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441771:Stage 3 [Intellectual Product]
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]

Phrase: "extra-neuronal NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   827 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "; Braak et al.,"

Phrase: "1994"

Phrase: "; Augustinack et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.135: All three types of tangles can be present in the same region of an AD patient simultaneously. 

Phrase: "All three types of tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0332307:Types [Qualitative Concept]
   726 E C1547052:*Type [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "present in the same region of an AD patient simultaneously."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0150312:Present [Quantitative Concept]
   739   C0449450:Present [Idea or Concept]
Processing 00000000.tx.136: In the brains used in this study, hyperphosphorylated tau (AT8 immunoreactivity) was detected in neurons in various stages of tangle development, including those exhibiting a diffuse AT8 immunoreactivity in the perikaryon (and representing neurons in the pre-neurofibrillary tangle stage). 

Phrase: "In the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "used in this study,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "hyperphosphorylated tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(AT8 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: ")"

Phrase: "was"

Phrase: "detected in neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0027882:Neurons [Cell]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in various stages"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "of tangle development,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "those exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "a diffuse AT8 immunoreactivity in the perikaryon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597879:immunoreactivity [Molecular Function]

Phrase: "("

Phrase: "and"

Phrase: "representing neurons in the pre-neurofibrillary tangle stage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0027882:Neurons [Cell]

Phrase: ")."
Processing 00000000.tx.137: Using double immunofluorescence to co-localize AGEs and hyperphosphorylated tau, AGE immunoreactivity could be detected in neurons in tangle stage 1, i.e. in neurons with pre-NFTs (Fig. 5). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "double immunofluorescence to"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0016318:Immunofluorescence [Laboratory Procedure]
   790   C0079603:Immunofluorescence [Laboratory Procedure]
   734 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   718 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "co-localize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392752:localize [Spatial Concept]

Phrase: "AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "hyperphosphorylated tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "AGE immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "could"

Phrase: "be"

Phrase: "detected in neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0027882:Neurons [Cell]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in tangle stage 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0441766:Stage 1 [Intellectual Product]
   827   C0205390:Stage [Temporal Concept]
   827   C1300072:Stage [Clinical Attribute]
   827   C1306673:Stage [Qualitative Concept]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "with pre-NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.138: In these neurons, AT8 immunoreactivity was nonfibrillar and diffusely distributed in the cytoplasm (Fig. 5). 

Phrase: "In these neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "AT8 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "nonfibrillar"

Phrase: "and"

Phrase: "diffusely"

Phrase: "distributed in the cytoplasm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010834:Cytoplasm [Cell Component]
   770   C1704711:Distributed [Functional Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.139: It has to be noted that these diffusely AT-8 positive neurons were always AGE-positive, indicating that hyperphosphorylation and AGE accumulation may be linked. 

Phrase: "It"

Phrase: "has"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "these diffusely AT-8 positive neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "always AGE-positive,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "indicating"

Phrase: "that hyperphosphorylation"

Phrase: "and"

Phrase: "AGE accumulation"

Phrase: "may"

Phrase: "be"

Phrase: "linked."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]
Processing 00000000.tx.140: Also, in tangle stage 2, the majority (70%) of nerve cells contained AGEs and AT8 immunoreactivity, whereas extra-neuronal NFTs (tangle stage 3) very rarely showed AGE immunoreactivity (Fig. 5AC). 

Phrase: "Also,"

Phrase: "in tangle stage 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0441767:Stage 2 [Intellectual Product]
   827   C0205390:Stage [Temporal Concept]
   827   C1300072:Stage [Clinical Attribute]
   827   C1306673:Stage [Qualitative Concept]

Phrase: "the majority"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680220:majority [Social Behavior]

Phrase: "(70%"

Phrase: ")"

Phrase: "of nerve cells"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0027882:Nerve Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0027740:Nerve [Tissue]
   861   C0027757:NERVE [Tissue]
   861   C1280541:Nerve [Body Part, Organ, or Organ Component]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   805 E C0599851:Neural [Functional Concept]
   789 E C0027769:nervy [Sign or Symptom]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "AT8 immunoreactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "whereas"

Phrase: "extra-neuronal NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   827 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(tangle stage 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0441771:Stage 3 [Intellectual Product]
   827   C0205390:Stage [Temporal Concept]
   827   C1300072:Stage [Clinical Attribute]
   827   C1306673:Stage [Qualitative Concept]

Phrase: ")"

Phrase: "very rarely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442824:Very [Qualitative Concept]
   861   C0522498:Rarely [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "AGE immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "(Fig. 5AC"

Phrase: ")."
Processing 00000000.tx.141: View larger version (95K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(95K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.142: Co-localization of AGEs and hyperphosphorylated tau (AT-8). 

Phrase: "Co-localization of AGEs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "hyperphosphorylated tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(AT-8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516077:At [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.143: Double immunofluorescence was used for the simultaneous detection of AGEs (A, green) and hyperphosphorylated tau (AT-8 antibody) (B, red). 

Phrase: "Double immunofluorescence"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "used for the simultaneous detection of AGEs"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   806   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   741   C1524063:Use of [Functional Concept]
   739   C0205179:Advanced [Qualitative Concept]
   739   C0444930:End [Spatial Concept]
   739   C0521115:Simultaneous [Temporal Concept]
   739   C0598528:glycation [Phenomenon or Process]
   739   C1273517:used [Finding]
   739   C1511790:Detection [Therapeutic or Preventive Procedure]
   739   C1514468:Products [Entity]
   739   C1548968:Simultaneous [Idea or Concept]
   739   C2746065:End [Temporal Concept]
   706 E C0042153:use [Functional Concept]
   706 E C0457083:Use [Functional Concept]
   706 E C0725066:Advance [Medical Device]
   706 E C1704444:Product [Quantitative Concept]
   706 E C1947944:Use [Intellectual Product]

Phrase: "(A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "hyperphosphorylated tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(AT-8 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "(B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.144: Double-labeled structures appear in yellow in (C). 

Phrase: "Double-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "labeled structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "appear in yellow in (C"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0221205:Yellow [Qualitative Concept]
   760   C0700364:APPEAR [Qualitative Concept]
   760   C0868928:Case [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.145: AGEs and hyperphosphorylated tau immunoreactivity was detected in neurons with pre-NFTs (see arrow in AC). 

Phrase: "AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "hyperphosphorylated tau immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "detected in neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0027882:Neurons [Cell]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "with pre-NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "arrow in AC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.146: Other tangle bearing neurons and the neuropil treads (arrow head) were only immunoreactive for hyperphosphorylated tau. 

Phrase: "Other tangle bearing neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "the neuropil treads"

Phrase: "(arrow head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0018670:Head [Body Location or Region]
   861   C1281590:Head [Body Part, Organ, or Organ Component]
   861   C1706305:Head [Manufactured Object]
   805 E C0205096:Cephalic [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "only immunoreactive for hyperphosphorylated tau."
Processing 00000000.tx.147: Scale bar = 50 m. 

Phrase: "Scale bar = 50 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.148: Figure 6. 

Phrase: "Figure 6."
Processing 00000000.tx.149: Co-localization of AGEs and nNOS. 

Phrase: "Co-localization of AGEs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "nNOS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417759:nNOS [Gene or Genome]
Processing 00000000.tx.150: Double immunofluorescence was used for the simultaneous detection of nNOS (A, C, red) and AGEs (B, D, green). 

Phrase: "Double immunofluorescence"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "used for the simultaneous detection of nNOS"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   757   C1524063:Use of [Functional Concept]
   748   C0521115:Simultaneous [Temporal Concept]
   748   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1273517:used [Finding]
   748   C1417759:nNOS [Gene or Genome]
   748   C1511790:Detection [Therapeutic or Preventive Procedure]
   748   C1548968:Simultaneous [Idea or Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "(A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "C,"

Phrase: "red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "and"

Phrase: "AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "(B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.151: Most pyramidal neurons of the cerebral cortex which show nNOS immunoreactivity were also AGE-positive. 

Phrase: "Most pyramidal neurons of the cerebral cortex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   824   C2333134:Neuron of cerebral cortex [Cell]
   748   C0027882:Neurons [Cell]

Phrase: "which"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "nNOS immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "were"

Phrase: "also AGE-positive."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]
Processing 00000000.tx.152: nNOS in the human cerebral cortex of patients with AD was localized in two types of neurons: pyramidal cells (C, arrow head) and interneurons (C, asterisk). 

Phrase: "nNOS in the human cerebral cortex of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1417759:nNOS [Gene or Genome]

Phrase: "with AD"

Phrase: "was"

Phrase: "localized in two types of neurons"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0027882:Neurons [Cell]
   753   C0205448:Two [Quantitative Concept]
   753   C0332307:Types [Qualitative Concept]
   753   C0392752:Localized [Spatial Concept]
   750   C0682689:neuron type [Cell]
   719 E C1547052:*Type [Quantitative Concept]

Phrase: ":"

Phrase: "pyramidal cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0206441:Pyramidal Cells [Cell]
   966 E C2334588:Pyramidal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(C,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "arrow head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0018670:Head [Body Location or Region]
   861   C1281590:Head [Body Part, Organ, or Organ Component]
   861   C1706305:Head [Manufactured Object]
   805 E C0205096:Cephalic [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "interneurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021792:Interneurons [Cell]

Phrase: "(C,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.153: AGEs were co-localized with nNOS only in the pyramidal cells, but not in interneurons (E). 

Phrase: "AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "were"

Phrase: "co-localized with nNOS only"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205171:Only [Quantitative Concept]
   760   C0392752:Localized [Spatial Concept]
   760   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1417759:nNOS [Gene or Genome]
   760   C1720467:Only [Intellectual Product]

Phrase: "in the pyramidal cells,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0206441:Pyramidal Cells [Cell]
   966 E C2334588:Pyramidal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "not in interneurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021792:Interneurons [Cell]
   790   C1518422:Not [Functional Concept]

Phrase: "(E"

Phrase: ")."
Processing 00000000.tx.154: Furthermore, not all AGE-immunopositive pyramidal cells show co-localization with nNOS (arrow in D and E). 

Phrase: "Furthermore,"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all AGE-immunopositive pyramidal cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   902   C0178537:age cells [Temporal Concept]
   861   C0206441:Pyramidal Cells [Cell]
   827 E C2334588:Pyramidal cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "co-localization with nNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "(arrow in D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0336721:Arrow [Manufactured Object]

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.155: Scale bar = 50 m. 

Phrase: "Scale bar = 50 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.156: Figure 7. 

Phrase: "Figure 7."
Processing 00000000.tx.157: Co-localization of caspase-3 with hyperphosphorylated tau (AT8) or AGEs. 

Phrase: "Co-localization of caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "with hyperphosphorylated tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(AT8"

Phrase: ")"

Phrase: "or"

Phrase: "AGEs."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.158: Double immunofluorescence pictures of caspase-3 (A) with AGE (B) and caspase-3 (D) with hyperphosphorylated tau (E) in the cerebral cortex of an AD patient is shown. 

Phrase: "Double immunofluorescence"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "pictures of caspase-3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0441468:picture [Manufactured Object]
   770   C0441469:Picture [Manufactured Object]

Phrase: "(A"

Phrase: ")"

Phrase: "with AGE (B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "and"

Phrase: "caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "D) with hyperphosphorylated tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "(E) in the cerebral cortex of an AD patient"

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.159: Caspase-3 (A, green) was co-localized with AGEs (B, red) in 75% of the caspase-3 positive neurons (arrows in C). 

Phrase: "Caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "co-localized with AGEs"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   748   C0205179:Advanced [Qualitative Concept]
   748   C0392752:Localized [Spatial Concept]
   748   C0444930:End [Spatial Concept]
   748   C0598528:glycation [Phenomenon or Process]
   748   C1514468:Products [Entity]
   748   C2746065:End [Temporal Concept]
   714 E C0725066:Advance [Medical Device]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "(B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "red) in 75% of the caspase-3 positive neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C3256265:Red 3 [Indicator, Reagent, or Diagnostic Aid]
   742   C0332575:Red [Finding]
   742   C1260956:Red [Qualitative Concept]

Phrase: "(arrows in C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0336721:arrows [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.160: Some neurons were also labeled with hyperphosphorylated tau and caspase-3 (DF, arrows in F). 

Phrase: "Some neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "also"

Phrase: "labeled with hyperphosphorylated tau"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C1708632:Labeled [Qualitative Concept]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(DF,"

Phrase: "arrows in F)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0336721:arrows [Manufactured Object]
Processing 00000000.tx.161: Scale bar: 50 m.  

Phrase: "Scale bar"

Phrase: ":"

Phrase: "50 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.162: AGE and nNOS Various isoforms of nitric oxide synthase are elevated in AD, indicating a critical role for NO in the pathomechanism. 

Phrase: "AGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "nNOS Various isoforms of nitric oxide synthase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "elevated in AD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205250:Elevated [Qualitative Concept]
   790   C3163633:Elevated [Qualitative Concept]

Phrase: "indicating"

Phrase: "a critical role for NO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the pathomechanism."
Processing 00000000.tx.163: In the isocortex of normal human brains, nNOS immunoreactivity has been found in two different types of interneurons, whereas isocortical pyramidal cells were generally free of immunoreactivity (Lth et al., 2000). 

Phrase: "In the isocortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175173:Isocortex [Body Part, Organ, or Organ Component]

Phrase: "of normal human brains,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "nNOS immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "has"

Phrase: "been"

Phrase: "found in two different types of interneurons,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0021792:Interneurons [Cell]
   748   C0150312:Found [Quantitative Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C0332307:Types [Qualitative Concept]
   748   C1705242:Different [Qualitative Concept]
   714 E C0243095:Find [Finding]
   714 E C1547052:*Type [Quantitative Concept]

Phrase: "whereas"

Phrase: "isocortical pyramidal cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0206441:Pyramidal Cells [Cell]
   867 E C2334588:Pyramidal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "generally free of immunoreactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332296:free [Functional Concept]
   770   C1880497:Free [Qualitative Concept]
   770   C1996904:Free [Qualitative Concept]

Phrase: "(Lth et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.164: Those nNOS-positive interneurons were identified in previous studies as Martinotti neurons in the rat and human cerebral cortex (Hedlich et al., 1990; Lth et al., 1994). 

Phrase: "Those nNOS-positive interneurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021792:Interneurons [Cell]

Phrase: "were"

Phrase: "identified in previous studies"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0205156:Previous [Temporal Concept]
   770   C0205396:Identified [Qualitative Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C1552607:previous [Temporal Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "as Martinotti neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in the rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "human cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]

Phrase: "(Hedlich et al.,"

Phrase: "1990"

Phrase: "; Lth et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.165: While the distribution and immunoreactivity of cortical interneurons expressing nNOS was unchanged in AD, nNOS was detectable in pyramidal neurons of the isocortex (Fig. 6A). 

Phrase: "While"

Phrase: "the distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "immunoreactivity of cortical interneurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597879:immunoreactivity [Molecular Function]

Phrase: "expressing"

Phrase: "nNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417759:nNOS [Gene or Genome]

Phrase: "was"

Phrase: "unchanged in AD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442739:Unchanged [Finding]
   790   C2346711:Unchanged [Qualitative Concept]

Phrase: "nNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417759:nNOS [Gene or Genome]

Phrase: "was"

Phrase: "detectable in pyramidal neurons of the isocortex"

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.166: Both tangle-bearing neurons and pyramidal neurons apparently unaffected by neurofibrillary degeneration were clearly nNOS positive. 

Phrase: "Both tangle-bearing neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "pyramidal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "apparently unaffected by neurofibrillary degeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2986417:Unaffected [Conceptual Entity]

Phrase: "were"

Phrase: "clearly nNOS positive."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]
Processing 00000000.tx.167: Aberrant expression of nNOS in cortical pyramidal cells was highly co-localized with nitrotyrosine, indicating that the protein was not only deposited but enzymatically active (Lth et al., 2002). 

Phrase: "Aberrant expression of nNOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in cortical pyramidal cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0206441:Pyramidal Cells [Cell]
   867 E C2334588:Pyramidal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "co-localized with nitrotyrosine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0047645:nitrotyrosine [Amino Acid, Peptide, or Protein]
   770   C0392752:Localized [Spatial Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "deposited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:deposited [Functional Concept]

Phrase: "but"

Phrase: "enzymatically active"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205177:Active [Functional Concept]

Phrase: "(Lth et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.168: In this study, double immunofluorescence of AGE and nNOS showed a co-localization of AGEs and nNOS in many but not all pyramidal cells in upper layers II and III and deep layers V and VI (Fig. 6A,B). 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "double immunofluorescence of AGE"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0016318:Immunofluorescence [Laboratory Procedure]
   770   C0079603:Immunofluorescence [Laboratory Procedure]
   715 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "and"

Phrase: "nNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417759:nNOS [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a co-localization of AGEs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "nNOS in many"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1417759:nNOS [Gene or Genome]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all pyramidal cells in upper layers II"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   778   C0206441:Pyramidal Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   745 E C2334588:Pyramidal cell [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "deep layers V"

Phrase: "and"

Phrase: "VI (Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1553638:6a [Medical Device]

Phrase: "B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.169: nNOS was observed in cortical interneurons; 

Phrase: "nNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417759:nNOS [Gene or Genome]

Phrase: "was"

Phrase: "observed in cortical interneurons"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0001613:Cortical [Body Part, Organ, or Organ Component]
   770   C0007776:Cortical [Body Part, Organ, or Organ Component]
   770   C0021792:Interneurons [Cell]
   770   C0022655:Cortical [Body Part, Organ, or Organ Component]
   770   C1441672:Observed [Functional Concept]
   715 E C0234875:bark [Organism Attribute]
   715 E C2700441:Bark [Plant]

Phrase: ";"
Processing 00000000.tx.170: however, no AGE depositions were observed there (Fig. 6CE). 

Phrase: "however,"

Phrase: "no AGE depositions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:DEPOSITIONS [Functional Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "there"

Phrase: "(Fig. 6CE"

Phrase: ")."
Processing 00000000.tx.171: AGE and Caspase-3 Activated caspase-3 has the properties of a cell death executioner protease and has been seen in neurons, astrocytes, and in blood vessels in AD. 

Phrase: "AGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "Caspase-3 Activated caspase-3"

Phrase: "has"

Phrase: "the properties of a cell death executioner protease"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0871161:properties [Qualitative Concept]
   744   C1292721:properties [Functional Concept]
   711 E C1882134:Property [Conceptual Entity]
   711 E C2347695:Property [Entity]

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "seen in neurons,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "and in blood vessels"
Meta Candidates (Total=13; Excluded=10; Pruned=0; Remaining=3)
   833   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   799 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   799 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   770   C1515981:And [Idea or Concept]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]
   740 E C0005767:Blood [Tissue]
   740 E C0005768:blood [Body Substance]
   740 E C0229664:Blood [Body Substance]
   740 E C0392895:Bloods [Population Group]
   722 E C0333275:Bloody [Qualitative Concept]

Phrase: "in AD."
Processing 00000000.tx.172: It also exhibits a high degree of co-localization with NFTs and senile plaques. 

Phrase: "It also"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a high degree of co-localization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C2348088:Degree [Quantitative Concept]

Phrase: "with NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "senile plaques."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]
Processing 00000000.tx.173: This suggests that activated caspase-3 may be a factor in functional decline and may have an important role in neuronal cell death in an AD brain. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that activated caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "be"

Phrase: "a factor in functional decline"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   797 E C0960756:factor A [Organic Chemical]
   760   C1521761:Factor [Functional Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "may"

Phrase: "have"

Phrase: "an important role in neuronal cell death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in an AD brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.174: As described by other groups, the percentage of apoptotic neurons in the investigated Brodmann area 22 was quite small (< 1%). 

Phrase: "As"

Phrase: "described by other groups,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552738:described [Idea or Concept]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "the percentage of apoptotic neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "in the investigated Brodmann area 22"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1272540:Brodmann area 22 [Body Part, Organ, or Organ Component]
   923   C2322884:Brodmann area 22 [Body Location or Region]
   861   C0599720:Brodmann area [Body Location or Region]
   812   C0017446:Area [Geographic Area]
   812   C0205146:Area [Spatial Concept]
   812   C1292732:investigated [Functional Concept]

Phrase: "was"

Phrase: "quite small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0700321:Small [Quantitative Concept]

Phrase: "("

Phrase: "< 1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.175: Among these few caspase-3 positive neurons, a co-localization of AGE with caspase-3 immunoreactivity could be observed in 75% of the neurons (Fig. 7AC). 

Phrase: "Among these few caspase-3 positive neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]

Phrase: "a co-localization of AGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "with caspase-3 immunoreactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597879:immunoreactivity [Molecular Function]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "could"

Phrase: "be"

Phrase: "observed in 75% of the neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0027882:Neurons [Cell]
   753   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 7AC"

Phrase: ")."
Processing 00000000.tx.176: However, the majority of neurons were positive for either AGE or caspase-3 alone. 

Phrase: "However,"

Phrase: "the majority of neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "were"

Phrase: "positive for either AGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]

Phrase: "or"

Phrase: "caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.177: Similar results were obtained by the combination of AT8 and caspase-3 immunoreaction. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained by the combination of AT8"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0205195:Combination [Qualitative Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1947911:Combination [Physical Object]
   719 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "caspase-3 immunoreaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0872193:immunoreaction [Organism Function]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.178: Some neurons were double labeled with AT8 and caspase-3 (Fig. 7DF), whereas other neurons show AT8 or caspase-3 immunoreactivity alone (Fig. 7DF).  

Phrase: "Some neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "labeled with AT8"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "caspase-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 7DF"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "other neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "AT8"

Phrase: "or"

Phrase: "caspase-3 immunoreactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597879:immunoreactivity [Molecular Function]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(Fig. 7DF"

Phrase: ")."
Processing 00000000.tx.179: Discussion Top Abstract Introduction Material and Methods Results Discussion References  The aim of this study was to examine the normal age-dependent deposition of AGEs in the human brain, the comparison of these data with those in AD, and a potential co-localization with markers of such as nitroxidative stress and neurodegeneration such as nNOS and caspase-3. 

Phrase: "Discussion Top Abstract Introduction Material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Material [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The aim of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1947946:Aim [Idea or Concept]
   760   C2948600:Aim [Pharmacologic Substance]
   760   C3540471:AIM [Gene or Genome]
   760   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the normal age-dependent deposition of AGEs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0333562:Deposition [Functional Concept]

Phrase: "in the human brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "the comparison of these data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "with those in AD,"

Phrase: "and"

Phrase: "a potential co-localization with markers of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "such as nitroxidative stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "neurodegeneration such as nNOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "caspase-3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.180: The study was expected to deliver more information about the difference of AGE-deposition between normal aging and AD, and about a possible pathogenetic role of AGEs in formation of AD specific lesions. 

Phrase: "The study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "deliver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
  1000   C1705822:Deliver [Activity]
  1000   C1874964:DELIVER [Pharmacologic Substance]

Phrase: "more information about the difference of AGE-deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1533716:Information [Idea or Concept]

Phrase: "between normal aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "AD,"

Phrase: "and about a possible pathogenetic role of AGEs"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   797   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   738   C0035820:Role [Social Behavior]
   738   C0205179:Advanced [Qualitative Concept]
   738   C0332149:Possible [Qualitative Concept]
   738   C0444930:End [Spatial Concept]
   738   C0598528:glycation [Phenomenon or Process]
   738   C1514468:Products [Entity]
   738   C1515981:And [Idea or Concept]
   738   C1705810:Role [Conceptual Entity]
   738   C1705910:Possible [Qualitative Concept]
   738   C2362652:Possible [Qualitative Concept]
   738   C2746065:End [Temporal Concept]
   704 E C0725066:Advance [Medical Device]
   704 E C1704444:Product [Quantitative Concept]

Phrase: "in formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of AD specific lesions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0221198:lesions [Finding]
   793 E C1546698:Lesion [Intellectual Product]
Processing 00000000.tx.181: In healthy, non-demented humans, an age-dependent increase could be detected in both the percentage of AGE-positive neurons and the intensity of the deposits. 

Phrase: "In healthy, non-demented humans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086418:Humans [Human]

Phrase: "an age-dependent increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "detected in both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "the percentage of AGE-positive neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "and"

Phrase: "the intensity of the deposits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522510:Intensity [Qualitative Concept]
Processing 00000000.tx.182: Our data support previous studies where a positive correlation between AGE-immunoreactivity in hippocampal pyramidal neurons and age was demonstrated. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "previous studies where"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "a positive correlation between AGE-immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707520:Correlation [Qualitative Concept]

Phrase: "in hippocampal pyramidal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "demonstrated."
Processing 00000000.tx.183: In this study, a more intense immunoreaction was observed in the more vulnerable CA3-4 pyramidal neurons compared with that of the more resistant CA1 neurons (Kimura et al., 1996). 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "a more intense immunoreaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0872193:immunoreaction [Organism Function]

Phrase: "was"

Phrase: "observed in the more vulnerable CA3-4 pyramidal neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0027882:Neurons [Cell]
   742   C1441672:Observed [Functional Concept]

Phrase: "compared with that of the more resistant CA1 neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0027882:Neurons [Cell]
   742   C0332325:Resistant [Functional Concept]
   742   C1707455:Compared [Activity]
   742   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "(Kimura et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.184: It is not clear which proteins or larger structures of the cell were actually modified by AGEs. 

Phrase: "It"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "which proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "larger structures of the cell"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0243092:cell structures [Cell Component]
   781 E C0007634:Cell structure [Cell]
   781 E C0935919:cell structure [Qualitative Concept]
   760   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "actually"

Phrase: "modified by AGEs."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   882   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   790   C0205349:Modified By [Qualitative Concept]
   753   C0205179:Advanced [Qualitative Concept]
   753   C0392747:Modified [Functional Concept]
   753   C0444930:End [Spatial Concept]
   753   C0598528:glycation [Phenomenon or Process]
   753   C1514468:Products [Entity]
   753   C2746065:End [Temporal Concept]
   719 E C0725066:Advance [Medical Device]
   719 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.185: However, neuronal AGEs that form granular deposits were associated with lipofuscin (Takeda et al., 2001). 

Phrase: "However,"

Phrase: "neuronal AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   937   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   804   C0205179:Advanced [Qualitative Concept]
   804   C0444930:End [Spatial Concept]
   804   C0598528:glycation [Phenomenon or Process]
   804   C1514468:Products [Entity]
   804   C2746065:End [Temporal Concept]
   771 E C0725066:Advance [Medical Device]
   771 E C1704444:Product [Quantitative Concept]
   748 E C0205088:Terminal [Temporal Concept]
   748 E C1705314:Terminal [Manufactured Object]
   748 E C1705315:Terminal [Spatial Concept]

Phrase: "that"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "granular deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "were"

Phrase: "associated with lipofuscin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0023789:Lipofuscin [Biologically Active Substance,Lipid]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Takeda et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.186: Lipofuscin is constituted not only of lipid peroxidation products but of AGEs which may be the origin of fluorescent pigments (Horie et al., 1997). 

Phrase: "Lipofuscin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023789:Lipofuscin [Biologically Active Substance,Lipid]

Phrase: "is"

Phrase: "constituted"

Phrase: "not only of lipid peroxidation products"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0023775:Lipid Peroxidation [Molecular Function]
   753   C0023779:Lipid [Lipid]
   753   C0178796:peroxidation [Phenomenon or Process]
   753   C0205171:Only [Quantitative Concept]
   753   C1514468:Products [Entity]
   753   C1518422:Not [Functional Concept]
   753   C1720467:Only [Intellectual Product]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "but of AGEs"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   882   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   753   C0205179:Advanced [Qualitative Concept]
   753   C0233535:but [Mental or Behavioral Dysfunction]
   753   C0444930:End [Spatial Concept]
   753   C0598528:glycation [Phenomenon or Process]
   753   C1514468:Products [Entity]
   753   C2746065:End [Temporal Concept]
   719 E C0725066:Advance [Medical Device]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "the origin of fluorescent pigments"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0079946:origin [Classification]
   760   C0439659:Origin [Temporal Concept]
   760   C1550512:origin [Intellectual Product]
   704 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   704 E C0314603:Genetic [Functional Concept]

Phrase: "(Horie et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.187: Humans are not the only species where an age-dependent accumulation of AGEs is observed. 

Phrase: "Humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the only species where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "an age-dependent accumulation of AGEs"

Phrase: "is"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.188: In dogs, distinct AGE-positive granules can be detected in Purkinje cells as occurs in humans, and accumulate in an age-dependent manner (Weber et al., 1998). 

Phrase: "In dogs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012984:Dogs [Mammal]
  1000   C1280551:Dogs [Mammal]

Phrase: "distinct AGE-positive granules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0010837:Granules [Cell Component]
   812   C0993609:Granules [Biomedical or Dental Material]
   729 E C0205248:Granular [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "detected in Purkinje cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0034143:Purkinje Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "occurs in humans,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086418:Humans [Human]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "accumulate in an age-dependent manner"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0001779:Age [Organism Attribute]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "(Weber et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.189: A dramatic increase in the number of AGE-loaded astrocytes could also be observed in the aging brain, whereas AGEs were very rarely observed in astrocytes of the subpial region in brains of young humans. 

Phrase: "A dramatic increase in the number of AGE-loaded astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "observed in the aging brain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0001811:Ageing [Organism Function]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1441672:Observed [Functional Concept]

Phrase: "whereas"

Phrase: "AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "were"

Phrase: "very rarely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442824:Very [Qualitative Concept]
   861   C0522498:Rarely [Qualitative Concept]

Phrase: "observed in astrocytes of the subpial region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004112:Astrocytes [Cell]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   748   C1441672:Observed [Functional Concept]

Phrase: "in brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of young humans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Humans [Human]
Processing 00000000.tx.190: The number that were immunoreactive in astrocytes in the subpial region increased continuously with age, and were highest in old human brains (Fig. 1B). 

Phrase: "The number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "immunoreactive in astrocytes"

Phrase: "in the subpial region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "continuously with age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "were"

Phrase: "highest in old human brains"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1522410:Highest [Qualitative Concept]
   726 E C0205250:High [Qualitative Concept]
   726 E C1299351:High [Qualitative Concept]
   726 E C2700149:HIGH [Intellectual Product]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.191: It was interesting to observe that these AGE-positive astrocytes first occurred at the braincerebrospinal fluid (CSF) border, which may suggest that AGEs or their precursors were taken up or diffused from the CSF into the subpial region and were then taken up by these astrocytes. 

Phrase: "It"

Phrase: "was"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "observe"

Phrase: "that"

Phrase: "these AGE-positive astrocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004112:Astrocytes [Cell]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "occurred at the braincerebrospinal fluid"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0005889:FLUID [Body Substance]
   760   C0302908:fluid [Substance]
   760   C0444611:Fluid [Qualitative Concept]
   760   C1704353:Fluid [Substance]
   760   C1709305:Occurred [Activity]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "(CSF) border,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205284:Border [Spatial Concept]
   861   C1522411:Border [Body Location or Region]
   861   C2828371:Border [Classification]

Phrase: "which"

Phrase: "may"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "or"

Phrase: "their precursors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1709634:Precursor [Idea or Concept]

Phrase: "were"

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "or"

Phrase: "diffused from the CSF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0012222:Diffused [Natural Phenomenon or Process]
   770   C3540512:CSF [Therapeutic or Preventive Procedure]
   737 E C0205219:Diffuse [Qualitative Concept]

Phrase: "into the subpial region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "by these astrocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]
Processing 00000000.tx.192: Alternatively, factors from the CSF may activate astrocytes to produce AGEs via activation of the myeloperoxidase system (Anderson et al., 1999). 

Phrase: "Alternatively,"

Phrase: "factors from the CSF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "astrocytes to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004112:Astrocytes [Cell]

Phrase: "produce"

Phrase: "AGEs via activation of the myeloperoxidase system"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   741   C0596035:activation product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205179:Advanced [Qualitative Concept]
   739   C0444930:End [Spatial Concept]
   739   C0598528:glycation [Phenomenon or Process]
   739   C1514468:Products [Entity]
   739   C2746065:End [Temporal Concept]
   706 E C0725066:Advance [Medical Device]
   706 E C1704444:Product [Quantitative Concept]

Phrase: "(Anderson et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.193: A more general reason for the observed increase in AGE levels in both cell types could be caused by higher levels of their precursors, such as glyoxal and methyglyoxal. 

Phrase: "A more general reason for the observed increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1550000:General Reason [Idea or Concept]
   744   C0392360:Reason [Idea or Concept]

Phrase: "in AGE levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "in both cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "caused by higher levels of their precursors,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   748   C0441889:Levels [Qualitative Concept]
   714   C0015127:cause [Functional Concept]
   714   C0205250:High [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714   C1299351:High [Qualitative Concept]
   714   C1524003:Cause [Conceptual Entity]
   714 E C1547707:Level [Geographic Area]
   714   C1709634:Precursor [Idea or Concept]
   714   C2700149:HIGH [Intellectual Product]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "such as glyoxal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017992:Glyoxal [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "methyglyoxal."
Processing 00000000.tx.194: Methylglyoxal levels could be caused to increase by the higher levels of triosephosphates which accumulate under impaired glycolytic flow through the TCA cycle and the mitochondrial chain (Beisswenger et al., 2003), a condition called pseudohypoxia in diabetes (Ido and Williamson, 1997). 

Phrase: "Methylglyoxal levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "could"

Phrase: "be"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase by the higher levels of triosephosphates"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0441889:Levels [Qualitative Concept]
   748   C0442805:Increase [Functional Concept]
   714   C0205250:High [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714   C1299351:High [Qualitative Concept]
   714 E C1547707:Level [Geographic Area]
   714   C2700149:HIGH [Intellectual Product]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "which"

Phrase: "accumulate under impaired glycolytic flow through"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0221099:Impaired [Functional Concept]
   753   C0684336:Impaired [Pathologic Function]
   753   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "the TCA cycle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008858:TCA Cycle [Molecular Function]
   861   C1511572:Cycle [Temporal Concept]

Phrase: "and"

Phrase: "the mitochondrial chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "(Beisswenger et al.,"

Phrase: "2003"

Phrase: ")"

Phrase: ","

Phrase: "a condition called pseudohypoxia in diabetes"

Phrase: "(Ido"

Phrase: "and"

Phrase: "Williamson,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.195: Another possible reason could be the lower capacity of the glyoxalase system for the detoxification of these compounds, e.g. by a depletion of its rate-limiting cofactor glutathione (Vander Jagt and Hunsaker, 2003). 

Phrase: "Another possible reason"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392360:Reason [Idea or Concept]

Phrase: "could"

Phrase: "be"

Phrase: "the lower capacity of the glyoxalase system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1516240:Capacity [Quantitative Concept]

Phrase: "for the detoxification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025516:Detoxification [Organism Function]
  1000   C0150543:Detoxification [Therapeutic or Preventive Procedure]

Phrase: "of these compounds,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205198:Compound [Qualitative Concept]
   966   C1706082:Compound [Chemical]

Phrase: "e.g."

Phrase: "by a depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333668:Depletion [Functional Concept]

Phrase: "of its rate-limiting cofactor glutathione"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Vander Jagt"

Phrase: "and"

Phrase: "Hunsaker,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.196: We have shown previously in humans and in transgenic APP-overexpressing mice that AGEs were detected in astrocytes that were in physical contact with amyloid plaques (Wong et al., 2001; Mnch et al., 2003). 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0086418:Humans [Human]

Phrase: "and in transgenic APP-overexpressing mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0025936:Mice, Transgenic [Mammal]
   753   C0003069:Transgenic [Animal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C1515981:And [Idea or Concept]
   753   C3538722:APP [Laboratory Procedure]
   719   C1514559:overexpress [Genetic Function]

Phrase: "that AGEs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "were"

Phrase: "detected in astrocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0004112:Astrocytes [Cell]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "were in physical contact"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0221190:Physical contact [Phenomenon or Process]
   833   C0392367:Physical contact [Phenomenon or Process]
   770   C0031809:Physical [Health Care Activity]
   770   C0205485:Physical [Functional Concept]
   770   C0332158:contact [Functional Concept]
   770   C0337611:Contact [Population Group]
   770   C1509143:Physical [Finding]
   770   C1705415:Contact [Idea or Concept]

Phrase: "with amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
  1000   C2936349:Plaques, Amyloid [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "(Wong et al.,"

Phrase: "2001"

Phrase: "; Mnch et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.197: However, we demonstrate in this study that astrocytes further away from plaques also accumulate AGEs, indicating that soluble factors may also contribute to AGE formation. 

Phrase: "However,"

Phrase: "we"

Phrase: "demonstrate in this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "that astrocytes further away from plaques also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0004112:Astrocytes [Cell]

Phrase: "accumulate"

Phrase: "AGEs,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "indicating"

Phrase: "that soluble factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "also"

Phrase: "contribute to AGE formation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0001779:Age [Organism Attribute]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
   770   C1880177:Contribute [Activity]
Processing 00000000.tx.198: AGE immunostaining could be observed in and has been consistently reported in blood vessels, in particular, in vessels of diabetics and smokers (Lyons, 1993; Nicholl et al., 1998). 

Phrase: "AGE immunostaining"

Phrase: "could"

Phrase: "be"

Phrase: "observed in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "consistently"

Phrase: "reported in blood vessels,"
Meta Candidates (Total=16; Excluded=11; Pruned=0; Remaining=5)
   833   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   799 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   799 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]
   740 E C0005767:Blood [Tissue]
   740 E C0005768:blood [Body Substance]
   740 E C0229664:Blood [Body Substance]
   740 E C0392895:Bloods [Population Group]
   737 E C3273238:Report [Intellectual Product]
   722 E C0333275:Bloody [Qualitative Concept]

Phrase: "in particular,"

Phrase: "in vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005847:Vessels [Body Part, Organ, or Organ Component]
   966 E C1511228:Vessel [Tissue]
   928 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "of diabetics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:diabetics [Finding]

Phrase: "and"

Phrase: "smokers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337664:smokers [Finding]

Phrase: "(Lyons,"

Phrase: "1993"

Phrase: "; Nicholl et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.199: There is no obvious explanation why AGE deposition increases in AD. 

Phrase: "There"

Phrase: "is"

Phrase: "no obvious explanation why AGE deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0333562:Deposition [Functional Concept]

Phrase: "increases in AD."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   790   C0442805:Increase [Functional Concept]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.200: It could be a consequence of the disease, or could be a part of its cause. 

Phrase: "It"

Phrase: "could"

Phrase: "be"

Phrase: "a consequence of the disease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "or"

Phrase: "could"

Phrase: "be"

Phrase: "a part of its cause."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]
Processing 00000000.tx.201: The latter hypothesis is supported by the fact that in Braak stages I and II, where neurofibrillary pathology is limited to the entorhinal cortex, the deposition of AGEs in astrocytes, nerve cells and blood vessels could be observed in the isocortex (Brodmann area 22). 

Phrase: "The latter hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "supported by the fact"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1521721:Supported [Conceptual Entity]
   737 E C0183683:Support [Medical Device]

Phrase: "that in Braak stages I"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0441766:Stage I [Intellectual Product]
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1306673:Stages [Qualitative Concept]
   726 E C0205390:Stage [Temporal Concept]
   726 E C1300072:Stage [Clinical Attribute]

Phrase: "and"

Phrase: "II,"

Phrase: "where neurofibrillary pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]

Phrase: "is"

Phrase: "limited to the entorhinal cortex,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0175196:Entorhinal Cortex [Body Part, Organ, or Organ Component]
   806   C1289526:Entorhinal cortex [Body Part, Organ, or Organ Component]
   760   C0007776:Cortex [Body Part, Organ, or Organ Component]
   760   C0439801:Limited [Functional Concept]
   760   C1176472:Cortex [Body Part, Organ, or Organ Component]
   760   C2700441:Cortex [Plant]
   760   C3542948:Limited [Intellectual Product]
   726 E C1549649:Limit [Idea or Concept]
   726 E C2349209:Limit [Conceptual Entity]

Phrase: "the deposition of AGEs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0333562:Deposition [Functional Concept]

Phrase: "in astrocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]

Phrase: "nerve cells"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0027882:Nerve Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0027740:Nerve [Tissue]
   861   C0027757:NERVE [Tissue]
   861   C1280541:Nerve [Body Part, Organ, or Organ Component]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   805 E C0599851:Neural [Functional Concept]
   789 E C0027769:nervy [Sign or Symptom]

Phrase: "and"

Phrase: "blood vessels"
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
  1000   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   966 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   966 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   928 E C1558950:VASCULAR [Finding]
   928 E C1801960:Vascular [Qualitative Concept]
   907 E C0005767:Blood [Tissue]
   907 E C0005768:blood [Body Substance]
   907 E C0229664:Blood [Body Substance]
   907 E C0392895:Bloods [Population Group]
   888 E C0333275:Bloody [Qualitative Concept]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "could"

Phrase: "be"

Phrase: "observed in the isocortex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0175173:Isocortex [Body Part, Organ, or Organ Component]
   770   C1441672:Observed [Functional Concept]

Phrase: "(Brodmann area 22"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1272540:Brodmann area 22 [Body Part, Organ, or Organ Component]
  1000   C2322884:Brodmann area 22 [Body Location or Region]
   901   C0599720:Brodmann area [Body Location or Region]
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.202: Foremost, and importantly, these data suggest that carbonyl stress precedes hyperphosphorylation and tangle formation. 

Phrase: "Foremost,"

Phrase: "and"

Phrase: "importantly,"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that carbonyl stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "precedes"

Phrase: "hyperphosphorylation"

Phrase: "and"

Phrase: "tangle formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]
Processing 00000000.tx.203: One possible link between carbonyl stress and hyperphosphorylation (as a prerequisite of tangle formation) could be the activation of tau kinases by reactive carbonyl compounds (AGE precursors). 

Phrase: "One possible link between carbonyl stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517892:Link [Intellectual Product]
   753   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "hyperphosphorylation"

Phrase: "("

Phrase: "as a prerequisite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679209:prerequisite [Idea or Concept]

Phrase: "of tangle formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: ")"

Phrase: "could"

Phrase: "be"

Phrase: "the activation of tau kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "by reactive carbonyl compounds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0596258:carbonyl compounds [Organic Chemical]
   793   C0205198:Compound [Qualitative Concept]
   793   C1706082:Compound [Chemical]

Phrase: "(AGE precursors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.204: For example, methylgloxal and acrolein activate p38 MAP kinase in a dose-dependent manner, increasing the phosphorylation of tau at the site recognized by PHF-1 (Reynolds et al., 2000; Liu et al., 2003). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "methylgloxal"

Phrase: "and"

Phrase: "acrolein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001204:Acrolein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "p38 MAP kinase in a dose-dependent manner,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C0257535:p38 map kinase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1120843:p38 MAP Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0752312:Map Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0024779:Map [Manufactured Object]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1706473:Map [Conceptual Entity]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the phosphorylation of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "at the site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "recognized by PHF-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597162:PHF [Cell or Molecular Dysfunction]

Phrase: "(Reynolds et al.,"

Phrase: "2000"

Phrase: "; Liu et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.205: In support of this hypothesis, tau hyperphosphorylation by the stress-inducible p38 kinase has also been reported to be present in neurons in AD (Zhu et al., 2000). 

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "tau hyperphosphorylation by the stress-inducible p38 kinase"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "present in neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "in AD (Zhu et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.206: Furthermore, reactive carbonyl compounds are known to inhibit phosphatases (Portero-Otin et al., 2002). 

Phrase: "Furthermore,"

Phrase: "reactive carbonyl compounds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0596258:carbonyl compounds [Organic Chemical]
   793   C0205198:Compound [Qualitative Concept]
   793   C1706082:Compound [Chemical]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "phosphatases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031678:Phosphatases [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1149880:phosphatase [Molecular Function]

Phrase: "(Portero-Otin et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.207: The discussion about AGEs as being early or late markers of AD is very much reminiscent of the long-lasting discussion about oxidative stress as being an early or late event in the disease. 

Phrase: "The discussion about AGEs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0557061:Discussion [Therapeutic or Preventive Procedure]
   748   C2584313:Discussion [Social Behavior]

Phrase: "as"

Phrase: "being"

Phrase: "early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "or"

Phrase: "late markers of AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0005516:Marker [Clinical Attribute]

Phrase: "is"

Phrase: "very much reminiscent of the long-lasting discussion"

Phrase: "about oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "as"

Phrase: "being"

Phrase: "an early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "or"

Phrase: "late event in the disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0441471:Event [Event]
Processing 00000000.tx.208: As with AGEs, more recent results indicate that increased oxidative damage really is an early event in AD that even decreases with disease progression and lesion formation (Smith et al., 1997; Nunomura et al., 2001; Pratico et al., 2002). 

Phrase: "As with AGEs,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   882   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   753   C0205179:Advanced [Qualitative Concept]
   753   C0444930:End [Spatial Concept]
   753   C0598528:glycation [Phenomenon or Process]
   753   C1514468:Products [Entity]
   753   C2746065:End [Temporal Concept]
   719 E C0725066:Advance [Medical Device]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "more recent results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that increased oxidative damage really"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0010957:Damage [Injury or Poisoning]
   812   C1883709:Damage [Functional Concept]

Phrase: "is"

Phrase: "an early event in AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0441471:Event [Event]

Phrase: "that even"

Phrase: "decreases with disease progression"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0242656:Disease Progression [Pathologic Function]
           progression
   833   C1947900:Disease progression NOS [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0392756:Decrease [Qualitative Concept]
   770   C0449258:Progression [Functional Concept]
   770   C0547047:Decrease [Quantitative Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "lesion formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(Smith et al.,"

Phrase: "1997"

Phrase: "; Nunomura et al.,"

Phrase: "2001"

Phrase: "; Pratico et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.209: Since some of the precursors (e.g. glyoxal) or end-products (carboxymethyl-lysine) of glycation and (radical-induced) lipid peroxidation reactions are identical, it is quite obvious that both markers are early markers of the disease. 

Phrase: "Since"

Phrase: "some of the precursors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205392:Some [Quantitative Concept]
   770   C3540770:Some [Intellectual Product]
   737   C1709634:Precursor [Idea or Concept]

Phrase: "("

Phrase: "e.g. glyoxal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017992:Glyoxal [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "end-products"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0444930:End [Spatial Concept]
   861   C1514468:Products [Entity]
   861   C2746065:End [Temporal Concept]
   827 E C1704444:Product [Quantitative Concept]
   805 E C0205088:Terminal [Temporal Concept]
   805 E C1705314:Terminal [Manufactured Object]
   805 E C1705315:Terminal [Spatial Concept]

Phrase: "(carboxymethyl-lysine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083528:carboxymethyl-lysine [Amino Acid, Peptide, or Protein]
   861   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "of glycation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598528:glycation [Phenomenon or Process]

Phrase: "and ("

Phrase: "radical-induced"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205263:Induced [Functional Concept]
   861   C0302912:Radical [Chemical Viewed Structurally]
   861   C0439807:Radical [Qualitative Concept]

Phrase: ")"

Phrase: "lipid peroxidation reactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0443286:Reaction [Functional Concept]
   793   C1114821:Reaction [Clinical Attribute]
   734   C0023775:Lipid Peroxidation [Molecular Function]

Phrase: "are"

Phrase: "identical,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205280:Identical [Qualitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "quite obvious"

Phrase: "that"

Phrase: "both markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0005516:Marker [Clinical Attribute]

Phrase: "are"

Phrase: "early markers of the disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1511983:Markers, Disease [Idea or Concept]
   726   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.210: We have shown previously that the presence of nNOS and nitrotyrosine in pyramidal neurons of the isocortex in a specific marker for AD (Lth et al., 2001, 2002). 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously"

Phrase: "that"

Phrase: "the presence of nNOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "nitrotyrosine in pyramidal neurons of the isocortex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0047645:nitrotyrosine [Amino Acid, Peptide, or Protein]

Phrase: "in a specific marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005516:Marker [Clinical Attribute]

Phrase: "for AD (Lth et al.,"

Phrase: "2001,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.211: In our study, AGE and nNOS are often co-localized which might suggest that they could be causatively linked. 

Phrase: "In our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "AGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "nNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417759:nNOS [Gene or Genome]

Phrase: "are"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "co-localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392752:Localized [Spatial Concept]

Phrase: "which"

Phrase: "might"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "they"

Phrase: "could"

Phrase: "be"

Phrase: "causatively"

Phrase: "linked."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]
Processing 00000000.tx.212: Activated caspase-3, a cell death executioner protease, exhibits a high degree of colocalization with NFTs and senile plaques in AD. 

Phrase: "Activated caspase-3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a cell death executioner protease,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   888   C0010656:Cell-Death Protease [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C1947941:Protease [Enzyme]

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a high degree of colocalization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "with NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "senile plaques in AD."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   770   C0392079:Senile [Finding]
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0332461:Plaque [Finding]
   715 E C0231337:Old age [Finding]
   715 E C1999167:Old age [Population Group]
Processing 00000000.tx.213: Although the total number of casapse-3 positive neurons was <1%, we have observed a co-localization of caspase-3 immunoreactivity with AGE in 75% of the neurons. 

Phrase: "Although"

Phrase: "the total number of casapse-3 positive neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0237753:*Number [Quantitative Concept]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "was <"

Phrase: "1%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "we"

Phrase: "have"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a co-localization of caspase-3 immunoreactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "with AGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "in 75%"

Phrase: "of the neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.214: However but the majority of neurons are positive either for AGE or for caspase-3 only. 

Phrase: "However"

Phrase: "but"

Phrase: "the majority of neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "are"

Phrase: "positive either for AGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0001779:Age [Organism Attribute]
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]

Phrase: "or for caspase-3 only."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205171:Only [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]
Processing 00000000.tx.215: Since the percentage of apoptotic neurons in area 22 in the AD patients was <1%, it is not possible to prove a causal link between AGE deposition and apoptosis via the caspase-3 pathway. 

Phrase: "Since"

Phrase: "the percentage of apoptotic neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "in area 22"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: "in the AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "was <"

Phrase: "1%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "it"

Phrase: "is"

Phrase: "not possible to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332149:Possible [Qualitative Concept]
   827   C1518422:Not [Functional Concept]
   827   C1705910:Possible [Qualitative Concept]
   827   C2362652:Possible [Qualitative Concept]

Phrase: "prove"

Phrase: "a causal link between AGE deposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517892:Link [Intellectual Product]
   753   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "apoptosis via the caspase-3 pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0162638:Apoptosis Pathway [Cell Function]
           Apoptosis
Processing 00000000.tx.216: However, other groups have suggested such a biochemical link between AGE accumulation, nNOS expression and apoptosis. 

Phrase: "However,"

Phrase: "other groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "such a biochemical link between AGE accumulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1517892:Link [Intellectual Product]
   748   C1704666:Link [Intellectual Product]

Phrase: "nNOS expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.217: In this study, Cellek and Moncada showed that AGEs, but not high glucose concentrations, led to caspase-3-dependent apoptosis in SH-SY5Y neuroblastoma cells but only in those differentiated neurons expressing nNOS (Cellek et al., 2003). 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "Cellek"

Phrase: "and"

Phrase: "Moncada"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that AGEs,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "but"

Phrase: "not high glucose concentrations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   844   C0427743:Glucose concentration [Laboratory Procedure]
   844   C1287281:Glucose concentration [Laboratory or Test Result]
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "led to caspase-3-dependent apoptosis"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   820   C1707312:Caspase-Dependent Apoptosis [Molecular Function]
   790   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0162638:Apoptosis [Cell Function]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C1708698:LED [Manufactured Object]
   753   C3244310:dependent [Functional Concept]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C1522538:Lead [Functional Concept]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in SH-SY5Y neuroblastoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "only in those differentiated neurons"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0007589:Differentiated [Cell Function]
   760   C0027882:Neurons [Cell]
   760   C0205171:Only [Quantitative Concept]
   760   C0205615:Differentiated [Qualitative Concept]
   760   C1720467:Only [Intellectual Product]
   745   C1159970:neuron differentiation [Cell Function]
   720 E C1518294:Neuronal Differentiation [Finding]

Phrase: "expressing"

Phrase: "nNOS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0907533:NNOS [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417759:nNOS [Gene or Genome]

Phrase: "(Cellek et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.218: Address correspondence to Dr H.J. 

Phrase: "Address correspondence to Dr H.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0282413:Correspondence [Intellectual Product]
Processing 00000000.tx.219: Lth, Paul Flechsig Institute of Brain Research, Department of Neuroanatomy, University of Leipzig, Jahnallee 59, D-04109 Leipzig, Germany. 

Phrase: "Lth,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033371:LTH [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "Paul Flechsig Institute of Brain Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0035172:Research Institute [Organization]
   753   C0021622:institute [Organization]
   753   C1272753:Institute [Idea or Concept]

Phrase: "Department of Neuroanatomy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "University of Leipzig,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Jahnallee 59,"

Phrase: "D-"

Phrase: "04109 Leipzig,"

Phrase: "Germany."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]
Processing 00000000.tx.220: Email: lueth{at}medizin.uni-leipzig.de .  Acknowledgments  This study was supported by the Bundesministerium fr Bildung, Forschung und Technologie (BMBF), Interdisciplinary Centre for Clinical Research at the University of Leipzig (01KS9504, Project C1 and N1), the Alzheimer Forschungs Initiative e.V. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "lueth{at}medizin.uni-leipzig.de .  Acknowledgments"

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported by the Bundesministerium fr Bildung,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C1521721:Supported [Conceptual Entity]
   753   C2348513:Fr. [Conceptual Entity]
   753   C3538902:FR [Gene or Genome]
   719 E C0183683:Support [Medical Device]

Phrase: "Forschung und Technologie"

Phrase: "(BMBF"

Phrase: ")"

Phrase: ","

Phrase: "Interdisciplinary Centre for Clinical Research"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0683939:center research [Manufactured Object,Organization]
   797   C2347782:Clinical Center [Organization]
   760   C0205099:Center [Spatial Concept]

Phrase: "at the University of Leipzig"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "(01KS9504,"

Phrase: "Project C1"

Phrase: "and"

Phrase: "N1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441962:N1 [Finding]

Phrase: ")"

Phrase: ","

Phrase: "the Alzheimer Forschungs Initiative e.V."
Processing 00000000.tx.221: (AFI), the BrainNet (Deutsches Referenzzentrum fr Erkrankungen des Zentralnervensystems; 01 GI 9999) and the European Commission (QLK6-CT-1999-02112). 

Phrase: "(AFI"

Phrase: ")"

Phrase: ","

Phrase: "the BrainNet"

Phrase: "(Deutsches Referenzzentrum fr Erkrankungen des Zentralnervensystems"

Phrase: "; 01 GI 9999"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3539617:GI [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the European Commission"

Phrase: "(QLK6-CT-1999-02112"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3540513:CT [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.222: We thank Barbara Br for her skillful assistance and for excellent technical help.  

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Barbara Br for her skillful assistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704648:Br. [Conceptual Entity]

Phrase: "and for excellent technical"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0449851:Technical [Functional Concept]
   770   C1515981:And [Idea or Concept]
   770   C1548784:Excellent [Qualitative Concept]
   770   C1961136:Excellent [Qualitative Concept]

Phrase: "help."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]
Processing 00000000.tx.223: References Top Abstract Introduction Material and Methods Results Discussion References  Anderson MM, Requena JR, Crowley JR, Thorpe SR, Heinecke JW (1999) The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Material [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Anderson MM,"

Phrase: "Requena JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Crowley JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Thorpe SR,"

Phrase: "Heinecke JW"

Phrase: "(1999"

Phrase: ")"

Phrase: "The myeloperoxidase system of human phagocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449913:System [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]

Phrase: "generates"

Phrase: "Nepsilon-"

Phrase: "(carboxymethyl)lysine on proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0083528:carboxymethyl-lysine [Amino Acid, Peptide, or Protein]
   770   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ":"

Phrase: "a mechanism for producing advanced glycation end products"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "at sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "of inflammation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]
Processing 00000000.tx.224: J Clin Invest 104:103113.[Abstract/Free FullText] Artwohl M, Graier WF, Roden M, Bischof M, Freudenthaler A, Waldhausl W, Baumgartner-Parzer SM (2003) Diabetic LDL triggers apoptosis in vascular endothelial cells. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "104"

Phrase: ":"

Phrase: "103113."

Phrase: "[Abstract/Free FullText"

Phrase: "] Artwohl M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Graier WF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043021:WF [Geographic Area]

Phrase: "Roden M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bischof M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Freudenthaler A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Waldhausl W,"

Phrase: "Baumgartner-Parzer SM (2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036154:SM [Geographic Area]

Phrase: ")"

Phrase: "Diabetic LDL"

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "apoptosis in vascular endothelial cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3156636:endothelial cell apoptosis [Cell Function]
   760   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.225: Diabetes 52:12401247.[Abstract/Free FullText] Atzori C, Ghetti B, Piva R, Srinivasan AN, Zolo P, Delisle MB, Mirra SS, Migheli A (2001) Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. 

Phrase: "Diabetes 52"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "12401247."

Phrase: "[Abstract/Free FullText"

Phrase: "] Atzori C,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: "Ghetti B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "Piva R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Srinivasan"

Phrase: "AN,"

Phrase: "Zolo P,"

Phrase: "Delisle MB,"

Phrase: "Mirra SS,"

Phrase: "Migheli A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(2001"

Phrase: ")"

Phrase: "Activation of the JNK/p38 pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "occurs in diseases"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0012634:Diseases [Disease or Syndrome]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]
   718 E C1836721:MALS [Finding]
   718 E C3538764:MALS [Gene or Genome]
   718 E C3540595:MAL [Gene or Genome]

Phrase: "characterized by tau protein pathology"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   797 E C1421563:protein tau [Gene or Genome]
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
   760   C1720655:Tau [Intellectual Product]
   760   C1880022:Characterized [Activity]
   760   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "is"

Phrase: "related to tau phosphorylation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C1158886:Phosphorylation [Molecular Function]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "but"

Phrase: "not to apoptosis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0162638:Apoptosis [Cell Function]
   790   C1518422:Not [Functional Concept]
   718 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.226: J Neuropathol Exp Neurol 60:11901197.[ISI][Medline] Augustinack JC, Schneider A, Mandelkow EM, Hyman BT (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. 

Phrase: "J Neuropathol Exp Neurol 60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "11901197."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Augustinack JC,"

Phrase: "Schneider A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Mandelkow EM,"

Phrase: "Hyman BT (2002"

Phrase: ")"

Phrase: "Specific tau phosphorylation sites"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   886   C0449604:Specific site [Spatial Concept]
   827   C1519063:Phosphorylation Site [Amino Acid Sequence]
   812   C0031715:Phosphorylation [Molecular Function]
   812   C0205145:Sites [Spatial Concept]
   812   C1158886:Phosphorylation [Molecular Function]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "correlate with severity of neuronal cytopathology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0243139:cytopathology [Occupation or Discipline]
   753   C0439793:Severity [Qualitative Concept]
   753   C0521390:Neuronal [Immunologic Factor]
   753   C2983285:Severity [Intellectual Product]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.227: Acta Neuropathol (Berl) 103:2635.[CrossRef][ISI][Medline] Beisswenger PJ, Howell SK, Smith K, Szwergold BS (2003) Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes. 

Phrase: "Acta Neuropathol"

Phrase: "(Berl"

Phrase: ")"

Phrase: "103"

Phrase: ":"

Phrase: "2635."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Beisswenger PJ,"

Phrase: "Howell SK,"

Phrase: "Smith K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Szwergold BS (2003"

Phrase: ")"

Phrase: "Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C2252256:methylglyoxal dehydrogenase activity [Molecular Function]
   751   C0683317:activity levels [Finding]
   736   C0205177:Activity [Functional Concept]
   736   C0439167:% activity [Quantitative Concept]
   736   C0441655:Activity [Activity]
   736   C1561536:*Activity [Idea or Concept]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.228: Biochim Biophys Acta 1637:98106.[ISI][Medline] Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. 

Phrase: "Biochim Biophys Acta 1637"

Phrase: ":"

Phrase: "98106."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Braak H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Braak E (1991"

Phrase: ")"

Phrase: "Neuropathological stageing of Alzheimer-related changes."
Processing 00000000.tx.229: Acta Neuropathol (Berl) 82:239259.[ISI][Medline] Braak H, Braak E, Kalus P (1989) Alzheimer's disease: areal and laminar pathology in the occipital isocortex. 

Phrase: "Acta Neuropathol"

Phrase: "(Berl"

Phrase: ")"

Phrase: "82"

Phrase: ":"

Phrase: "239259."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Braak H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Braak E,"

Phrase: "Kalus P (1989"

Phrase: ")"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "areal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0017446:Area [Geographic Area]
   928   C0205146:Area [Spatial Concept]
   928   C1504310:Areae [Plant]

Phrase: "and"

Phrase: "laminar pathology in the occipital isocortex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030664:Pathology [Biomedical Occupation or Discipline]
   753   C0205469:pathology [Functional Concept]
   753   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.230: Acta Neuropathol (Berl) 77:494506.[CrossRef][ISI][Medline] Braak H, Braak E, Bohl J (1993) Staging of Alzheimer-related cortical destruction. 

Phrase: "Acta Neuropathol"

Phrase: "(Berl"

Phrase: ")"

Phrase: "77"

Phrase: ":"

Phrase: "494506."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Braak H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Braak E,"

Phrase: "Bohl J (1993"

Phrase: ")"

Phrase: "Staging of Alzheimer-related cortical destruction."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0332305:Staging [Functional Concept]
   719 E C0205390:Stage [Temporal Concept]
   719 E C1300072:Stage [Clinical Attribute]
   719 E C1306673:Stage [Qualitative Concept]
Processing 00000000.tx.231: Eur Neurol 33:403408.[ISI][Medline] Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. 

Phrase: "Eur Neurol 33"

Phrase: ":"

Phrase: "403408."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Braak E,"

Phrase: "Braak H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mandelkow EM (1994"

Phrase: ")"

Phrase: "A sequence of cytoskeleton changes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "related to the formation of neurofibrillary tangles"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C1522492:Formation [Functional Concept]
   745 E C3543859:neurofibrillary tangle [Cell Component]
   714 E C0163712:Relate [Organic Chemical]

Phrase: "and"

Phrase: "neuropil threads."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521175:Neuropil Threads [Acquired Abnormality]
   827   C1710394:Thread [Manufactured Object]
   827   C1882475:Thread [Intellectual Product]
Processing 00000000.tx.232: Acta Neuropathol (Berl) 87:554567.[CrossRef][ISI][Medline] Bulteau AL, Verbeke P, Petropoulos I, Chaffotte AF, Friguet B (2001) Proteasome inhibition in glyoxal-treated fibroblasts and resistance of glycated glucose-6-phosphate dehydrogenase to 20 S proteasome degradation in vitro. 

Phrase: "Acta Neuropathol"

Phrase: "(Berl"

Phrase: ")"

Phrase: "87"

Phrase: ":"

Phrase: "554567."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bulteau AL,"

Phrase: "Verbeke P,"

Phrase: "Petropoulos I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Chaffotte AF,"

Phrase: "Friguet B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(2001"

Phrase: ")"

Phrase: "Proteasome inhibition in glyoxal-treated fibroblasts"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "resistance of glycated glucose-6-phosphate dehydrogenase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237834:Resistance [Mental Process]
   748   C1514892:Resistance [Physiologic Function]

Phrase: "to 20 S proteasome degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.233: J Biol Chem 276:4566245668.[Abstract/Free FullText] Castellani RJ, Harris PL, Sayre LM, Fujii J, Taniguchi N, Vitek MP, Founds H, Atwood CS, Perry G, Smith MA (2001) Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine. 

Phrase: "J Biol Chem 276"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "4566245668."

Phrase: "[Abstract/Free FullText"

Phrase: "] Castellani RJ,"

Phrase: "Harris PL,"

Phrase: "Sayre LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Fujii J,"

Phrase: "Taniguchi N,"

Phrase: "Vitek MP,"

Phrase: "Founds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Atwood CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Perry G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Smith MA (2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0554249:Smith [Professional or Occupational Group]

Phrase: ")"

Phrase: "Active glycation in neurofibrillary pathology of Alzheimer disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0598528:glycation [Phenomenon or Process]

Phrase: ":"

Phrase: "N(epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439098:Epsilon [Intellectual Product]

Phrase: ")"

Phrase: "-"

Phrase: "(carboxymethyl) lysine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083528:carboxymethyl-lysine [Amino Acid, Peptide, or Protein]
   861   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "hexitol-lysine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.234: Free Radical Biol Med 31:175180.[CrossRef][ISI][Medline] Cellek S, Qu W, Schmidt AM, Moncada S (2003) Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes. 

Phrase: "Free Radical Biol Med 31"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]
   804   C0302912:Radical [Chemical Viewed Structurally]
   804   C0332296:free [Functional Concept]
   804   C0439807:Radical [Qualitative Concept]
   804   C0450355:31 [Intellectual Product]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]

Phrase: ":"

Phrase: "175180."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cellek S,"

Phrase: "Qu W,"

Phrase: "Schmidt"

Phrase: "AM"

Phrase: ","

Phrase: "Moncada"

Phrase: "S ("

Phrase: "2003"

Phrase: ")"

Phrase: "Synergistic action of advanced glycation end products"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441472:Action [Functional Concept]
   748   C3266814:Action [Activity]

Phrase: "and"

Phrase: "endogenous nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "leads to neuronal apoptosis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   797   C1660771:neuron apoptosis [Cell Function]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0162638:Apoptosis [Cell Function]
   770   C0181586:leads [Medical Device]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   748 E C1836846:Apoptotic neurons [Finding]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: ":"

Phrase: "a new insight into selective nitrergic neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0233820:Insight [Mental Process]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.235: Diabetologia 47:331339.[CrossRef][ISI][Medline] Gallyas F (1971) Silver staining of Alzheimer's neurofibrillary changes by means of physical development. 

Phrase: "Diabetologia 47"

Phrase: ":"

Phrase: "331339."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gallyas F (1971"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: ")"

Phrase: "Silver staining of Alzheimer's neurofibrillary changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1293950:Silver Staining [Laboratory Procedure]
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "by means of physical development."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0871079:physical development [Natural Phenomenon or Process]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.236: Acta Morphol Acad Sci Hung 19:18.[ISI][Medline] Gasic-Milenkovic J, Dukic-Stefanovic S, Deuther-Conrad W, Gartner U, Mnch G (2003) Beta-amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon -gamma and advanced glycation endproducts in a murine microglia cell line. 

Phrase: "Acta Morphol Acad Sci Hung 19"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0268596:ACAD [Disease or Syndrome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]
   766   C0544691:hang [Injury or Poisoning]
   766   C1823998:HANG [Gene or Genome]

Phrase: ":"

Phrase: "18."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gasic-Milenkovic J,"

Phrase: "Dukic-Stefanovic S,"

Phrase: "Deuther-Conrad W,"

Phrase: "Gartner U,"

Phrase: "Mnch G (2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Beta-amyloid peptide"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C2825879:Amyloid, Beta [Laboratory Procedure]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "potentiates"

Phrase: "inflammatory responses"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1155266:inflammatory responses [Pathologic Function]
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "induced by lipopolysaccharide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0023810:Lipopolysaccharide [Lipid]
   790   C0205263:Induced [Functional Concept]

Phrase: "interferon -gamma"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0021740:Interferon Gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0021745:Interferon-gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C1149405:interferon-gamma [Molecular Function]
  1000   C2757040:Interferon gamma [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0017011:Gamma [Natural Phenomenon or Process]
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1552644:Gamma [Intellectual Product]
   861   C2349976:Gamma [Quantitative Concept]

Phrase: "and"

Phrase: "advanced glycation endproducts in a murine microglia cell line."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0205179:Advanced [Qualitative Concept]
   742   C0598528:glycation [Phenomenon or Process]
   708 E C0725066:Advance [Medical Device]
Processing 00000000.tx.237: Eur J Neurosci 17:813821.[CrossRef][ISI][Medline] Gastard MC, Troncoso JC, Koliatsos VE (2003) Caspase activation in the limbic cortex of subjects with early Alzheimer's disease. 

Phrase: "Eur J Neurosci 17"

Phrase: ":"

Phrase: "813821."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gastard MC,"

Phrase: "Troncoso JC,"

Phrase: "Koliatsos"

Phrase: "VE ("

Phrase: "2003"

Phrase: ")"

Phrase: "Caspase activation in the limbic cortex of subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1159825:Caspase Activation [Molecular Function]
   744   C1879547:Activation [Activity]

Phrase: "with early Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0679245:early disease [Temporal Concept]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.238: Ann Neurol 54:393398.[CrossRef][ISI][Medline] Hedlich A, Lth HJ, Werner L, Br B, Hanisch U, Winkelmann E (1990) Gabaergic NADPH-diaphorase-positive Martinotti cells in the visual cortex in rats. 

Phrase: "Ann Neurol 54"

Phrase: ":"

Phrase: "393398."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hedlich A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Lth HJ,"

Phrase: "Werner L,"

Phrase: "Br B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "Hanisch U,"

Phrase: "Winkelmann E (1990"

Phrase: ")"

Phrase: "Gabaergic NADPH-diaphorase-positive Martinotti cells in the visual cortex"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   757   C0439178:% positive cells [Quantitative Concept]
   743   C2325047:Martinotti cell [Cell]
   741   C1166657:cell cortex [Cell Component]
   739   C0007634:Cells [Cell]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "in rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.239: J Hirnforsch 31:681687.[ISI][Medline] Horie K, Miyata T, Yasuda T, Takeda A, Yasuda Y, Maeda K, Sobue G, Kurokawa K (1997) Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons. 

Phrase: "J Hirnforsch 31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450355:31 [Intellectual Product]

Phrase: ":"

Phrase: "681687."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Horie K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Miyata T,"

Phrase: "Yasuda T,"

Phrase: "Takeda A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Yasuda Y,"

Phrase: "Maeda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Sobue G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Kurokawa K (1997"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: "Immunohistochemical localization of advanced glycation end products,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "pentosidine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070317:pentosidine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "carboxymethyllysine in lipofuscin pigments of Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0083528:carboxymethyl-lysine [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "aged neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.240: Biochem Biophys Res Commun 236:327332.[CrossRef][ISI][Medline] Ido Y, Williamson JR (1997) Hyperglycemic cytosolic reductive stress pseudohypoxia: implications for diabetic retinopathy. 

Phrase: "Biochem Biophys Res Commun 236"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "327332."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ido Y,"

Phrase: "Williamson JR (1997"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: ")"

Phrase: "Hyperglycemic cytosolic reductive stress pseudohypoxia"

Phrase: ":"

Phrase: "implications for diabetic retinopathy."
Processing 00000000.tx.241: Invest Ophthalmol Vis Sci 38:14671470.[ISI][Medline] Jellinger KA, Stadelmann C (2001) Problems of cell death in neurodegeneration and Alzheimer's Disease. 

Phrase: "Invest"

Phrase: "Ophthalmol Vis Sci 38"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1571809:VIS [Therapeutic or Preventive Procedure]
   812   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "14671470."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jellinger KA,"

Phrase: "Stadelmann C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: "(2001"

Phrase: ")"

Phrase: "Problems of cell death"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1546466:Problems [Idea or Concept]
   737 E C0033213:Problem [Finding]

Phrase: "in neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "Alzheimer's Disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.242: J Alzheim Dis 3:3140. 

Phrase: "J Alzheim Dis 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C1515149:J 3 [Cell]
   812   C0451119:DIS [Intellectual Product]
   812   C1444662:DIS [Finding]

Phrase: ":"

Phrase: "3140."
Processing 00000000.tx.243: Kaji Y, Amano S, Usui T, Oshika T, Yamashiro K, Ishida S, Suzuki K, Tanaka S, Adamis AP, Nagai R, Horiuchi S (2003) Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells. 

Phrase: "Kaji Y,"

Phrase: "Amano S,"

Phrase: "Usui T,"

Phrase: "Oshika T,"

Phrase: "Yamashiro K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ishida S,"

Phrase: "Suzuki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Tanaka S,"

Phrase: "Adamis AP,"

Phrase: "Nagai R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Horiuchi"

Phrase: "S ("

Phrase: "2003"

Phrase: ")"

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "function of receptors"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   858   C0920644:function receptors [Molecular Function]
   790   C0031843:function [Physiologic Function]
   790   C0542341:Function [Functional Concept]
   790   C0700205:FUNCTION [Classification]
   790   C1705273:Function [Intellectual Product]
   718 E C0205245:Functional [Functional Concept]
   718 E C2700217:Functional [Conceptual Entity]

Phrase: "for advanced glycation end products"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "in bovine corneal endothelial cells."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   890   C1182654:Corneal endothelial cell [Cell]
   861   C0225336:Endothelial Cells [Cell]
   825   C0014259:Corneal Endothelium [Tissue]
   812   C0007452:Bovine [Mammal]
   812   C0007634:Cells [Cell]
   812   C0010031:Corneal [Body Part, Organ, or Organ Component]
   812   C0014257:Endothelial [Tissue]
   812   C1140701:bovine [Mammal]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C1278889:Cornea [Body Part, Organ, or Organ Component]
Processing 00000000.tx.244: Invest Ophthalmol Vis Sci 44:521528.[Abstract/Free FullText] Kimura T, Takamatsu J, Ikeda K, Kondo A, Miyakawa T, Horiuchi S (1996) Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons. 

Phrase: "Invest"

Phrase: "Ophthalmol Vis Sci 44"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1571809:VIS [Therapeutic or Preventive Procedure]
   812   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "521528."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kimura T,"

Phrase: "Takamatsu J,"

Phrase: "Ikeda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kondo A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Miyakawa T,"

Phrase: "Horiuchi"

Phrase: "S ("

Phrase: "1996"

Phrase: ")"

Phrase: "Accumulation of advanced glycation end products of the Maillard reaction"

Phrase: "with age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "in human hippocampal neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.245: Neurosci Lett 208:5356.[CrossRef][ISI][Medline] Ko LW, Ko EC, Nacharaju P, Liu WK, Chang E, Kenessey A, Yen SH (1999) An immunochemical study on tau glycation in paired helical filaments. 

Phrase: "Neurosci Lett 208"

Phrase: ":"

Phrase: "5356."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ko LW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415842:LW [Gene or Genome]

Phrase: "Ko EC,"

Phrase: "Nacharaju P,"

Phrase: "Liu WK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332174:/wk [Temporal Concept]
   861   C0439230:wk [Temporal Concept]

Phrase: "Chang E,"

Phrase: "Kenessey A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Yen SH (1999"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0038108:SH [Geographic Area]
   827   C1555429:Yen [Quantitative Concept]

Phrase: ")"

Phrase: "An immunochemical study on tau glycation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "in paired helical filaments."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0597162:paired helical filament [Cell or Molecular Dysfunction]
   827   C1709450:Paired [Qualitative Concept]
   793   C0010851:Filament [Cell Component]
   743 E C1979891:Filamentous [Qualitative Concept]
Processing 00000000.tx.246: Brain Res 830:301313.[CrossRef][ISI][Medline] Liu BF, Miyata S, Hirota Y, Higo S, Miyazaki H, Fukunaga M, Hamada Y, Ueyama S, Muramoto O, Uriuhara A, Kasuga M (2003) Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells. 

Phrase: "Brain Res 830"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "301313."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liu BF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006409:BF [Geographic Area]
   861   C1824728:BF [Gene or Genome]

Phrase: "Miyata S,"

Phrase: "Hirota Y,"

Phrase: "Higo S,"

Phrase: "Miyazaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Fukunaga M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hamada Y,"

Phrase: "Ueyama S,"

Phrase: "Muramoto O,"

Phrase: "Uriuhara A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Kasuga"

Phrase: "M ("

Phrase: "2003"

Phrase: ")"

Phrase: "Methylglyoxal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034338:Methylglyoxal [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis through activation of p38 mitogen-activated protein kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   784   C3266896:activation of apoptosis [Cell Function]
   742   C0162638:Apoptosis [Cell Function]

Phrase: "in rat mesangial cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0227651:Mesangial Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755   C0017655:Mesangium [Body Part, Organ, or Organ Component]
Processing 00000000.tx.247: Kidney Int 63:947957.[CrossRef][ISI][Medline] Lue LF, Walker DG, Rogers J (2001) Modeling microglial activation in Alzheimer's disease with human post-mortem microglial cultures. 

Phrase: "Kidney Int 63"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0022646:Kidney [Body Part, Organ, or Organ Component]
   827   C0063789:INT [Organic Chemical]
   827   C0227665:kidney [Body Part, Organ, or Organ Component]
   827   C1278978:Kidney [Body Part, Organ, or Organ Component]
   827   C1514845:KIDNEY [Tissue]
   827   C3272375:INT [Intellectual Product]
   734 E C0027697:Nephritides [Disease or Syndrome]

Phrase: ":"

Phrase: "947957."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lue LF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416933:LF [Gene or Genome]
   861   C2986618:LF [Gene or Genome]

Phrase: "Walker DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Rogers J (2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C3463939:Roger [Eukaryote]

Phrase: ")"

Phrase: "Modeling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870071:Modeling [Intellectual Product,Research Activity]
   966 E C3161035:Model [Intellectual Product]

Phrase: "microglial activation in Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "with human post-mortem microglial cultures."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0010453:Cultures [Idea or Concept]
   771 E C0220814:culture [Functional Concept]
   771 E C0430400:Culture [Laboratory Procedure]
   771 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.248: Neurobiol Aging 22:945956.[CrossRef][ISI][Medline] Lth HJ, Hedlich A, Hilbig H, Winkelmann E, Mayer B (1994) Morphological analyses of NADPH-diaphorase/nitric oxide synthase positive structures in human visual cortex. 

Phrase: "Neurobiol"

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "22"

Phrase: ":"

Phrase: "945956."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lth HJ,"

Phrase: "Hedlich A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Hilbig H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Winkelmann E,"

Phrase: "Mayer B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(1994"

Phrase: ")"

Phrase: "Morphological analyses of NADPH-diaphorase/nitric oxide synthase positive structures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C0002778:Analysis [Laboratory Procedure]
   706   C0936012:Analysis [Research Activity]
   706   C1524024:analysis [Functional Concept]

Phrase: "in human visual cortex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0042817:Visual Cortex [Body Part, Organ, or Organ Component]
   827   C0007776:Cortex [Body Part, Organ, or Organ Component]
   827   C0234621:Visual [Functional Concept]
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]
Processing 00000000.tx.249: J Neurocytol 23:770782.[ISI][Medline] Lth HJ, Holzer M, Gertz HJ, Arendt T (2000) Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a. 

Phrase: "J Neurocytol 23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "770782."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lth HJ,"

Phrase: "Holzer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gertz HJ,"

Phrase: "Arendt T (2000"

Phrase: ")"

Phrase: "Aberrant expression of nNOS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in pyramidal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "co-localized with p21ras"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392752:Localized [Spatial Concept]

Phrase: "and"

Phrase: "p16INK4a."
Processing 00000000.tx.250: Brain Res 852:4555.[CrossRef][ISI][Medline] Lth HJ, Holzer M, Gartner U, Staufenbiel M, Arendt T (2001) Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology. 

Phrase: "Brain Res 852"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "4555."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lth HJ,"

Phrase: "Holzer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gartner U,"

Phrase: "Staufenbiel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Arendt T (2001"

Phrase: ")"

Phrase: "Expression of endothelial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "inducible NOS-isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "increased in Alzheimer's disease,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   773   C0277564:Acquired disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "in APP23 transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and after experimental brain lesion"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0596546:experimental brain lesion [Research Activity]
   806   C0221505:brain lesion [Disease or Syndrome]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0221198:Lesion [Finding]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1515981:And [Idea or Concept]
   760   C1517586:Experimental [Qualitative Concept]
   760   C1546698:Lesion [Intellectual Product]

Phrase: "in rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: ":"

Phrase: "evidence for an induction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "by amyloid pathology."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.251: Brain Res 913:5767.[CrossRef][ISI][Medline] Lth HJ, Mnch G, Arendt T (2002) Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. 

Phrase: "Brain Res 913"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "5767."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lth HJ,"

Phrase: "Mnch G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Arendt T (2002"

Phrase: ")"

Phrase: "Aberrant expression of NOS isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "structurally"

Phrase: "related to nitrotyrosine formation."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0047645:nitrotyrosine [Amino Acid, Peptide, or Protein]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C1522492:Formation [Functional Concept]
   737 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.252: Brain Res 953:135143.[CrossRef][ISI][Medline] Lyons TJ (1993) Glycation and oxidation: a role in the pathogenesis of atherosclerosis. 

Phrase: "Brain Res 953"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "135143."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lyons TJ (1993"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039247:TJ [Geographic Area]

Phrase: ")"

Phrase: "Glycation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598528:glycation [Phenomenon or Process]

Phrase: "and"

Phrase: "oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: ":"

Phrase: "a role in the pathogenesis of atherosclerosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.253: Am J Cardiol 71:26B31B.[CrossRef][Medline] Mattson MP, Carney JW, Butterfield DA (1995) A tombstone in Alzheimer's? 

Phrase: "Am"

Phrase: "J Cardiol 71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450389:71 [Intellectual Product]

Phrase: ":"

Phrase: "26B31B."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mattson MP,"

Phrase: "Carney JW,"

Phrase: "Butterfield DA (1995"

Phrase: ")"

Phrase: "A tombstone in Alzheimer's?"
Processing 00000000.tx.254: Nature 373:481.[ISI][Medline] McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E.M. 

Phrase: "Nature 373"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "481."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McKhann,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Drachman,"

Phrase: "D."

Phrase: ","

Phrase: "Folstein,"

Phrase: "M."

Phrase: ","

Phrase: "Katzman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Stadlan,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.255: (1984). 

Phrase: "(1984"

Phrase: ")."
Processing 00000000.tx.256: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. 

Phrase: "Clinical diagnosis of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332140:Diagnosis, clinical [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: ":"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "of the NINCDS-ADRDA Work Group"
Meta Candidates (Total=23; Excluded=5; Pruned=0; Remaining=18)
   810   C0027765:Neurologic Disorders [Disease or Syndrome]
   795   C0009460:Communicative Disorders [Mental or Behavioral Dysfunction]
   786   C0009452:Communicative [Social Behavior]
   786   C0012634:Disorders [Disease or Syndrome]
   786   C0021622:institute [Organization]
   786   C0038454:Stroke [Disease or Syndrome]
           Stroke, neurological
   786   C0043227:Work [Occupational Activity]
   786   C0205494:Neurologic [Qualitative Concept]
   786   C0332285:Of [Spatial Concept]
   786   C0441833:Group [Idea or Concept]
   786   C0687744:group [Population Group]
   786   C1257890:Group [Population Group]
   786   C1272753:Institute [Idea or Concept]
   786   C1552516:Group [Health Care Related Organization]
   786   C1705428:Group [Conceptual Entity]
   786   C1705429:Group [Population Group]
   786   C3245503:national [Intellectual Product]
   730 E C0027763:Nervous System [Body System]
   730 E C0422837:NERVOUS SYSTEM [Finding]
   730 E C1269560:Nervous system [Body System]
   714 E C0027855:Neurology [Biomedical Occupation or Discipline]
   714 E C0679154:communicativeness [Social Behavior]

Phrase: "under the auspices"

Phrase: "of Department of Health and Human Services Task Force"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0162458:Task Force [Governmental or Regulatory Activity]
   793   C0441722:Force [Phenomenon or Process]
   793   C0563538:Force [Phenomenon or Process]
   793   C3540678:Task [Occupational Activity]
   756   C0041711:Department of Health and Human Services [Health Care Related Organization]
           department health human services
   737 E C0729333:Dynamic [Functional Concept]

Phrase: "on Alzheimer's Disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.257: Neurology 34:939944.[Abstract] Monfort JC, Javoy-Agid F, Hauw JJ, Dubois B, Agid Y (1985) Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index. 

Phrase: "Neurology 34"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: ":"

Phrase: "939944."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Monfort JC,"

Phrase: "Javoy-Agid F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Hauw JJ,"

Phrase: "Dubois B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "Agid Y (1985"

Phrase: ")"

Phrase: "Brain glutamate decarboxylase in Parkinson's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017785:Glutamate Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   753   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with particular reference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514811:Reference [Idea or Concept]
   861   C1706462:Reference [Conceptual Entity]

Phrase: "to a premortem severity index."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0439793:Severity [Qualitative Concept]
   827   C0918012:Index [Intellectual Product]
   827   C1552854:index [Idea or Concept]
   827   C1637833:% index [Quantitative Concept]
   827   C2983285:Severity [Intellectual Product]
   755 E C0205082:Severe [Qualitative Concept]
Processing 00000000.tx.258: Brain 108:301313.[Abstract] Mnch G, Schicktanz D, Behme A, Gerlach M, Riederer P, Palm D, Schinzel R (1999) Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT library. 

Phrase: "Brain 108"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "301313."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mnch G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Schicktanz D,"

Phrase: "Behme A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Gerlach M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Riederer P,"

Phrase: "Palm D,"

Phrase: "Schinzel R (1999"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "Amino acid specificity of glycation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "and"

Phrase: "protein-AGE crosslinking reactivities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   729   C0205332:Reactive [Qualitative Concept]

Phrase: "determined with a dipeptide SPOT library."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0012512:Dipeptide [Amino Acid, Peptide, or Protein]
   753   C0023621:Library [Manufactured Object,Organization]
   753   C0329155:Spot [Fish]
   753   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1427618:SPOT [Gene or Genome]
   753   C1705203:Spot [Conceptual Entity]
Processing 00000000.tx.259: Nat Biotechnol 17:10061010.[CrossRef][ISI][Medline] Mnch G, Lth HJ, Wong A, Arendt T, Hirsch E, Ravid R, Riederer P (2000) Crosslinking of alpha-synuclein by advanced glycation endproductsan early pathophysiological step in Lewy body formation? 

Phrase: "Nat Biotechnol 17"

Phrase: ":"

Phrase: "10061010."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mnch G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Lth HJ,"

Phrase: "Wong A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Arendt T,"

Phrase: "Hirsch E,"

Phrase: "Ravid R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Riederer P (2000"

Phrase: ")"

Phrase: "Crosslinking of alpha-synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0178576:crosslinking [Natural Phenomenon or Process]

Phrase: "by advanced glycation endproductsan early pathophysiological step in Lewy body formation?"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0220781:formation [Biologic Function]
   790   C0439634:formation [Spatial Concept]
   790   C1522492:Formation [Functional Concept]
Processing 00000000.tx.260: J Chem Neuroanat 20:253257.[CrossRef][ISI][Medline] Mnch G, Apelt J, Rosemarie Kientsch E, Stahl P, Lth HJ, Schliebs R (2003) Advanced glycation endproducts and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology. 

Phrase: "J Chem Neuroanat 20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "253257."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mnch G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Apelt J,"

Phrase: "Rosemarie Kientsch E,"

Phrase: "Stahl P,"

Phrase: "Lth HJ,"

Phrase: "Schliebs R (2003"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "Advanced glycation endproducts"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205179:Advanced [Qualitative Concept]
   827   C0598528:glycation [Phenomenon or Process]
   793 E C0725066:Advance [Medical Device]

Phrase: "and"

Phrase: "pro-inflammatory cytokines in transgenic Tg2576 mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "with amyloid plaque pathology."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]
   734   C0333463:amyloid plaque [Acquired Abnormality]
   734   C2936349:Plaque, Amyloid [Acquired Abnormality]
Processing 00000000.tx.261: J Neurochem 86:283289.[CrossRef][ISI][Medline] Nicholl ID, Stitt AW, Moore JE, Ritchie AJ, Archer DB, Bucala R (1998) Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. 

Phrase: "J Neurochem 86"

Phrase: ":"

Phrase: "283289."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nicholl ID,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: "Stitt AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "Moore JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "Ritchie AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Archer DB,"

Phrase: "Bucala R (1998"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "Increased levels of advanced glycation endproducts"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the lenses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0023318:Lenses [Medical Device]
   966 E C0023317:Lens [Body Part, Organ, or Organ Component]
   966 E C0996842:Lens [Plant]
   966 E C1278892:Lens [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "blood vessels of cigarette smokers."
Meta Candidates (Total=11; Excluded=9; Pruned=0; Remaining=2)
   806   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   773 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   773 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   735 E C1558950:VASCULAR [Finding]
   735 E C1801960:Vascular [Qualitative Concept]
   714 E C0005767:Blood [Tissue]
   714 E C0005768:blood [Body Substance]
   714 E C0229664:Blood [Body Substance]
   714 E C0392895:Bloods [Population Group]
Processing 00000000.tx.262: Mol Med 4:594601.[ISI][Medline] Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA (2001) Oxidative damage is the earliest event in Alzheimer disease. 

Phrase: "Mol Med 4"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "594601."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nunomura A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Perry G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Aliev G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Hirai K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Takeda A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Balraj EK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008415:EK [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Jones PK,"

Phrase: "Ghanbari H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Wataya T,"

Phrase: "Shimohama S,"

Phrase: "Chiba S,"

Phrase: "Atwood CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Petersen RB,"

Phrase: "Smith MA (2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0554249:Smith [Professional or Occupational Group]

Phrase: ")"

Phrase: "Oxidative damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]

Phrase: "is"

Phrase: "the earliest event in Alzheimer disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441471:Event [Event]
Processing 00000000.tx.263: J Neuropathol Exp Neurol 60:759767.[ISI][Medline] Otth C, Concha, II, Arendt T, Stieler J, Schliebs R, Gonzalez-Billault C, Maccioni RB (2002) AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. 

Phrase: "J Neuropathol Exp Neurol 60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "759767."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Otth C,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: "Concha,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0229316:Concha [Body Part, Organ, or Organ Component]

Phrase: "II,"

Phrase: "Arendt T,"

Phrase: "Stieler J,"

Phrase: "Schliebs R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gonzalez-Billault C,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0868928:Case [Functional Concept]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]

Phrase: "Maccioni RB (2002"

Phrase: ")"

Phrase: "AbetaPP"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576."
Processing 00000000.tx.264: J Alzheim Dis 4:417430. 

Phrase: "J Alzheim Dis 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0451119:DIS [Intellectual Product]
   812   C1444662:DIS [Finding]

Phrase: ":"

Phrase: "417430."
Processing 00000000.tx.265: Pei JJ, Braak H, An WL, Winblad B, Cowburn RF, Iqbal K, Grundke-Iqbal I (2002) Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease. 

Phrase: "Pei JJ,"

Phrase: "Braak H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "An WL,"

Phrase: "Winblad B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "Cowburn RF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0201660:RF [Laboratory Procedure]
   861   C0748398:RF [Finding]

Phrase: "Iqbal K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Grundke-Iqbal I (2002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "Up-regulation of mitogen-activated protein kinases ERK1/2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0041904:Up-Regulation [Cell Function,Molecular Function]
   764   C0162493:Up-Regulation [Genetic Function]
   742   C0547043:Up [Spatial Concept]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1282911:Up [Spatial Concept]
   742   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "MEK1/2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1150604:MEK1 [Molecular Function]
   861   C1334474:MEK1 [Gene or Genome]
   861   C1708799:MEK1 [Gene or Genome]

Phrase: "is"

Phrase: "associated with the progression of neurofibrillary degeneration"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0085400:Neurofibrillary degeneration [Acquired Abnormality]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0011164:Degeneration [Pathologic Function]
   748   C0242656:progression [Pathologic Function]
   748   C0449258:Progression [Functional Concept]
   748   C1880269:Degeneration [Functional Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.266: Brain Res Mol Brain Res 109:4555.[ISI][Medline] Perry G, Cash AD, Smith MA (2002) Alzheimer disease and oxidative stress. 

Phrase: "Brain Res Mol Brain Res 109"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   799   C0006104:Brain [Body Part, Organ, or Organ Component]
   799   C0027960:Mole [Neoplastic Process]
   799   C0324740:Mole [Mammal]
   799   C0439189:Mole [Quantitative Concept]
   799   C1269537:Brain [Body Part, Organ, or Organ Component]
   799   C1456781:mole [Neoplastic Process]
   799   C1824986:mol [Gene or Genome]
   799   C2347379:RES [Finding]
   716 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "4555."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Perry G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Cash AD,"

Phrase: "Smith MA (2002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0554249:Smith [Professional or Occupational Group]

Phrase: ")"

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.267: J Biomed Biotechnol 2:120123.[CrossRef][Medline] Portero-Otin M, Pamplona R, Bellmunt MJ, Ruiz MC, Prat J, Salvayre R, Negre-Salvayre A (2002) Advanced glycation end product precursors impair epidermal growth factor receptor signaling. 

Phrase: "J Biomed Biotechnol 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0332030:Biomed [Health Care Related Organization]

Phrase: ":"

Phrase: "120123."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Portero-Otin M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Pamplona R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bellmunt MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Ruiz MC,"

Phrase: "Prat J,"

Phrase: "Salvayre R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Negre-Salvayre A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(2002"

Phrase: ")"

Phrase: "Advanced glycation end product precursors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1709634:Precursor [Idea or Concept]

Phrase: "impair"

Phrase: "epidermal growth factor receptor signaling."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C1514762:Receptor Signaling [Molecular Function]
   804   C0037083:Signaling [Cell Function]
   804   C3537152:signaling [Biologic Function]
   771   C0034802:Epidermal Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   771   C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]
   717   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   717   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   717   C1323367:epidermal growth factor [Molecular Function]
Processing 00000000.tx.268: Diabetes 51:15351542.[Abstract/Free FullText] Pratico D, Clark CM, Liun F, Rokach J, Lee VY, Trojanowski JQ (2002) Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. 

Phrase: "Diabetes 51"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "15351542."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pratico D,"

Phrase: "Clark CM,"

Phrase: "Liun F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Rokach J,"

Phrase: "Lee VY,"

Phrase: "Trojanowski JQ"

Phrase: "(2002"

Phrase: ")"

Phrase: "Increase of brain oxidative stress"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0038435:Stress [Finding]
   760   C0311404:Oxidative [Functional Concept]
   760   C0442805:Increase [Functional Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   756   C0231298:Increased stress [Functional Concept]
   704 E C1517378:Gain [Quantitative Concept]

Phrase: "in mild cognitive impairment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1270972:Mild Cognitive Impairment [Mental or Behavioral Dysfunction]
   901   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   827   C0684336:Impairment [Pathologic Function]

Phrase: ":"

Phrase: "a possible predictor of Alzheimer disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2698872:Predictor [Idea or Concept]
Processing 00000000.tx.269: Arch Neurol 59:972976.[Abstract/Free FullText] Reber F, Geffarth R, Kasper M, Reichenbach A, Schleicher ED, Siegner A, Funk RH (2003) Graded sensitiveness of the various retinal neuron populations on the glyoxal-mediated formation of advanced glycation end products and ways of protection. 

Phrase: "Arch Neurol 59"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230467:arch [Body Location or Region]
   827   C0741204:ARCH [Body Space or Junction]

Phrase: ":"

Phrase: "972976."

Phrase: "[Abstract/Free FullText"

Phrase: "] Reber F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Geffarth R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kasper M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Reichenbach A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Schleicher ED,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "Siegner A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Funk RH (2003"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035493:Rh [Element, Ion, or Isotope]
   827   C2699077:Rh- [Classification]
   827   C2699078:Rh+ [Classification]

Phrase: ")"

Phrase: "Graded sensitiveness of the various retinal neuron populations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   731   C2350029:Sensitive Population [Population Group]

Phrase: "on the glyoxal-mediated formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "of advanced glycation end products"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "ways of protection."
Processing 00000000.tx.270: Graefes Arch Clin Exp Ophthalmol 241:213225.[ISI][Medline] Reddy VP, Obrenovich ME, Atwood CS, Perry G, Smith MA (2002) Involvement of Maillard reactions in Alzheimer disease. 

Phrase: "Graefes Arch Clin Exp Ophthalmol 241"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0230467:arch [Body Location or Region]
   799   C0741204:ARCH [Body Space or Junction]
   799   C1315013:CLIN [Intellectual Product]
   799   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "213225."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Reddy VP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883540:{VP} [Quantitative Concept]

Phrase: "Obrenovich"

Phrase: "ME,"

Phrase: "Atwood CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Perry G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Smith MA (2002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0554249:Smith [Professional or Occupational Group]

Phrase: ")"

Phrase: "Involvement of Maillard reactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involvement [Functional Concept]

Phrase: "in Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.271: Neurotox Res 4:191209.[CrossRef][Medline] Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH (2000) Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta. 

Phrase: "Neurotox Res 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "191209."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Reynolds CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]

Phrase: "Betts JC,"

Phrase: "Blackstock WP,"

Phrase: "Nebreda AR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986463:AR+ [Finding]

Phrase: "Anderton BH (2000"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0004684:BH [Geographic Area]
   827   C1412800:BH [Gene or Genome]
   827   C2986890:BH [Idea or Concept]

Phrase: ")"

Phrase: "Phosphorylation sites on tau"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C1519063:Phosphorylation Site [Amino Acid Sequence]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0205145:Sites [Spatial Concept]
   770   C1158886:Phosphorylation [Molecular Function]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "identified by nanoelectrospray mass spectrometry"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0037813:Mass Spectrometry [Laboratory Procedure]
   760   C0205396:Identified [Qualitative Concept]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0577559:Mass [Finding]
   760   C1306372:*Mass [Quantitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C3152252:Mass [Quantitative Concept]

Phrase: ":"

Phrase: "differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "in vitro between the mitogen-activated protein kinases ERK2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0021135:In Vitro [Intellectual Product]
   764   C1533691:in vitro [Qualitative Concept]
           vitro
   764   C2827718:In Vitro [Functional Concept]

Phrase: "c-Jun N-terminal kinase"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0248813:c-jun N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0380051:c-JUN N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1367731:JUN N-terminal kinase [Gene or Genome]
   911   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1334482:Jun kinase [Gene or Genome]
   875   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1707271:C-Terminal [Amino Acid Sequence]
   840   C0162508:c-Jun [Gene or Genome]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0205088:Terminal [Temporal Concept]
   804   C1553033:[c] [Quantitative Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "P38,"

Phrase: "and"

Phrase: "glycogen synthase kinase-3beta."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.272: J Neurochem 74:15871595.[CrossRef][ISI][Medline] Roth KA (2001) Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion. 

Phrase: "J Neurochem 74"

Phrase: ":"

Phrase: "15871595."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Roth KA (2001"

Phrase: ")"

Phrase: "Caspases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "causation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085978:Causation [Idea or Concept]
  1000   C1524003:Causation [Conceptual Entity]

Phrase: "correlation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "confusion."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009676:Confusion [Mental or Behavioral Dysfunction]
  1000   C1963086:Confusion [Finding]
   928 E C1547301:Confused [Intellectual Product]
Processing 00000000.tx.273: J Neuropathol Exp Neurol 60:829838.[ISI][Medline] Sasaki N, Fukatsu R, Tsuzuki K, Hayashi Y, Yoshida T, Fujii N, Koike T, Wakayama I, Yanagihara R, Garruto R, Amano N, Makita Z (1998) Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. 

Phrase: "J Neuropathol Exp Neurol 60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "829838."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sasaki N,"

Phrase: "Fukatsu R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Tsuzuki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hayashi Y,"

Phrase: "Yoshida T,"

Phrase: "Fujii N,"

Phrase: "Koike T,"

Phrase: "Wakayama I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Yanagihara R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Garruto R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Amano N,"

Phrase: "Makita Z (1998"

Phrase: ")"

Phrase: "Advanced glycation end products in Alzheimer's disease"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   853   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   774   C0679246:advanced disease [Finding]
   748   C0205179:Advanced [Qualitative Concept]
   748   C0444930:End [Spatial Concept]
   748   C0598528:glycation [Phenomenon or Process]
   748   C1514468:Products [Entity]
   748   C2746065:End [Temporal Concept]
   746   C0679247:Terminal Disease [Disease or Syndrome]
   714 E C0725066:Advance [Medical Device]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "other neurodegenerative diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.274: Am J Pathol 153:11491155.[Abstract/Free FullText] Sasaki N, Toki S, Chowei H, Saito T, Nakano N, Hayashi Y, Takeuchi M, Makita Z (2001) Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. 

Phrase: "Am"

Phrase: "J Pathol 153"

Phrase: ":"

Phrase: "11491155."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sasaki N,"

Phrase: "Toki S,"

Phrase: "Chowei H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Saito T,"

Phrase: "Nakano N,"

Phrase: "Hayashi Y,"

Phrase: "Takeuchi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Makita Z (2001"

Phrase: ")"

Phrase: "Immunohistochemical distribution of the receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "for advanced glycation end products"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "astrocytes in Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004112:Astrocytes [Cell]
Processing 00000000.tx.275: Brain Res 888:256262.[CrossRef][ISI][Medline] Sebekova K, Schinzel R, Ling H, Simm A, Xiang G, Gekle M, Mnch G, Vamvakas S, Heidland A (1998) Advanced glycated albumin impairs protein degradation in the kidney proximal tubules cell line LLC-PK1. 

Phrase: "Brain Res 888"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "256262."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sebekova K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Schinzel R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Ling H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Simm A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Xiang G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Gekle M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mnch G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Vamvakas S,"

Phrase: "Heidland A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1998"

Phrase: ")"

Phrase: "Advanced"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205179:Advanced [Qualitative Concept]
   966 E C0725066:Advance [Medical Device]

Phrase: "glycated albumin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0061700:Glycated albumin [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   861   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "impairs"

Phrase: "protein degradation in the kidney proximal tubules cell line LLC-PK1."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0597297:Protein Degradation [Molecular Function]
   756   C0597304:Protein Degradation [Molecular Function]
   756   C1623036:Protein Degradation [Molecular Function]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0243125:degradation [Functional Concept]
   738   C0699900:Degradation [Organism Function]
Processing 00000000.tx.276: Cell Mol Biol (Noisy-le-grand) 44:10511060. 

Phrase: "Cell Mol Biol (Noisy-le-grand"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   876   C0023172:cell le [Cell]
   799   C0439090:LE [Idea or Concept]
   799   C1423767:LE [Gene or Genome]
   727   C0028263:Noise [Phenomenon or Process]

Phrase: ")"

Phrase: "44"

Phrase: ":"

Phrase: "10511060."
Processing 00000000.tx.277: Smith MA, Taneda S, Richey PL, Miyata S, Yan SD, Stern D, Sayre LM, Monnier VM, Perry G (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. 

Phrase: "Smith MA,"

Phrase: "Taneda S,"

Phrase: "Richey PL,"

Phrase: "Miyata S,"

Phrase: "Yan SD,"

Phrase: "Stern D,"

Phrase: "Sayre LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Monnier VM,"

Phrase: "Perry G (1994"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Advanced Maillard reaction end products"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   804   C0444930:End [Spatial Concept]
   804   C1514468:Products [Entity]
   804   C2746065:End [Temporal Concept]
   771 E C1704444:Product [Quantitative Concept]
   748 E C0205088:Terminal [Temporal Concept]
   748 E C1705314:Terminal [Manufactured Object]
   748 E C1705315:Terminal [Spatial Concept]

Phrase: "are"

Phrase: "associated with Alzheimer disease pathology."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0243083:associated disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.278: Proc Natl Acad Sci USA 91:57105714.[Abstract] Smith MA, Sayre LM, Vitek MP, Monnier VM, Perry G (1995) Early AGEing and Alzheimer's. 

Phrase: "Proc Natl Acad Sci USA 91"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "57105714."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Smith MA,"

Phrase: "Sayre LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Vitek MP,"

Phrase: "Monnier VM,"

Phrase: "Perry G (1995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Early AGEing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "Alzheimer's."
Processing 00000000.tx.279: Nature 374:316.[Medline] Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G (1997) Widespread peroxynitrite mediated damage in Alzheimer's disease. 

Phrase: "Nature 374"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "316."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Smith MA,"

Phrase: "Richey Harris PL,"

Phrase: "Sayre LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "Beckman JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Perry G (1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Widespread peroxynitrite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "damage in Alzheimer's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010957:Damage [Injury or Poisoning]
   770   C1883709:Damage [Functional Concept]
Processing 00000000.tx.280: J Neurosci. 

Phrase: "J Neurosci."
Processing 00000000.tx.281: 17:26532657.[Abstract/Free FullText] Su JH, Zhao M, Anderson AJ, Srinivasan A, Cotman CW (2001) Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. 

Phrase: "17"

Phrase: ":"

Phrase: "26532657."

Phrase: "[Abstract/Free FullText"

Phrase: "] Su JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Zhao M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Anderson AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Srinivasan A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Cotman CW (2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0454665:CW [Geographic Area]

Phrase: ")"

Phrase: "Activated caspase-3 expression in Alzheimer's"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "aged control brain"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0243148:control [Qualitative Concept]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: ":"

Phrase: "correlation with Alzheimer pathology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707520:Correlation [Qualitative Concept]
Processing 00000000.tx.282: Brain Res 898:350357.[CrossRef][ISI][Medline] Takeda A, Wakai M, Niwa H, Dei R, Yamamoto M, Li M, Goto Y, Yasuda T, Nakagomi Y, Watanabe M, Inagaki T, Yasuda Y, Miyata T, Sobue G (2001) Neuronal and glial advanced glycation end product [Nepsilon-(carboxymethyl)lysine]] in Alzheimer's disease brains. 

Phrase: "Brain Res 898"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "350357."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Takeda A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Wakai M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Niwa H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Dei R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Yamamoto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Li M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Goto Y,"

Phrase: "Yasuda T,"

Phrase: "Nakagomi Y,"

Phrase: "Watanabe M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Inagaki T,"

Phrase: "Yasuda Y,"

Phrase: "Miyata T,"

Phrase: "Sobue G (2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "glial advanced glycation end product"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   804   C0205179:Advanced [Qualitative Concept]
   804   C0444930:End [Spatial Concept]
   804   C0598528:glycation [Phenomenon or Process]
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]
   804   C2746065:End [Temporal Concept]
   771 E C0725066:Advance [Medical Device]
   748 E C0205088:Terminal [Temporal Concept]
   748 E C1705314:Terminal [Manufactured Object]
   748 E C1705315:Terminal [Spatial Concept]

Phrase: "[Nepsilon-"

Phrase: "(carboxymethyl)lysine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0083528:carboxymethyl-lysine [Amino Acid, Peptide, or Protein]
   861   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "]"

Phrase: "]"

Phrase: "in Alzheimer's disease brains."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.283: Acta Neuropathol (Berl) 101:2735.[ISI][Medline] Takeuchi M, Watai T, Sasaki N, Choei H, Iwaki M, Ashizawa T, Inagaki Y, Yamagishi S, Kikuchi S, Riederer P, Saito T, Bucala R, Kameda Y (2003) Neurotoxicity of acetaldehyde-derived advanced glycation end products for cultured cortical neurons. 

Phrase: "Acta Neuropathol"

Phrase: "(Berl"

Phrase: ")"

Phrase: "101"

Phrase: ":"

Phrase: "2735."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Takeuchi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Watai T,"

Phrase: "Sasaki N,"

Phrase: "Choei H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Iwaki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ashizawa T,"

Phrase: "Inagaki Y,"

Phrase: "Yamagishi S,"

Phrase: "Kikuchi S,"

Phrase: "Riederer P,"

Phrase: "Saito T,"

Phrase: "Bucala R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kameda Y (2003"

Phrase: ")"

Phrase: "Neurotoxicity of acetaldehyde-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "advanced glycation end products for cultured cortical neurons."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   744   C0205179:Advanced [Qualitative Concept]
   744   C0444930:End [Spatial Concept]
   744   C0598528:glycation [Phenomenon or Process]
   744   C1514468:Products [Entity]
   744   C2746065:End [Temporal Concept]
   711 E C0725066:Advance [Medical Device]
   711 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.284: J Neuropathol Exp Neurol 62:486496.[ISI][Medline] Vander Jagt DL, Hunsaker LA (2003) Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase. 

Phrase: "J Neuropathol Exp Neurol 62"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "486496."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Vander Jagt DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3642216:/dL [Quantitative Concept]

Phrase: "Hunsaker LA (2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023031:La [Element, Ion, or Isotope]

Phrase: ")"

Phrase: "Methylglyoxal metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1156566:methylglyoxal metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "diabetic complications"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0342257:Diabetic Complications [Pathologic Function]
   861   C0009566:Complications [Pathologic Function]
   861   C1171258:complications [Pathologic Function]
   827 E C2362589:Complication [Idea or Concept]
   777 E C0231242:Complicated [Functional Concept]

Phrase: ":"

Phrase: "roles of aldose reductase,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "glyoxalase-I,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022956:Glyoxalase I [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415104:GLYOXALASE I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "betaine aldehyde dehydrogenase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0053517:Betaine-aldehyde dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0001985:Aldehyde Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0053516:betaine aldehyde [Organic Chemical]
   901   C0684287:aldehyde dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0001992:Aldehyde [Organic Chemical]
   827   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "2-oxoaldehyde dehydrogenase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0046489:2-Oxoaldehyde dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.285: Chem Biol Interact 143144:341351.[ISI] Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. 

Phrase: "Chem Biol"

Phrase: "Interact"

Phrase: "143144"

Phrase: ":"

Phrase: "341351."

Phrase: "[ISI] Vitek MP,"

Phrase: "Bhattacharya K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Glendening JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Stopa E,"

Phrase: "Vlassara H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Bucala R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Manogue K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Cerami A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1994"

Phrase: ")"

Phrase: "Advanced glycation end products"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "contribute to amyloidosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0002726:Amyloidosis [Disease or Syndrome]
   790   C1880177:Contribute [Activity]

Phrase: "in Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.286: Proc Natl Acad Sci USA 91:476670.[Abstract] Weber K, Schmahl W, Mnch G (1998) Distribution of advanced glycation end products in the cerebellar neurons of dogs. 

Phrase: "Proc Natl Acad Sci USA 91"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "476670."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Weber K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Schmahl W,"

Phrase: "Mnch G (1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Distribution of advanced glycation end products"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0680977:product distribution [Functional Concept]
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]

Phrase: "in the cerebellar neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0682702:Cerebellar neuron [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "of dogs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012984:Dogs [Mammal]
  1000   C1280551:Dogs [Mammal]
Processing 00000000.tx.287: Brain Res 791:1117.[CrossRef][ISI][Medline] Wong A, Lth HJ, Deuther-Conrad W, Dukic-Stefanovic S, Gasic-Milenkovic J, Arendt T, Mnch G (2001) Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease. 

Phrase: "Brain Res 791"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "1117."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wong A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Lth HJ,"

Phrase: "Deuther-Conrad W,"

Phrase: "Dukic-Stefanovic S,"

Phrase: "Gasic-Milenkovic J,"

Phrase: "Arendt T,"

Phrase: "Mnch G (2001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Advanced glycation endproducts"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205179:Advanced [Qualitative Concept]
   827   C0598528:glycation [Phenomenon or Process]
   793 E C0725066:Advance [Medical Device]

Phrase: "co-localize with inducible nitric oxide synthase"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   853   C0669372:Nitric Oxide Synthase, Inducible [Amino Acid, Peptide, or Protein,Enzyme]
           Inducible NOS
   853   C1417760:NITRIC OXIDE SYNTHASE, INDUCIBLE [Gene or Genome]
   853   C1533698:Inducible Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0132555:Nitric Oxide Synthase [Amino Acid, Peptide, or Protein,Enzyme]
           synthase
   778   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   748   C0030015:oxide [Inorganic Chemical]
   748   C0205263:Inducible [Functional Concept]
   748   C0392752:localize [Spatial Concept]
   748   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.288: Brain Res 920:3240.[CrossRef][ISI][Medline] Zhu X, Rottkamp CA, Boux H, Takeda A, Perry G, Smith MA (2000) Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. 

Phrase: "Brain Res 920"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "3240."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zhu X,"

Phrase: "Rottkamp CA,"

Phrase: "Boux H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Takeda A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Perry G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Smith MA (2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0554249:Smith [Professional or Occupational Group]

Phrase: ")"

Phrase: "Activation of p38 kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "links"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "tau phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "cell cycle-related events in Alzheimer disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1511572:event cycle [Temporal Concept]
   748   C0441471:Events [Event]
   748   C3541888:Events [Classification]
Processing 00000000.tx.289: J Neuropathol Exp Neurol 59:880888.[ISI][Medline] This Article Abstract FREE Full Text (PDF) All Versions of this Article: 15/2/211 most recent bhh123v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (1) Request Permissions Google Scholar Articles by Lth, H.-J. 

Phrase: "J Neuropathol Exp Neurol 59"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "880888."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "This Article Abstract FREE Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1527021:Text [Intellectual Product]
   804   C1554111:Text [Idea or Concept]
   804   C1705606:Text [Intellectual Product]
   804   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "15/2/211 most recent bhh123v1"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0557854:Services [Occupational Activity]
   966 E C2825316:Service [Manufactured Object]
   966 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in ISI Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282111:Web [Manufactured Object]

Phrase: "of Science Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]
   748   C0205314:New [Temporal Concept]
   714   C0033213:Issue [Finding]
   714   C1706387:Issue [Intellectual Product]

Phrase: "Add to My Personal Archive Download"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003738:archive [Manufactured Object]
   753   C0024552:MY [Geographic Area]
   753   C1519021:Personal [Organism Attribute]
   753   C1554162:Archive [Idea or Concept]
   753   C1883712:Add [Functional Concept]

Phrase: "to citation manager Search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552603:search [Intellectual Product]
   827   C1706202:Search [Activity]

Phrase: "for citing articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706852:Article [Intellectual Product]

Phrase: "in"

Phrase: ":"

Phrase: "ISI Web of Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282111:Web [Manufactured Object]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "Request Permissions Google Scholar Articles by Lth,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1706852:Article [Intellectual Product]

Phrase: "H.-J."
Processing 00000000.tx.290: Articles by Mnch, G. 

Phrase: "Articles by Mnch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.291: PubMed PubMed Citation Articles by Lth, H.-J. 

Phrase: "PubMed PubMed Citation Articles by Lth,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "H.-J."
Processing 00000000.tx.292: Articles by Mnch, G. 

Phrase: "Articles by Mnch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.293: Online ISSN 1460-2199 - Print ISSN 1047-3211 Copyright  2006 Oxford University Press Oxford Journals Oxford University Press Site Map Privacy Policy Frequently Asked Questions Other Oxford University Press sites: Oxford University Press American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics

Phrase: "Online ISSN 1460-2199 - Print ISSN 1047-3211 Copyright  2006 Oxford University Press Oxford Journals Oxford University Press Site Map Privacy Policy Frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C2735290:Privacy policy [Intellectual Product]
   782   C0242456:Policy [Intellectual Product]

Phrase: "Asked"

Phrase: "Questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "Other Oxford University Press sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: ":"

Phrase: "Oxford University Press American National Biography Booksellers' Information Service Children's Fiction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0887933:fiction [Intellectual Product]

Phrase: "and"

Phrase: "Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary"

Phrase: "of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   852   C0947619:Finger.right [Body Part, Organ, or Organ Component]
   782   C0035621:Rights [Qualitative Concept]
   782   C0205090:Right [Spatial Concept]

Phrase: "and"

Phrase: "Permissions Science School Books Social Sciences Very Short Introductions World's Classics"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   788   C0439658:classics [Qualitative Concept]
   755 E C0439858:Classic [Qualitative Concept]

